<SEC-DOCUMENT>0001520138-21-000754.txt : 20211201
<SEC-HEADER>0001520138-21-000754.hdr.sgml : 20211201
<ACCEPTANCE-DATETIME>20211201091548
ACCESSION NUMBER:		0001520138-21-000754
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20211130
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20211201
DATE AS OF CHANGE:		20211201

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOVIE INC.
		CENTRAL INDEX KEY:			0001580149
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				462510769
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39015
		FILM NUMBER:		211461585

	BUSINESS ADDRESS:	
		STREET 1:		2120 COLORADO AVE.
		STREET 2:		SUITE 230
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90404
		BUSINESS PHONE:		310-444-4300

	MAIL ADDRESS:	
		STREET 1:		2120 COLORADO AVE.
		STREET 2:		SUITE 230
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NANOANTIBIOTICS, INC.
		DATE OF NAME CHANGE:	20130625
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bivi-20211130_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:bivi="http://nanoantibiotics.com/20211130">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_030_bivi_nanoantibiotics.com_20211130 -->
<!-- Field: Set; Name: xdx; ID: xdx_047_20211130_20211130 -->
<!-- Field: Set; Name: xdx; ID: xdx_05D_edei%2D%2DEntityCentralIndexKey_0001580149 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-11-30to2021-11-30" name="dei:EntityCentralIndexKey">0001580149</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-11-30to2021-11-30" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="bivi-20211130.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-11-30to2021-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001580149</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-30</xbrli:startDate>
        <xbrli:endDate>2021-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 4pt solid; font-size: 1pt; border-bottom: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: center"><span style="font: 12pt Times New Roman, Times, Serif"><b>UNITED STATES<br /> SECURITIES AND EXCHANGE COMMISSION</b></span><b><span style="font: 10pt Times New Roman, Times, Serif"><br />
WASHINGTON, D.C. 20549</span></b></p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: center"><span style="font: 12pt Times New Roman, Times, Serif"><b>FORM
<span id="xdx_90B_edei--DocumentType_c20211130__20211130_zqu05PVzNm8a"><ix:nonNumeric contextRef="From2021-11-30to2021-11-30" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.75pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>CURRENT
REPORT PURSUANT<br />
TO SECTION 13 OR 15(d) OF<br />
THE SECURITIES EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Date
of Report (Date of earliest event reported) <b><span id="xdx_900_edei--DocumentPeriodEndDate_c20211130__20211130_zKy61huFc9Yc"><ix:nonNumeric contextRef="From2021-11-30to2021-11-30" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">November 30, 2021</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: center"><span style="font: 18pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline"><span id="xdx_904_edei--EntityRegistrantName_c20211130__20211130_zvWKyi7nWYne"><ix:nonNumeric contextRef="From2021-11-30to2021-11-30" name="dei:EntityRegistrantName">BioVie Inc.</ix:nonNumeric></span></span></b></span><b><span style="text-decoration: underline"><span style="font: 10pt Times New Roman, Times, Serif"><br />
</span></span></b><span style="font: 10pt Times New Roman, Times, Serif">(Exact Name of Registrant as Specified in Its Charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 34%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_905_edei--EntityIncorporationStateCountryCode_c20211130__20211130_zaJ7ASvUPHrg"><ix:nonNumeric contextRef="From2021-11-30to2021-11-30" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 33%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_902_edei--EntityFileNumber_c20211130__20211130_zNJsr4nXxMa5"><ix:nonNumeric contextRef="From2021-11-30to2021-11-30" name="dei:EntityFileNumber">000-55292</ix:nonNumeric></span></b></span></td>
    <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 33%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_900_edei--EntityTaxIdentificationNumber_c20211130__20211130_zx6ZajfEJ8Vk"><ix:nonNumeric contextRef="From2021-11-30to2021-11-30" name="dei:EntityTaxIdentificationNumber">46-2510769</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State
    or Other Jurisdiction<br />
    of Incorporation)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Commission
    File Number)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(I.R.S.
    Employer Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 34%"><span id="xdx_909_edei--EntityAddressAddressLine1_c20211130__20211130_zAWH04GT2Ty6" style="font: 10pt Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="From2021-11-30to2021-11-30" name="dei:EntityAddressAddressLine1">9120
Double Diamond Parkway</ix:nonNumeric></b></span><b><span style="font: 10pt Times New Roman, Times, Serif">, <span id="xdx_90F_edei--EntityAddressAddressLine2_c20211130__20211130_zII2W3umFrG5"><ix:nonNumeric contextRef="From2021-11-30to2021-11-30" name="dei:EntityAddressAddressLine2">Suite 1400</ix:nonNumeric> </span><span id="xdx_90C_edei--EntityAddressCityOrTown_c20211130__20211130_zEQsSn2DRMV9"><ix:nonNumeric contextRef="From2021-11-30to2021-11-30" name="dei:EntityAddressCityOrTown">Reno</ix:nonNumeric></span>, </span></b><b><span id="xdx_90A_edei--EntityAddressStateOrProvince_c20211130__20211130_z3bAHa6IJzKd" style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2021-11-30to2021-11-30" name="dei:EntityAddressStateOrProvince">NV</ix:nonNumeric></span></b></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 33%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 33%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90D_edei--EntityAddressPostalZipCode_c20211130__20211130_zLcbHPaPYfpj"><ix:nonNumeric contextRef="From2021-11-30to2021-11-30" name="dei:EntityAddressPostalZipCode">89521</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Address
    of Principal Executive Offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Zip
    Code)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_908_edei--CityAreaCode_c20211130__20211130_zM5ac3l3JKa7"><ix:nonNumeric contextRef="From2021-11-30to2021-11-30" name="dei:CityAreaCode">(775)</ix:nonNumeric></span>
<span id="xdx_908_edei--LocalPhoneNumber_c20211130__20211130_zvF6lFtFkdF1"><ix:nonNumeric contextRef="From2021-11-30to2021-11-30" name="dei:LocalPhoneNumber">888-3162</ix:nonNumeric> </span><span style="text-decoration: underline"><br />
</span></b>(Registrant&#146;s Telephone Number, Including Area Code)</span></p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-top: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt; text-align: center; width: 100%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Former
Name or Former Address, if Changed Since Last Report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Title
    of each class</span></td>
    <td style="border-top: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 24%; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Trading
    Symbol(s)</span></td>
    <td style="border-top: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Name
    of each exchange on which<br />
    registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-right: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_edei--Security12bTitle_c20211130__20211130_zEQQKPsDTRa7"><ix:nonNumeric contextRef="From2021-11-30to2021-11-30" name="dei:Security12bTitle">Class
    A Common Stock, par value $0.0001 per share</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_edei--TradingSymbol_c20211130__20211130_z4u2mMp4Yuqd"><ix:nonNumeric contextRef="From2021-11-30to2021-11-30" name="dei:TradingSymbol">BIVI</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The <span id="xdx_909_edei--SecurityExchangeName_c20211130__20211130_zREr1ntCEgw9"><ix:nonNumeric contextRef="From2021-11-30to2021-11-30" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market, LLC</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.3in; text-align: left"><span id="xdx_901_edei--WrittenCommunications_c20211130__20211130_zINN24v6McUh"><ix:nonNumeric contextRef="From2021-11-30to2021-11-30" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></td><td><span style="font: 10pt Times New Roman, Times, Serif">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.3in; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_edei--SolicitingMaterial_c20211130__20211130_zoybmca91GGk"><ix:nonNumeric contextRef="From2021-11-30to2021-11-30" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td><td><span style="font: 10pt Times New Roman, Times, Serif">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.3in; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90B_edei--PreCommencementTenderOffer_c20211130__20211130_zLrYQmj07D6d"><ix:nonNumeric contextRef="From2021-11-30to2021-11-30" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.3in; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_edei--PreCommencementIssuerTenderOffer_c20211130__20211130_zbypO7fXRSz1"><ix:nonNumeric contextRef="From2021-11-30to2021-11-30" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933
(&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">Emerging
growth company <span id="xdx_900_edei--EntityEmergingGrowthCompany_c20211130__20211130_zTtXMVUOgMSh"><ix:nonNumeric contextRef="From2021-11-30to2021-11-30" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 4pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 0pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Item&#160;1.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 90%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Entry
    into a Material Definitive Agreement.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Loan
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 30, 2021 (the &#8220;Closing Date&#8221;), BioVie Inc. (the &#8220;Company&#8221;) entered into a Loan and Security
Agreement and the Supplement to the Loan and Security Agreement (together, the &#8220;Loan Agreement&#8221;) with Avenue Venture
Opportunities Fund II, L.P. (&#8220;AVOPII&#8221;) and Avenue Venture Opportunities Fund, L.P. (&#8220;AVOPI&#8221; and, together
with AVOPII, the &#8220;Lenders,&#8221;) for growth capital loans in an aggregate principal amount of up to $20,000,000 (the
&#8220;Loan&#8221;), with (i) $15,000,000 funded on the Closing Date (&#8220;Tranche 1&#8221;) and (ii) up to $5,000,000 to be made
available to the Company on or prior to September 15, 2022, subject to the Company&#8217;s achievement of certain milestones with
respect to certain of its ongoing clinical trials (&#8220;Tranche 2&#8221;). The Loan bears interest at an annual rate equal to the
greater of (a)&#160;the sum of 7.00% plus the prime rate as reported in The Wall Street Journal and (b) 10.75%. The Loan is secured
by a lien upon and security interest in all of the Company&#8217;s assets, including intellectual property, subject to agreed
exceptions. The maturity date of the Loan is December&#160;1, 2024. The Company may, at its discretion, request an additional growth
capital loan in an amount equal to $5,000,000 (i) upon the Company&#8217;s achievement of additional milestones with respect to
certain of its ongoing clinical trials (ii) upon the mutual written agreement of the Company and the Lenders each acting in its sole
discretion, and (iii) subject to execution and delivery by the Company and the Lenders of amendments to the loan documents and the
Warrant (as defined below) to reflect such additional loan and approval of each Lender&#8217;s investment committee (&#8220;Tranche
3&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Up to $5,000,000 of the principal amount of the
Loan outstanding may be converted, at the option of the Lenders, into shares of the Company&#8217;s Class A common stock at a conversion
price of $6.98 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Pursuant to the Supplement to the Loan Agreement,
the Company paid an aggregate commitment fee of $200,000 and will make monthly interest-only payments during the first eighteen months
of the term of the Loan, which may be increased up to an additional six months from the end of such eighteen month period prior to receipt
of the Tranche 2 Loan. Following the interest-only period, the Company will make equal monthly payments of principal, plus accrued interest,
until the Loan&#8217;s maturity date when all remaining principal and accrued interest must be paid. If the Company prepays the Loan,
it will be required to pay (a)&#160;a prepayment fee in an amount equal to 3.0% of the principal amount of the Loan that is prepaid during
the interest-only period; and (b)&#160;a prepayment fee in an amount equal to 1.0% of the principal amount of the Loan that is prepaid
after the interest-only period. On the Loan&#8217;s maturity date, or on the date of the prepayment of the Loan, the Company must also
make a final payment equal to 4.25% of the sum of (a) the Loan amount funded under Tranche 1 and Tranche 2, plus (b) the aggregate principal
amount of additional growth capital loans borrowed under Tranche 3.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">The Loan Agreement contains certain representations
and warranties by the Company and other agreements that are customary in loan agreements of this type. The Loan Agreement also contains
customary events of default, including&#160;non-payment&#160;of principal or interest, violations of covenants, bankruptcy and material
judgments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">The Company intends to use the proceeds of the
Loan for general corporate purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Loan, pursuant to the funding of Tranche 1 on the Closing Date, the Company issued to the Lenders warrants to purchase
360,824 shares of Class A common stock of the Company (the &#8220;Warrants&#8221;) at an exercise price per share equal to $5.82 (the
&#8220;Stock Purchase Price&#8221;). The warrants, which are exercisable until November 30, 2026 (the &#8220;Expiration Date&#8221;),
were offered and sold by the Company in reliance on the exemption from registration provided by Section&#160;4(a)(2) of the Securities
Act of 1933, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Lenders may exercise the Warrants at any time, or from time to time
up to and including the Expiration Date, by making a cash payment equal to the exercise price multiplied by the quantity of shares. The
Lenders may also exercise the Warrants on a cashless or &#8220;net issuance&#8221; basis by receiving a net number of shares calculated
pursuant to the formula set forth in the Warrants. The Warrants are subject to anti-dilution adjustments for stock dividends, stock splits,
and reverse stock splits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">The foregoing descriptions of the Loan and Security
Agreement, the Supplement to the Loan and Security Agreement and the Warrant do not purport to be complete and are qualified in their
entirety by the full text of the Loan and Security Agreement, the Supplement to the Loan and Security Agreement and the Warrant, which
are attached as Exhibits 10.1, 10.2 and 10.3, respectively, to this Current Report on&#160;Form&#160;8-K&#160;and&#160;are incorporated
herein by reference.</p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Item
    2.03</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Creation
    of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">The
disclosure concerning the Loan set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Item
    3.02</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Unregistered
    Sales of Equity Securities.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">The
disclosure concerning the Warrant set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Item
    7.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Regulation
    FD Disclosure.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">On
December 1, 2021, the Company issued a press release announcing the completion of the Loan as described in more detail in Item 1.01
of this Current Report on Form 8-K. The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">The
information furnished in this Item 7.01, including Exhibit 99.1, shall not be deemed to be &#147;filed&#148; for purposes of Section
18 of the Securities Exchange Act of 1934 (the &#147;Exchange Act&#148;), as amended, or otherwise subject to the liabilities of that
section, and shall not be deemed to be incorporated by reference into any filing made by the Company under the Exchange Act or the Securities
Act, regardless of any general incorporation language in any such filings, except as shall be expressly set forth by specific reference
in such a filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Item
    9.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">Financial
    Statements and Exhibits</span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(a)
Exhibits</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 87%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="bivi-20211130_8kex10z1.htm"><span style="font: 10pt Times New Roman, Times, Serif">10.1</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="bivi-20211130_8kex10z1.htm"><span style="font: 10pt Times New Roman, Times, Serif">Loan and Security Agreement, dated November 30, 2021, among BioVie Inc. Avenue Venture Opportunities Fund II, L.P., and Avenue Venture Opportunities Fund, L.P.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="bivi-20211130_8kex10z2.htm"><span style="font: 10pt Times New Roman, Times, Serif">10.2</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="bivi-20211130_8kex10z2.htm"><span style="font: 10pt Times New Roman, Times, Serif">Supplement to Loan and Security Agreement, dated November 30, 2021, among BioVie Inc., Avenue Venture Opportunities Fund II, L.P. and Avenue Venture Opportunities Fund, L.P.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="bivi-20211130_8kex10z3.htm">10.3</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><a href="bivi-20211130_8kex10z3.htm">Form of Warrant to Purchase Shares of Class A Common Stock of BioVie Inc.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="bivi-20211130_8kex99z1.htm"><span style="font: 10pt Times New Roman, Times, Serif">99.1</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="bivi-20211130_8kex99z1.htm"><span style="font: 10pt Times New Roman, Times, Serif">Press
    Release, dated December 1, 2021.</span></a></td></tr>
  </table>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>SIGNATURE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Dated:
December 1, 2021</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>BIOVIE
    INC.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 51%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 38%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 6%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">/s/
    Joanne Wendy Kim</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">Name:&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">Joanne
    Wendy Kim</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">Chief
    Financial Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<!-- Field: Page; Sequence: 4 -->
<div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
<!-- Field: /Page -->

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjUEKwjAQRU/QOwxZS02q3XRpURGrSBFxG+0owTZTJrHqkbylsUUcBobh//e/ECOxpIWpkeE4KwvYY9PW2iOUeEFGe8bgyFfrDMIt8WqcZ219//7AnAKDgUljJU9B6K2dcVhloNR4IseJAplm6RR2GxF99ZzsxVRovdE1aFvBjqllg17za0jY6ydZal591QHZGbIhLpaD/IZEqgS21OkH8c1BUeQiGvUTiSXTvf3W3J2nBuY1NqHLDeh/ow8UeUlE -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>bivi-20211130_8kex10z1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Execution
Copy</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOAN
AND SECURITY AGREEMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated
as of November 30, 2021</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">between</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BIOVIE
INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
Nevada corporation,</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
&#147;<U>Borrower</U>&#148;,</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AVENUE
VENTURE OPPORTUNITIES FUND II, L.P.,</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
Delaware limited partnership (&#147;<U>AVOF 2</U>&#148;),</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
a lender</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AVENUE
VENTURE OPPORTUNITIES FUND, L.P.,</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
Delaware limited partnership (&#147;<U>Avenue</U>&#147;)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
administrative agent and collateral agent (in such capacity &#147;<U>Agent</U>&#148;)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
as a lender (in such capacity, together with AVOF 2, a &#147;<U>Lender</U>&#148; and collectively, the &#147;<U>Lenders</U>&#148;)</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOAN
AND SECURITY AGREEMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Loan and Security Agreement dated as of November 30, 2021 is by and between Borrower (as defined in the Supplement (as defined below)),
Agent (as defined in the Supplement (as defined below)) and Lender (as defined in the Supplement (as defined below)) (as amended, amended
and restated, supplemented, or otherwise modified from time to time, the &#147;<B><U>Loan Agreement</U></B>&#148;) pursuant to which
Lender agrees to make available to Borrower a loan facility governed by the terms and conditions set forth in this Loan Agreement and
one or more Supplements executed by Borrower and Lender which incorporate this Loan Agreement by reference. Each Supplement constitutes
a supplement to and forms part of this Loan Agreement, and will be read and construed as one with this Loan Agreement, so that this Loan
Agreement and any Supplement constitute a single agreement between the parties (this Loan Agreement and the Supplement, each as amended,
amended and restated, supplemented, or otherwise modified from time to time are collectively referred to as this <B>&#147;<U>Agreement</U>&#148;</B>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
the parties agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<DIV STYLE="float:LEFT; width:48%">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
1 - </B>INTERPRETATION</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Definitions.
</B>The terms defined in Article 11 and in the Supplement will have the meanings therein specified for purposes of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inconsistency.
</B>In the event of any inconsistency between the provisions of any Supplement and this Loan Agreement, the provisions of the Supplement
will be controlling for the purpose of all relevant transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
2 - </B>THE COMMITMENT AND LOANS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Commitment</B>. Subject to the terms and conditions of this Agreement, each Lender agrees to make term loans to Borrower from time to
time from the Closing Date and to and including the Termination Date in an aggregate principal amount not exceeding the Commitment. The
Commitment is not a revolving credit commitment, and Borrower does not have the right to reborrow Loans repaid hereunder. Each Loan requested
by Borrower to be made on a single Business Day shall be for a minimum principal amount set forth in the Supplement, except to the extent
the remaining Commitment is a lesser amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notes
Evidencing Loans; Repayment</B>. Each Loan shall be evidenced by a separate Note payable to the order of each Lender, in the total principal
amount of such Lender&#146;s pro rata share of the Loan. Principal and interest of each Loan shall be payable at the times and in the
manner set forth in the Note and regularly scheduled payments thereof shall be effected by automatic debit of the appropriate funds from
Borrower&#146;s Primary Operating Account as specified in the Supplement hereto. Repayment of the Loans and payment of all other amounts
owed to each Lender will be paid by Borrower in the currency in which the same has been provided (i.e., United States Dollars).</FONT></P>

</DIV>
<DIV STYLE="float:right; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Procedures
for Borrowing</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>At
least five (5) Business Days prior to a proposed Borrowing Date following the Closing Date (or such lesser period of time as may be agreed
upon by Lender in its sole discretion), each Lender participating in the Loan shall have received from Borrower a written request for
a borrowing hereunder (a <B>&#147;<U>Borrowing Request</U>&#148;</B>). Each Borrowing Request shall be in substantially the form of
<U>Exhibit &#147;B&#148;</U> to the Supplement, shall be executed by a responsible executive or financial officer of Borrower, and
shall state how much is requested, and shall be accompanied by such other information and documentation as Lenders may reasonably request,
including the executed Note(s) for the Loan(s) covered by the Borrowing Request. Notwithstanding the foregoing, the Borrowing Request
with respect to the initial borrowing on the Closing Date shall be due no later than 1:00 p.m. Pacific Standard Time one (1) Business
Day prior to the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>No
later than 1:00 p.m. Pacific Standard Time on the Borrowing Date, if Borrower has satisfied the conditions precedent in Article 4 by
9:00 a.m. Pacific Standard Time on such Borrowing Date, each Lender shall make its pro rata share of the Loan available to Borrower in
immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest</B>.
Except as otherwise specified in the applicable Note and/or Supplement, Basic Interest on the outstanding principal balance of each Loan
shall accrue daily at the Designated Rate from the Borrowing Date. If the outstanding principal balance of such Loan is not paid at maturity,
interest shall accrue at the Default Rate until paid in full, as further set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intentionally
Omitted</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest
Rate Calculation</B>. Basic Interest, along with charges and fees under this Agreement and any </FONT></P>

</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan Document, shall be calculated for
actual days elapsed on the basis of a 360-day year, which results in higher interest, charge or fee payments than if a 365-day year were
used. In no event shall Borrower be obligated to pay Lenders interest, charges or fees at a rate in excess of the highest rate permitted
by applicable law from time to time in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Default
Interest</B>. Any Obligations that are not paid when due and payable hereunder (after giving effect to any applicable grace periods)
shall bear interest from their respective maturities, whether scheduled or accelerated, at the Default Rate, compounded monthly. Borrower
shall pay such interest on demand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Late
Charges.</B> If Borrower is late in making any scheduled payment in respect of the Obligations by more than five (5) days, then Borrower
agrees to pay a late charge of five percent (5%) of the payment due, but not less than $50.00 for any one such delinquent payment. This
late charge may be charged by Lenders for the purpose of defraying the expenses incidental to the handling of such delinquent amounts.
Borrower acknowledges that such late charge represents a reasonable sum considering all of the circumstances existing on the date of
this Agreement and represents a fair and reasonable estimate of the costs that will be sustained by Lenders due to the failure of Borrower
to make timely payments. Borrower further agrees that proof of actual damages would be costly and inconvenient. Such late charge shall
be paid without prejudice to the right of Lenders and Agent to collect any other amounts provided to be paid or to declare a default
under this Agreement or any of the other Loan Documents or from exercising any other rights and remedies of Agent or Lenders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lender&#146;s
Records</B>. Principal, Basic Interest and all other sums owed under any Loan Document shall be evidenced by entries in records maintained
by each Lender for such purpose. Each payment on and any other credits with respect to principal, Basic Interest and all other sums outstanding
under any Loan Document shall be evidenced by entries in such records. Absent manifest error, Lenders&#146; records shall be conclusive
evidence thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Grant
of Security Interests; Filing of Financing Statements. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>To
secure the timely payment and performance of all of Borrower&#146;s Obligations, Borrower hereby grants Agent, for the ratable benefit
of Lenders. continuing security interests in all of the Collateral. In connection with the foregoing, Borrower authorizes Agent to prepare
and file any financing statements describing
the Collateral</FONT></P>

</DIV>
<DIV STYLE="float:right; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> without otherwise obtaining Borrower&#146;s signature or consent with respect to the filing of such financing statements.
Such financing statements may indicate the Collateral as &#147;all assets of the Debtor&#148; or words of similar effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>In
furtherance of Borrower&#146;s grant of the security interests in the Collateral pursuant to Section 2.10(a) above, Borrower hereby
pledges and grants to Agent, for the ratable benefit of Lenders, a security interest in all the Shares, together with all proceeds and
substitutions thereof, all cash, stock and other moneys and property paid thereon, all rights to subscribe for securities declared or
granted in connection therewith, and all other cash and noncash proceeds of the foregoing, as security for the performance of the Obligations.
On the Closing Date or at any time thereafter following Agent&#146;s request, the certificate or certificates for the Shares will be
delivered to Agent, accompanied by an instrument of assignment duly executed in blank by Borrower, unless such Shares have not been certificated.
To the extent required by the terms and conditions governing the Shares, Borrower shall cause the books of each entity whose Shares are
part of the Collateral and any transfer agent to reflect the pledge of the Shares. Upon the occurrence and during the continuance of
an Event of Default hereunder, Agent may effect the transfer of any securities included in the Collateral (including but not limited
to the Shares) into the name of Agent and cause new certificates representing such securities to be issued in the name of Agent or its
transferee(s). Borrower will execute and deliver such documents, and take or cause to be taken such actions, as Agent may reasonably
request to perfect or continue the perfection of Agent&#146;s security interest in the Shares. Except as provided in the following sentence,
Borrower shall be entitled to exercise any voting rights with respect to the Shares and to give consents, waivers and ratifications in
respect thereof, provided that no vote shall be cast or consent, waiver or ratification given or action taken which would constitute
a violation of any of the terms of this Agreement. All such rights to vote and give consents, waivers and ratifications shall terminate
upon the occurrence and continuance of an Event of Default and Agent&#146;s written notice to Borrower of Agent&#146;s intent to exercise
its rights and remedies under this Agreement, including this Section 2.10(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Borrower
is and shall remain absolutely and unconditionally liable for the performance of its Obligations, including, without limitation, any
deficiency by reason of the failure of the Collateral to satisfy all amounts due to each Lender under any of the Loan Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>All
Collateral pledged by Borrower under this Agreement and any Supplement shall secure the timely</FONT></P>

</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">timely payment and performance of all Obligations.
Except as expressly provided in this Agreement, no Collateral pledged under this Agreement or any Supplement shall be released (other
than the sale or distribution of Collateral in the ordinary course of business and as otherwise permitted hereunder) until such time
as all Obligations have been satisfied and paid in full (other than inchoate indemnity obligations).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
3 - </B>REPRESENTATIONS AND WARRANTIES</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrower
represents and warrants as of the Closing Date and each Borrowing Date, that, except as set forth in any Supplement or the Disclosure
Letter, if any:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Due
Organization</B>. Borrower is a corporation duly organized and validly existing in good standing under the laws of the jurisdiction of
its incorporation, and is duly qualified to conduct business and is in good standing in each other jurisdiction in which its business
is conducted or its properties are located, except where the failure to be so qualified would not reasonably be expected to have a Material
Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Authorization,
Validity and Enforceability</B>. The execution, delivery and performance of all Loan Documents executed by Borrower are within Borrower&#146;s
powers, have been duly authorized, and are not in conflict with Borrower&#146;s certificate of incorporation or by-laws, or the terms
of any charter or other organizational document of Borrower, as amended from time to time; and all such Loan Documents constitute valid
and binding obligations of Borrower, enforceable in accordance with their terms (except as may be limited by bankruptcy, insolvency and
similar laws affecting the enforcement of creditors&#146; rights in general, and subject to general principles of equity).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compliance
with Applicable Laws</B>. Borrower has complied with all applicable licensing, permit and fictitious name requirements necessary to lawfully
conduct the business in which it is engaged, and to any sales, leases or the furnishing of services by Borrower, including without limitation
those requiring consumer or other disclosures, the noncompliance with which would have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Conflict</B>. The execution, delivery, and performance by Borrower of all Loan Documents are not in conflict with any applicable law, rule, regulation, order or directive, or any indenture, agreement, or undertaking to which Borrower is a party or by which Borrower may be bound or affected and to the extent that such conflict would reasonably be expected to have a Material Adverse Effect.  Without limiting the generality of the foregoing, </FONT></P>

</DIV>
<DIV STYLE="float:right; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the issuance of the Warrant and the grant of registration
rights in connection therewith do not violate any agreement or instrument by which Borrower is bound or require the consent of any holders
of Borrower&#146;s securities other than consents which have been obtained prior to the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Litigation, Claims or Proceedings</B>. There is no litigation, tax claim, proceeding or dispute pending, or, to the knowledge of Borrower,
threatened against or affecting Borrower, its property or the conduct of its business that, individually or in the aggregate, would reasonably
be expected to result in liability or damages to Borrower in excess of the Threshold Amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Correctness
of Financial Statements</B>. Borrower&#146;s financial statements (other than any projections which are subject to significant uncertainties
and contingencies) which have been delivered to Agent for distribution to Lenders fairly and accurately, in all material respects, reflect
Borrower&#146;s financial condition in accordance with GAAP as of the latest date of such financial statements; and, since that date
there has been no Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Subsidiaries</B>. As of the Closing Date, Borrower is not a majority owner of any Subsidiary or in a control relationship with any other
business entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Environmental
Matters</B>. To its knowledge after reasonable inquiry, Borrower has concluded that Borrower is in compliance with Environmental Laws,
except to the extent a failure to be in such compliance would not reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Event of Default</B>. No Default or Event of Default has occurred and is continuing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Full
Disclosure</B>. None of the representations or warranties made by Borrower in the Loan Documents as of the date such representations
and warranties are made or deemed made, and none of the written statements contained in any exhibit, report, statement or certificate
furnished by or on behalf of Borrower in connection with the Loan Documents (including disclosure materials delivered by or on behalf
of Borrower to Agent prior to the Closing Date or pursuant to Section 5.2 hereof, other than projections which are subject to significant
uncertainties and contingencies), taken as a whole and together with any supplements thereto, contains any untrue statement of a material
fact or omits any material fact required to be stated therein or necessary to make the statements made therein, in light of the circumstances
under which they are made, not misleading as of the time when made or delivered.</FONT></P>

</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Specific
Representations Regarding Collateral. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title.
</B>Except for the security interests created by this Agreement and Permitted Liens, (i) Borrower is the legal and beneficial owner of
the Collateral, and (ii) the Collateral is subject to no Liens. Except as disclosed in the Disclosure Letter, there exist no prior assignments
or encumbrances of record with the U.S. Patent and Trademark Office or U.S. Copyright Office affecting any Collateral in favor of any
third party, other than Permitted Liens.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rights
to Payment.</B> The names of the obligors, amount owing to Borrower, due dates and all other information with respect to the Rights to
Payment are and will be correctly stated in all material respects in all Records applicable to such Rights to Payment. Borrower further
represents and warrants, to its knowledge, that each Person appearing to be obligated on a Right to Payment in excess of the Threshold
Amount has authority and capacity to contract and is bound as it appears to be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Location
of Collateral.</B> As of the Closing Date, Borrower&#146;s chief executive office, Inventory, Records, Equipment, and any other offices
or places of business are located at the address(es) shown on the Supplement or the Perfection Certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Business
Names.</B> Other than its full corporate name, Borrower has not conducted business using any trade names or fictitious business names
except as shown on the Supplement or the Perfection Certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Copyrights,
Patents, Trademarks and Licenses</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Borrower
owns or is licensed or otherwise has the right to use all of the patents, trademarks, service marks, trade names, copyrights, contractual
franchises, authorizations and other similar rights that are reasonably necessary for the operation of its business, without known conflict
with the rights of any other Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>To
Borrower&#146;s knowledge, no slogan or other advertising device, product, process, method, substance, part or other material now employed,
or now contemplated
to be employed, by Borrower infringes upon any rights held by any other Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>No
claim or litigation regarding any of the foregoing is pending or, to Borrower&#146;s knowledge, threatened, and, to Borrower&#146;s
knowledge, no patent, invention, device, application, principle or any statute, law, rule, regulation, standard or code is pending or</FONT></P>
</DIV>

<DIV STYLE="float:right; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">proposed which, in either case, would reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Regulatory
Compliance. </B>Borrower has met the minimum funding requirements of ERISA with respect to any employee benefit plans subject to ERISA.
No event has occurred resulting from Borrower&#146;s failure to comply with ERISA that is reasonably likely to result in Borrower&#146;s
incurring any liability that would have a Material Adverse Effect. Borrower is not required to be registered as an &#147;investment
company&#148; or a company &#147;controlled&#148; by an &#147;investment company&#148; within the meaning of the Investment Company
Act of 1940. Borrower is not engaged principally, or as one of its important activities, in the business of extending credit for the
purpose of purchasing or carrying margin stock (within the meaning of Regulations T and U of the Board of Governors of the Federal Reserve
System). Borrower has complied in all material respects with all the provisions of the Federal Fair Labor Standards Act except to the
extent the failure to comply would reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares.
</B>Borrower has full power and authority to create a first priority Lien on the Shares and no disability or contractual obligation exists
that would prohibit Borrower from pledging the Shares pursuant to this Agreement. To Borrower&#146;s knowledge, there are no subscriptions,
warrants, rights of first refusal or other restrictions on transfer relative to, or options exercisable with respect to the Shares other
than the Warrant. The Shares have been and will be duly authorized and validly issued, and are fully paid and non-assessable other than
the Warrant. To Borrower&#146;s knowledge, the Shares are not the subject of any present or threatened (in writing) suit, action, arbitration,
administrative or other proceeding, and Borrower knows of no reasonable grounds for the institution of any such proceedings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compliance
with Anti-Corruption Laws. </B>Borrower has not taken any action that would cause a violation of any anti-corruption law, including but
not limited to, the Foreign Corrupt Practices Act, the United Kingdom Bribery Act, and all other applicable anti-corruption laws in each
case, in any material respects. Borrower, its employees, agents and representatives have not, directly or indirectly, offered, paid,
given, promised or authorized the payment of any money, gift or anything of value to any person acting in an official capacity for any
government department, agency or instrumentality, including state-owned or controlled companies or entities, and public international
organizations, as well as a political party or official thereof or candidate for political office except in compliance with applicable
law. None of Borrower&#146;s principals or staff are officers, employees or </FONT></P>

</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">representatives of governments, government agencies, or
government-owned or controlled enterprises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Survival.
</B>The representations and warranties of Borrower as set forth in this Loan Agreement survive the execution and delivery of this Loan
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
4 - </B>CONDITIONS PRECEDENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Conditions
to First Loan</B>. The obligation of each Lender to make its first Loan hereunder is, in addition to the conditions precedent specified
in Section 4.2 and in any Supplement, subject to the fulfillment of the following conditions and to the receipt by Lenders of the documents
described below, duly executed and in form and substance satisfactory to each Lender and its counsel:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Resolutions</B>.
A certified copy of the resolutions of the Board of Directors of Borrower authorizing the execution, delivery and performance by Borrower
of the Loan Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incumbency
and Signatures</B>. A certificate of the secretary of Borrower certifying the names of the officer or officers of Borrower authorized
to sign the Loan Documents, together with a sample copy of the true signature of each such officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Legal
Opinion</B>. The opinion of Reed Smith LLP and Sherman &amp; Howard L.L.C., as legal counsel for Borrower, as to such matters as Agent
or any Lender may reasonably request, in form and substance satisfactory to Agent and Lenders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Charter
Documents</B>. Copies of the organizational and charter documents of Borrower (e.g., Articles or Certificate of Incorporation and Bylaws),
as amended through the Closing Date, certified by an officer of Borrower as being true, correct and complete as of such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement</B>. Counterparts of this Loan Agreement, the Supplement and the Disclosure Letter, with all schedules completed and attached
thereto, and disclosing such information as is reasonably acceptable to Lenders therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financing
Statements</B>. Filing copies (or other evidence of filing satisfactory to Agent and its counsel) of such UCC financing statements, collateral
assignments, account control agreements, and termination statements, with respect to the Collateral as Agent shall request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
</DIV>
<DIV STYLE="float:right; width:48%">


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intellectual
Property Security Agreement.</B> An Intellectual Property Security Agreement executed by Borrower in form and substance satisfactory
to Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lien
Searches</B>. UCC lien, judgment, bankruptcy and tax lien searches of Borrower from such jurisdictions or offices as Agent may reasonably
request, all as of a date reasonably satisfactory to Agent and its counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Good
Standing Certificate</B>. A certificate of status or good standing of Borrower as of a date acceptable to Agent from the jurisdiction
of Borrower&#146;s organization and any foreign jurisdictions, as applicable, where Borrower is qualified to do business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Warrant</B>.
The Warrant issued by Borrower to each Lender exercisable for such number, type and class of shares of Borrower&#146;s capital stock,
and for an initial exercise price as is specified therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insurance
Certificates</B>. Insurance certificates showing Borrower&#146;s insurance coverage provided by Medmarc Insurance Group and Evanston
Insurance Company<B>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
Documents</B>. Such other documents and instruments as Agent or Lenders may reasonably request to effectuate the intents and purposes
of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Conditions
to All Loans</B>. The obligation of each Lender to make its initial Loan and any subsequent Loan is subject to the following further
conditions precedent that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Default</B>. No Default or Event of Default has occurred and is continuing or will result from the making of any such Loan, and the representations
and warranties of Borrower contained in Article 3 of this Loan Agreement and the Disclosure Letter are true and correct in all material
respects as of the Borrowing Date of such Loan (unless such representation or warranty relates to a different date, in which case such
representation or warranty will be true and correct in all material respects as of such date).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Material Adverse Change</B>. No event has occurred that has had or could reasonably be expected to have a Material Adverse Change<B>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Borrowing
Request</B>. Borrower shall have delivered to Agent a Borrowing Request for such Loan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</div>

<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Note</B>.
Borrower shall have delivered an executed Note evidencing such Loan, substantially in the form attached to the Supplement as an exhibit
thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Supplemental
Lien Filings</B>. Borrower shall have executed and delivered such amendments or supplements to this Agreement and additional Security
Documents, financing statements and third party waivers as Agent may reasonably request in connection with the proposed Loan, in order
to create, protect or perfect or to maintain the perfection of Lender&#146;s Liens on the Collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial
Projections</B>. Borrower shall have delivered to Agent, for distribution to Lenders, Borrower&#146;s business plan and/or financial
projections or forecasts as most recently approved by Borrower&#146;s Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
5 - </B>AFFIRMATIVE COVENANTS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the term of this Agreement and until its performance of all Obligations (other than inchoate indemnity obligations), Borrower will:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notice
to Lenders</B>. Promptly give written notice to Lenders of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Any
litigation or administrative or regulatory proceeding affecting Borrower where the amount claimed against Borrower is at the Threshold
Amount or more, or where the granting of the relief requested would reasonably be expected to have a Material Adverse Effect; or of the
acquisition by Borrower of any commercial tort claim, including brief details of such claim and such other information as Agent may reasonably
request to enable Agent to better perfect its Lien in such commercial tort claim as Collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Any
dispute which may exist between Borrower and any governmental or regulatory authority that would reasonably be expected to have a Material
Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>The
occurrence of any Default or any Event of Default.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Any
change in the location of any of Borrower&#146;s places of business or Collateral at least ten (10) days (or such later date as agreed
by Lender) in advance of such change, or of the establishment of any new, or the discontinuance of any existing, place of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

</DIV>
<DIV STYLE="float:right; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Any
dispute or default by Borrower or any other party under any joint venture, partnering, distribution, cross-licensing, strategic alliance,
collaborative research or manufacturing, license or similar agreement which would reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Any
other matter which has resulted or would reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Any
Subsidiary Borrower intends to acquire or create.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial
Statements</B>. Deliver to Agent for distribution to the Lenders, or cause to be delivered to Agent for distribution to the Lenders,
in form and detail reasonably satisfactory to Lenders the following financial and other information; provided that Borrower will be deemed
to have delivered such information to the extent Borrower posts the relevant documents to its website, to www.sec.gov, or to such other
website and delivers a link thereto to Agent as notified to Lenders in lieu of delivering hard copies thereof to Agent:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interim
Financial Statements</B>. To the extent Borrower has the capacity to prepare monthly financial statements or undertakes the obligation
to do so for any party other than Lenders, as soon as available but no later than thirty (30) days after the end of each month, Borrower&#146;s
unaudited balance sheet as of the end of such period, and Borrower&#146;s unaudited income statement and cash flow statement for such
period and for that portion of Borrower&#146;s financial reporting year ending with such period, prepared in accordance with GAAP and
attested by a responsible financial officer of Borrower as being complete and correct in all material respects and fairly presenting
Borrower&#146;s financial condition and the results of Borrower&#146;s operations as of the date(s) and for the period(s) covered thereby.
At all other times, the foregoing quarterly interim financial statements shall be delivered no later than forty-five (45) days after
the end of each fiscal quarter, (and for the avoidance of doubt, no monthly financial statements shall be required during such time).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Year-End
Financial Statements</B>. As soon as available but no later than one hundred twenty (120) days after the end of each financial reporting
year, a complete copy of Borrower&#146;s audit report, which shall include balance sheet, income statement, statement of changes in
equity and statement of cash flows for such year, prepared in accordance with GAAP and certified by EisnerAmper LLP or another independent
certified public accountant selected by Borrower and reasonably satisfactory to Lenders (the <B>&#147;<U>Accountant</U>&#148;</B>).
The Accountant&#146;s </FONT></P>
</div>

<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">certification shall not be qualified or limited due to a restricted or limited examination by the Accountant of
any material portion of Borrower&#146;s records. Notwithstanding the foregoing, if Borrower&#146;s Board of Directors does not require
Borrower&#146;s financial statements to be audited for a particular reporting year, then Borrower shall deliver to Agent unaudited financial
statements for such year, including the items described in, and in the timeframe specified in, this Section&nbsp;5.2(b) (other than the
Accountant&#146;s certification).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compliance
Certificates</B>. No later than thirty (30) days after the end of each month, a certificate of the chief financial officer of Borrower
(or other executive officer) substantially in the form of <U>Exhibit &#147;C&#148;</U> to the Supplement (a <B>&#147;<U>Compliance
Certificate</U>&#148;</B>) stating, among other things, whether any Default or Event of Default exists on the date of such certificate,
and if so, setting forth the details thereof and the action which Borrower is taking or proposes to take with respect thereto, and, prior
to such time as Borrower&#146; has the capacity to deliver monthly financial statements, setting forth Borrower&#146;s cash balance
and remaining months liquidity. If requested by any Lender, a Compliance Certificate also shall be delivered to Agent on the Closing
Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Government
Required Reports</B>. Promptly after sending, issuing, making available, or filing, copies of all reports, proxy statements, and financial
statements that Borrower sends or makes available generally to its stockholders, and, not later than five (5) Business Days after actual
filing or the date such filing was first due, all registration statements and reports that Borrower files or is required to file with
the Securities and Exchange Commission, or any other governmental or regulatory authority having similar authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
Information</B>. Such other information as any Lenders may from time to time reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Board
Packages</B>. In addition to the information described in Section 5.2(e), Borrower will promptly provide Agent, for distribution to the
Lenders, with copies of information and notices it supplies to its shareholders, and copies of all information, notices, minutes, consents
and other materials, financial or otherwise, which Borrower provides to its Board of Directors
(collectively, <B>&#147;<U>Board Packages</U>&#148;</B>); <U>provided</U>, <U>however</U>, that Borrower need not provide Lenders with copies
of routine Board actions, such as option and stock grants under Borrower&#146;s equity incentive plan in the normal course of business;
and <U>provided</U>, <U>further</U>, <U>however</U>, that such Board Packages may be redacted to the extent that (i) based on the advice
of counsel, Borrower&#146;s Board of Directors determines such redaction </FONT></P>

</DIV>
<DIV STYLE="float:right; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is reasonably necessary to preserve the attorney-client privilege,
to protect highly confidential proprietary information, or to comply with its fiduciary duty or any applicable law or regulation, (ii)
such redacted material relates to Lenders (or Borrower&#146;s strategy regarding the Loans or Lenders), or (iii) such redacted material
relates to &#147;closed door&#148; executive sessions of the Borrower&#146;s Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Reserved</B>.<B>]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Existence</B>.
Maintain and preserve Borrower&#146;s existence, present form of business, and all rights and permits to the extent necessary to the
normal course operation of its business; and maintain, or caused to be maintained, all Borrower&#146;s property in good working order
and condition, ordinary wear and tear excepted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insurance</B>.
Obtain and keep in force insurance in such amounts and types as is customary in the industry in which the Borrower operates, with insurance
carriers having a policyholder rating of not less than &#147;A&#148; and financial category rating of Class VII in &#147;Best&#146;s
Insurance Guide,&#148; unless otherwise approved by Lenders (it being understood that Medmarc Insurance Group and Evanston Insurance
Company are acceptable to Lenders). Such insurance policies shall be in form and substance reasonably satisfactory to Lenders, and shall
list Agent as an additional insured or loss payee, as applicable, on endorsement(s) in form reasonably acceptable to Agent. Borrower
shall furnish to Agent such endorsements, and upon Lender&#146;s request, copies of any or all such policies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounting
Records</B>. Maintain adequate books, accounts and records, and prepare all financial statements in accordance with GAAP, and in compliance
with the regulations of any governmental or regulatory authority having jurisdiction over Borrower or Borrower&#146;s business; and
permit employees or agents of Agent at such reasonable times as Agent may request, at Borrower&#146;s expense (not to exceed one (1)
such inspection and no more than $2,500 in any 12-month period unless an Event of Default has occurred and is continuing), to inspect
Borrower&#146;s properties, and to examine, review and audit, and make copies and memoranda of Borrower&#146;s books, accounts and
records.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compliance
with Laws</B>. Comply with all laws (including Environmental Laws), rules, regulations applicable to, and all orders and directives of
any governmental or regulatory authority having jurisdiction over, Borrower or Borrower&#146;s business, and with all material agreements
to which Borrower is a party, except where the failure to so comply would not have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Taxes
and Other Liabilities</B>. Pay all Borrower&#146;s Indebtedness when due; pay all material taxes and other governmental or regulatory
assessments before delinquency or before any penalty attaches thereto, except as may be contested in good faith by the appropriate procedures
and for which Borrower shall maintain appropriate reserves; and timely file all required material tax returns (subject to any applicable
extensions).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special
Collateral Covenants. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Maintenance
of Collateral; Inspection.</B> Do all things reasonably necessary to maintain, preserve, protect and keep all Collateral in good working
order and salable condition, ordinary wear and tear excepted, deal with the Collateral in all commercially reasonable ways as are considered
good practice by owners of like property, and use the Collateral lawfully and, to the extent applicable, only as permitted by Borrower&#146;s
insurance policies. Maintain, or cause to be maintained, complete and accurate Records, in all material respects, relating to the Collateral.
Upon reasonable prior notice at reasonable times during normal business hours, Borrower hereby authorizes Agent&#146;s and Lenders&#146;
officers, employees, representatives and agents to inspect the Collateral and to discuss the Collateral and the Records relating thereto
with Borrower&#146;s officers and employees, and, in the case of any Right to Payment, after consultation with Borrower, with any Person
which is or may be obligated thereon (not to exceed one (1) such inspection and no more than $2,500 in any 12-month period unless an
Event of Default has occurred and is continuing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Documents
of Title.</B> Not sign or authorize the signing of any financing statement or other document naming Borrower as debtor or obligor, or
acquiesce or cooperate in the issuance of any bill of lading, warehouse receipt or other document or instrument of title with respect
to any Collateral, except those negotiated to Agent, or those naming Agent as secured party, or if solely to create, perfect or maintain
a Permitted Lien.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change
in Location or Name.</B> Without at least 30 days&#146; prior written notice to Lenders: (a) not relocate
any Collateral or Records, its chief executive office, or establish a place of business at a location other than as specified in the
Disclosure Letter; and (b) not change its name, mailing address, location of Collateral (other than (i) movable property such as laptop
computers, and (ii) other Collateral with a book value less than $50,000), jurisdiction of incorporation or its legal structure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Decals,
Markings.</B> At the request of Lender, firmly affix a decal, stencil or other marking to designated</FONT></P>
</DIV>
<DIV STYLE="float:right; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">items of Equipment valued in excess
of $50,000, indicating thereon the security interest of Lender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Agreement
with Persons in Possession of Collateral.</B> Use its commercially reasonable efforts to obtain and maintain such acknowledgments, consents,
waivers and agreements (each a <B>&#147;<U>Waiver</U>&#148;</B>) from the owner, operator, lienholder, mortgagee, landlord or any Person
in possession of tangible Collateral (other than movable property such as laptop computers) in excess of $100,000 per location as Lenders
may require, all in form and substance reasonably satisfactory to Lenders. Notwithstanding anything to the contrary in this Section 5.9(e),
Borrower and Lenders acknowledge and agree that all material Intellectual Property and Records that are maintained on items of Collateral
for which Borrower is unable to provide a Waiver also shall be maintained or backed up in a manner sufficient that Agent shall be able
to have reasonable access to such Intellectual Property and Records in accordance with the exercise of Agent&#146;s rights hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain
Agreements on Rights to Payment.</B> Other than in the ordinary course of business, not make any material discount, credit, rebate or
other reduction in the original amount owing on a material Right to Payment or accept in satisfaction of such Right to Payment less than
the original amount thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Authorization
for Automated Clearinghouse Funds Transfer.</B> (i) Authorize each Lender to initiate debit entries to Borrower&#146;s Primary Operating
Account, specified in the Disclosure Letter, through Automated Clearinghouse (<B>&#147;<U>ACH</U>&#148;</B>) transfers, in order to
satisfy the regularly scheduled payments of principal and interest; (ii) provide each Lender at least thirty (30) days&#146; notice
of any change in Borrower&#146;s Primary Operating Account; and (iii) grant each Lender any additional authorizations necessary to begin
ACH debits from a new account which becomes the Primary Operating Account.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Anti-Corruption
Laws. </B>Provide, to the knowledge of the Borrower, true, accurate and complete information, in all material respects, in all product
orders, reimbursement requests and other communications relating to Borrower and its products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
6 - </B>NEGATIVE COVENANTS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the term of this Agreement and until the performance of all Obligations (other than inchoate indemnity obligations), Borrower will not:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indebtedness.
</B>Incur Indebtedness for borrowed money, or the deferred purchase price of </FONT></P>
</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">property, or capital or equipment leases which would be
capitalized in accordance with GAAP; or become liable as a surety, guarantor, accommodation party or otherwise for or upon the obligation
of any other Person, except:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Indebtedness
incurred for the acquisition of supplies, inventory or other property or services on normal trade credit;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Indebtedness
incurred pursuant to one or more transactions permitted under <U>Section 6.4</U>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Indebtedness
of Borrower under this Agreement and the other Loan Documents;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Subordinated
Debt;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>any
Indebtedness approved by Lenders prior to the Closing Date as set forth in the Disclosure Letter;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Indebtedness
secured by a lien described in clause (c) of the defined term &#147;Permitted Liens&#148; not to exceed $100,000 in aggregate principal
amount outstanding at any time;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Indebtedness
incurred under corporate credit cards not to exceed $150,000 in aggregate principal amount outstanding at any time;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>guaranties
and similar surety obligations in respect of Indebtedness permitted under this Section 6.1;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Indebtedness
to finance insurance premiums;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Letters
of credit securing performance of real property leases, provided that such Indebtedness does not exceed ($25,000) outstanding at any
time; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>extensions,
refinancings and renewals of any of the foregoing; provided that the principal amount thereof is not increased.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Liens</B>.
Create, incur, assume or permit to exist any Lien, or grant any other Person a negative pledge, on any of Borrower&#146;s property,
except Permitted Liens and any negative pledge in respect of any asset subject to a Lien permitted by clause (c) of the definition of
Permitted Liens. Borrower, Lenders and Agent agree that this covenant is not intended to constitute a lien, deed of trust, equitable
mortgage, or security interest of any kind on any of Borrower&#146;s real property, and this Agreement shall not be recorded or recordable.
Notwithstanding the foregoing, however, violation of this covenant by Borrower shall constitute an Event of Default.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

</DIV>
<DIV STYLE="float:right; width:48%">



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividends</B>.
Pay any dividends or purchase, redeem or otherwise acquire or make any other distribution with respect to any of Borrower&#146;s capital
stock, except (a) dividends or other distributions solely of the equity interests of Borrower, (b) so long as no Event of Default has
occurred and is continuing, repurchases of stock from employees or contractors (or any spouses, successors, administrators, heirs or
legatees of any of the foregoing) upon the death, disability or termination of employment or services of such individual not to exceed
$100,000 in any calendar year, (c) the conversion of Borrower&#146;s convertible securities into other securities pursuant to the terms
of such convertible securities or otherwise in exchange thereof, (d) the purchase, redemption or other acquisition of shares of Borrower&#146;s
capital stock with the proceeds received from a substantially concurrent issue of new shares of its capital stock, (e) cash payments
in lieu of issuing fractional shares in connection with the exercise of warrants, options, or other securities convertible into or exchangeable
for equity interests in another Person and (f) non-cash repurchases of equity interest of Borrower deemed to occur upon exercise of stock
options or warrants (or equivalent) if such equity interests represent a portion of the exercise price and/or related tax liability in
respect of such options or warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fundamental
Changes</B>. (a) Liquidate or dissolve; (b) enter into, or permit any of Borrower&#146;s Subsidiaries to enter into, any Change of Control;
or (c) acquire, or permit any of Borrower&#146;s Subsidiaries to acquire, all or substantially all of the capital stock or property
of another Person except as permitted by Section 6.6 or Section 6.14. Notwithstanding anything to the contrary in this Section 6.4, Borrower
may enter into a transaction that will constitute a Change of Control so long as: (i) the Person that results from such Change of Control
(the <B>&#147;<U>Surviving Entity</U>&#148;</B>) shall have executed and delivered to Lenders an agreement in form and substance reasonably
satisfactory to each Lender, containing an assumption by the Surviving Entity of the due and punctual payment and performance of all
Obligations and performance and observance of each covenant and condition of Borrower in the Loan Documents; (ii) all such obligations
of the Surviving Entity to s shall be guaranteed by any Person that directly or indirectly owns or controls 50% or more of the voting
stock of the Surviving Entity; (iii) immediately after giving effect to such Change of Control, no Event of Default or, event which with
the lapse of time or giving of notice or both, would result in an Event of Default shall have occurred and be continuing; and (iv) the
credit risk to Lenders in each Lender&#146;s sole discretion, with respect to the Obligations and the Collateral shall not be increased.
In determining whether the proposed Change of Control would result in an increased credit risk, each Lender may </FONT></P>
</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">consider, among other
things, changes in Borrower&#146;s management team, employee base, access to equity markets, venture capital support, financial position
and/or disposition of intellectual property rights which may reasonably be anticipated as a result of the Change of Control. In addition,
(i) a Subsidiary may merge or consolidate into another Subsidiary and (ii) Borrower may consolidate or merge with any of Borrower&#146;s
Subsidiaries provided that Borrower is the continuing or surviving Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sales
of Assets</B>. Sell, transfer, lease, license, allow to lapse, terminate, or otherwise dispose of (a <B>&#147;<U>Transfer</U>&#148;</B>)
any of Borrower&#146;s assets except (a) non-exclusive licenses and sublicenses of Intellectual Property in the ordinary course of
business consistent with industry practice, provided that such licenses of Intellectual Property neither result in a legal transfer
of title of the licensed Intellectual Property nor have the same effect as a sale of such Intellectual Property; (b) Transfers and
abandonments of worn-out, obsolete or surplus property (each as determined by Borrower in its reasonable judgment); (c) Transfers of
Inventory in the ordinary course of business; (d) Transfers constituting Permitted Liens; (e) Transfers permitted in Section 6.3,
6.4, 6.6 or 6.7 hereunder; (f) Transfers of assets (other than Intellectual Property) for fair consideration and in the ordinary
course of its business; and (g) asset sales or other Transfers consisting of non-exclusive licenses, sublicenses or contributions of
Intellectual Property, or licenses, sublicenses or contributions of Intellectual Property that may be exclusive in respects other
than territory and that may be exclusive as to territory only as to a specific geographical territory outside the United States,
pursuant to licensing, manufacturing, joint marketing, distribution or research and development, collaboration, consortium, or joint
development agreements or other arrangements in the ordinary course of business or consistent with past practice, or where no past
practice exists, consistent with market practice and on customary terms for the life sciences and pharmaceuticals
industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loans/Investments</B>.
Make or suffer to exist any Investments, except:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>accounts
receivable in the ordinary course of Borrower&#146;s business;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Investments
in domestic certificates of deposit issued by, and other domestic investments with, financial institutions organized under the laws of
the United States or a state thereof, having at least $100,000,000 in capital and a rating of at least &#147;investment grade&#148;
or &#147;A&#148; by Moody&#146;s or any successor rating agency;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


</DIV>
<DIV STYLE="float:right; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Investments
in marketable obligations of the United States of America and in open market commercial paper given the highest credit rating by a national
credit agency and maturing not more than one year from the creation thereof;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>temporary
advances to cover incidental expenses to be incurred in the ordinary course of business;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Investments
in joint ventures, strategic alliances, licensing and similar arrangements customary in Borrower&#146;s industry and which do not require
Borrower to assume or otherwise become liable for the obligations of any third party not directly related to or arising out of such arrangement
or, without the prior written consent of Required Lenders, require Borrower to transfer ownership of non-cash assets to such joint venture
or other entity;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Investments
in and acquisitions of (i) one or more wholly-owned domestic Subsidiaries of Borrower, so long as in accordance with Section 6.14(a)
of this Loan Agreement, each such Person has been made a co-borrower hereunder or has executed and delivered to Agent an agreement, in
form and substance reasonably satisfactory to Required Lenders, containing a guaranty of the Obligations, and (ii) one or more wholly-owned
foreign Subsidiaries of Borrower with the prior written consent of Required Lenders;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Investments
approved by Lenders prior to the Closing Date as set forth in the Disclosure Letter;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Investments
accepted in connection with Transfers permitted by Section 6.5;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>non-cash
loans approved by Borrower&#146;s Board of Directors to employees, officers or directors relating to the purchase of equity securities
of Borrower pursuant to employee stock purchase plans or agreements approved by Borrower&#146;s Board of Directors, limited to an aggregate
total of $100,000 at any time outstanding;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Investments
(including debt obligations) received in connection with the bankruptcy or reorganization of customers or suppliers and in settlement
of delinquent obligations of, and other disputes with, customers or suppliers arising in the ordinary course of Borrower&#146;s business;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Investments
permitted under Section 6.11 and 6.14;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Investments
consisting of notes receivable of, or prepaid royalties and other loans or credit extensions </FONT></P>
</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to, customers, suppliers and distributors
in the ordinary course of business;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Investments
by wholly owned Subsidiaries in other wholly owned Subsidiaries or in Borrower; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Investments
consisting of deposit accounts; provided Lender has a perfected security interest therein to the extent required by Section 6.11.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transactions
with Related Persons</B>. Directly or indirectly enter into any transaction with or for the benefit of a Related Person on terms more
favorable to the Related Person than would have been obtainable in an &#147;arms&#146; length&#148; dealing, except (a) sales of equity
securities by Borrower and incurrence of Subordinated Debt for capital raising purposes, (b) Investments permitted under clauses (d),
(f), (i) or (m) of Section 6.6, (c) employment and consulting arrangements, including stock options, employee compensation, and severance
arrangements in the ordinary course of business, and (d) customary reimbursement and indemnity arrangements in the ordinary course of
business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
Business</B>. Engage in any material line of business other than the business Borrower conducts as of the Closing Date and any business
substantially similar, related or incidental thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financing
Statements and Other Actions.</B> Fail to execute and deliver to Agent all financing statements, notices and other documents
(including, without limitation, any filings with the United States Patent and Trademark Office and the United States Copyright
Office) from time to time reasonably requested by Agent to maintain a perfected first priority security interest in the Collateral
in favor of Agent, subject to Permitted Liens; perform such other acts, and execute and deliver to Agent such additional
conveyances, assignments, agreements and instruments, as Agent may at any time reasonably request in connection with the
administration and enforcement of this Agreement or Agent&#146;s rights, powers and remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compliance.
</B>Become required to be registered as an &#147;investment company&#148; or controlled by an &#147;investment company,&#148; within
the meaning of the Investment Company Act of 1940, or become principally engaged in, or undertake as one of its important activities,
the business of extending credit for the purpose of purchasing or carrying margin stock, or use the proceeds of any Loan for such purpose.
Fail to meet the minimum funding requirements of ERISA, permit a Reportable Event or Prohibited Transaction, as defined in ERISA, to
occur, fail to comply with the Federal Fair Labor Standards Act or violate any law or regulation, in each </FONT></P>

</DIV>
<DIV STYLE="float:right; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each case, which violation would
reasonably be expected to have a Material Adverse Effect or a material adverse effect on the Collateral or the priority of Agent&#146;s
Lien on the Collateral, or permit any of its subsidiaries to do any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
Deposit and Securities Accounts. </B>Maintain any Deposit Accounts or accounts holding securities owned by Borrower except (a) Deposit
Accounts and investment/securities accounts as set forth in the Disclosure Letter with respect to which an account control agreement
has been executed and delivered to Agent, and (b) other Deposit Accounts and securities/investment accounts, in each case, with respect
to which Borrower and Agent shall have taken such action as Agent reasonably deems necessary to obtain a perfected first priority security
interest therein, including without limitation the execution and delivery of an account control agreement, subject to Permitted Liens.
Notwithstanding anything to the contrary, the provisions of this Section 6.11 shall not apply to Excluded Accounts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepayment
of Indebtedness</B>. Prepay, redeem or otherwise satisfy in any manner prior to the scheduled repayment thereof any Indebtedness (other
than the Loans and Indebtedness permitted by <U>Section 6.1</U> hereof). Notwithstanding the foregoing, the parties agree that the conversion
or exchange into Borrower&#146;s equity securities of any Indebtedness (other than the Loans) shall not be prohibited by this Section
6.12.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayment
of Subordinated Debt</B>. Repay, prepay, redeem or otherwise satisfy in any manner any Subordinated Debt, except in accordance with the
terms of any subordination agreement among Borrower, Agent and the holder(s) of such Subordinated Debt. Notwithstanding the foregoing,
each Lender agrees that the conversion or exchange into Borrower&#146;s equity securities of any Subordinated Debt and the payment of
cash in lieu of fractional shares shall not be prohibited by this Section 6.13.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subsidiaries</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Acquire
or create any Subsidiary, unless such Subsidiary becomes, at Lender&#146;s option, either a co-borrower hereunder or executes and delivers
to Agent one or more agreements, in form and substance reasonably satisfactory to Required Lenders, containing a guaranty of the Obligations
that is secured by first priority Liens on such Person&#146;s assets, subject to Permitted Liens. For clarity, the parties acknowledge
and agree that Required Lenders shall have the exclusive right to determine whether any such Person will be made a co-borrower hereunder
or a guarantor of the Obligations. Prior to the acquisition or creation of any such Subsidiary, Borrower </FONT></P>
</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shall have the exclusive right to determine whether any such Person will be made a co-borrower hereunder
or a guarantor of the Obligations. Prior to the acquisition or creation of any such Subsidiary, Borrower shall notify Lenders thereof
in writing, which notice shall contain the jurisdiction of such Person&#146;s formation and include a description of such Person&#146;s
fully diluted capitalization and Borrower&#146;s purpose for its acquisition or creation of such Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Sell,
transfer, encumber or otherwise dispose of Borrower&#146;s ownership interest in any Subsidiary other than Permitted Liens.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Cause
or permit a Subsidiary to do any of the following: (i) grant Liens on such Subsidiary&#146;s assets, except for Liens that would constitute
Permitted Liens if incurred by Borrower and Liens on any property held or acquired by such Subsidiary in the ordinary course of its business
securing Indebtedness incurred or assumed for the purpose of financing all or any part of the cost of acquiring such property; <U>provided</U>,
that such Lien attaches solely to the property acquired with such Indebtedness and that the principal amount of such Indebtedness does
not exceed one hundred percent (100%) of the cost of such property; and (ii) issue any additional Shares, except to Borrower or a wholly
owned Subsidiary of Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Leases</B>.
Create, incur, assume, or suffer to exist any obligation as lessee for the rental or hire of any personal property
(&#147;<B>Personal Property Leases</B>&#148;), except for Personal Property Leases of Equipment in the ordinary course of business
that do not in the aggregate require Borrower to make payments (including taxes, insurance, maintenance and similar expenses which
Borrower is required to pay under the terms of any such lease) in any calendar year in excess of $150,000 in aggregate amount. For
the avoidance of doubt, this Section 6.15 will not be applicable to Indebtedness otherwise permitted under Section 6.1(f) of this
Loan Agreement or leases of real property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Anti-Corruption
Laws. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Take
any action that would cause a violation of any anti-corruption law, including but not limited to, the Foreign Corrupt Practices Act,
the United Kingdom Bribery Act, and all other applicable anti-corruption laws.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Directly
or indirectly, offer, pay, give, promise or authorize the payment of any money, gift, or anything of value to any person acting in an
official capacity for any government department, agency, or instrumentality, including state-owned or controlled companies or entities,
and public international organizations, as well as a political party or official thereof or candidates for political office, except in
compliance with applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
</DIV>
<DIV STYLE="float:right; width:48%">


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
7 - </B>EVENTS OF DEFAULT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Events
of Default; Acceleration</B>. Upon the occurrence and during the continuation of any Event of Default, the obligation of each Lender
to make any additional Loan shall be suspended. The occurrence and continuation of any of the following (each, an <B>&#147;<U>Event
of Default</U>&#148;</B>) shall at the option of Agent, at the direction of Required Lenders (1) make all sums of Basic Interest and
principal, as well as any other Obligations and amounts owing under any Loan Documents, immediately due and payable without notice of
default, presentment or demand for payment, protest or notice of nonpayment or dishonor or any other notices or demands, and (2) give
Agent the right to exercise any other right or remedy provided by contract or applicable law:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Borrower
shall fail to pay any principal or interest under this Agreement or any Note, or fail to pay any fees or other charges when due under
any Loan Document, and such failure continues for three (3) Business Days or more after the same first becomes due; or an Event of Default
as defined in any other Loan Document shall have occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Any
representation or warranty made, or financial statement, certificate or other document provided, by Borrower under any Loan Document
shall prove to have been false or misleading in any material respect when made or deemed made herein.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>If
there occurs any circumstance or circumstances that could reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>(i)
Borrower shall fail to pay its debts generally as they become due; or (ii) Borrower shall commence any Insolvency Proceeding with respect
to itself, an involuntary Insolvency Proceeding shall be filed against Borrower, or a custodian, receiver, trustee, assignee for the
benefit of creditors, or other similar official, shall be appointed to take possession, custody or control of the properties of Borrower,
and such involuntary Insolvency Proceeding, petition or appointment is acquiesced to by Borrower or is not dismissed within forty five
(45) days; or (iii) the dissolution, winding up, or termination of the business or cessation of operations of Borrower (including any
transaction or series of related transactions deemed to be a liquidation, dissolution or winding up of Borrower pursuant to the provisions
of Borrower&#146;s charter documents); or (iv) Borrower shall take any corporate action for the purpose of effecting, approving, or
consenting to any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Borrower
shall be in default beyond any applicable period of grace or cure under any other </FONT></P>
</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">agreement
involving the borrowing of money, the purchase of property, the advance of credit or any other monetary liability of any kind to any
Lender or to any Person in an amount in excess of the Threshold Amount.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Any
governmental or regulatory authority shall take any judicial or administrative action, or any defined benefit pension plan maintained
by Borrower shall have any unfunded liabilities, any of which, in the reasonable judgment of Required Lenders, would reasonably be expected
to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Any
sale, transfer or other disposition of all or a substantial or material part of the assets of Borrower, including without limitation
to any trust or similar entity, shall occur.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Any
judgment(s) singly or in the aggregate in excess of the Threshold Amount (excluding amounts covered by insurance to the extent the relevant
independent third-party insurer has accepted coverage therefor) shall be entered against Borrower which remain unsatisfied, unvacated
or unstayed pending appeal for fifteen (15) or more days after entry thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Borrower
shall fail to perform or observe any covenant contained in Article 6 of this Loan Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Borrower
shall fail to perform or observe any covenant contained in Article 5 or elsewhere in this Loan Agreement or any other Loan Document (other
than a covenant which is dealt with specifically elsewhere in this Article 7) and, if capable of being cured, the breach of such covenant
is not cured within 10 days after the sooner to occur of Borrower&#146;s receipt of notice of such breach from Agent or any Lender or
the date on which such breach first becomes known to any officer of Borrower (the &#147;<B>Notice Date</B>&#148;); <U>provided</U>,
<U>however</U> that if such breach is not capable of being cured within such 10-day period and Borrower timely notifies Lenders of such
fact and Borrower diligently pursues such cure, then the cure period shall be extended to the date requested in Borrower&#146;s notice
but in no event more than 30 days from the Notice Date; <U>provided</U>, <U>further</U>, that such 30-day opportunity to cure shall not
apply in the case of any failure to perform or observe any covenant which has been the subject of a prior failure within the preceding
180 days or which is a willful and knowing breach by Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Remedies
upon Default.</B> Upon the occurrence and during the continuance of an Event of Default, Agent shall be entitled to, at its option, exercise
any or all of the rights and remedies available to a secured party under the UCC or any other applicable law, and exercise any or all
of its rights and remedies provided for in this Agreement </FONT></P>

</DIV>
<DIV STYLE="float:right; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and in any other Loan Document. The obligations of Borrower under this Agreement
shall continue to be effective or be reinstated, as the case may be, if at any time any payment of any Obligations is rescinded or must
otherwise be returned by any Lender or Agent upon, on account of, or in connection with, the insolvency, bankruptcy or reorganization
of Borrower or otherwise, all as though such payment had not been made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sale
of Collateral.</B> Upon the occurrence and during the continuance of an Event of Default, Agent may, at the direction of Required Lenders,
sell all or any part of the Collateral, at public or private sales, to the Lenders or a designee of Lenders, a wholesaler, retailer or
investor, for cash, upon credit or for future delivery, and at such price or prices as Required Lenders may deem commercially reasonable.
To the extent permitted by law, each Borrower hereby specifically waives all rights of redemption and any rights of stay or appraisal
which it has or may have under any applicable law in effect from time to time. Any such public or private sales shall be held at such
times and at such place(s) as Required Lenders may determine. In case of the sale of all or any part of the Collateral on credit or for
future delivery, the Collateral so sold may be retained by Agent until the selling price is paid by the purchaser, but neither Agent
nor any Lender shall incur any liability in case of the failure of such purchaser to pay for the Collateral and, in case of any such
failure, such Collateral may be resold. Agent may, at the direction of Required Lenders, instead of exercising its power of sale, proceed
to enforce its security interest in the Collateral by seeking a judgment or decree of a court of competent jurisdiction. Without limiting
the generality of the foregoing, if an Event of Default is in existence, in each case, at the direction of Required Lenders:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to the rights of any third parties, Agent may license, or sublicense, whether general, special or otherwise, and whether on an exclusive
or non-exclusive basis, any Copyrights, Patents or Trademarks included in the Collateral throughout the world for such term or terms,
on such conditions and in such manner as Required Lenders shall in their sole discretion determine;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Agent
may (without assuming any obligations or liability thereunder), at any time and from time to time, enforce (and shall have the exclusive
right to enforce) against any licensee or sublicensee all rights and remedies of Borrower in, to and under any Copyright Licenses, Patent
Licenses or Trademark Licenses and take or refrain from taking any action under any thereof, and Borrower hereby releases Agent and each
Lender from, and agrees to hold Agent and each Lender free and harmless from and against any claims arising out of, any lawful action
so taken or omitted to be taken with respect thereto other than, with respect to Agent or any Lender, claims arising </FONT></P>

</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">out of the gross
negligence or willful misconduct of Agent or such Lender, respectively; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
request by Agent, Borrower will execute and deliver to Agent a power of attorney, in form and substance reasonably satisfactory to Agent,
for the implementation of any lease, assignment, license, sublicense, grant of option, sale or other disposition of a Copyright, Patent
or Trademark. In the event of any such disposition pursuant to this <U>clause 3</U>, Borrower shall supply its know-how and expertise
relating to the products or services made or rendered in connection with Patents, the manufacture and sale of the products bearing Trademarks,
and its customer lists and other records relating to such Copyrights, Patents or Trademarks and to the distribution of said products,
to Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If,
at any time when Required Lenders shall determine to exercise its right to sell the whole or any part of the Shares hereunder, such
Shares or the part thereof to be sold shall not, for any reason whatsoever, be effectively registered under the Securities Act (or
any similar statute), then Agent may, at the direction of Required Lenders in their sole discretion (subject only to applicable
requirements of law), sell such Shares or part thereof by private sale in such manner and under such circumstances as Required
Lenders may deem necessary or advisable, but subject to the other requirements of this <U>Article 7</U>, and shall not be required
to effect such registration or to cause the same to be effected. Without limiting the generality of the foregoing, in any such
event, Agent may, at the direction of Required Lenders in their discretion, (i) in accordance with applicable securities laws
proceed to make such private sale notwithstanding that a registration statement for the purpose of registering such Shares or part
thereof could be or shall have been filed under the Securities Act (or similar statute), (ii) approach and negotiate with a single
possible purchaser to effect such sale, and (iii) restrict such sale to a purchaser who is an accredited investor under the
Securities Act and who will represent and agree that such purchaser is purchasing for its own account, for investment and not with a
view to the distribution or sale of such Shares or any part thereof. In addition to a private sale as provided above in this <U>Article
7</U>, if any of the Shares shall not be freely distributable to the public without registration under the Securities Act (or
similar statute) at the time of any proposed sale pursuant to this <U>Article 7</U>, then Agent shall not be required to effect such
registration or cause the same to be effected but, in its discretion (subject only to applicable requirements of law), may require
that any sale hereunder (including a sale at auction) be conducted subject to restrictions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
</DIV>
<DIV STYLE="float:right; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;as
to the financial sophistication and ability of any Person permitted to bid or purchase at any such sale;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;as
to the content of legends to be placed upon any certificates representing the Shares sold in such sale, including restrictions on future
transfer thereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;as
to the representations required to be made by each Person bidding or purchasing at such sale relating to such Person&#146;s access to
financial information about Borrower or any of its Subsidiaries and such Person&#146;s intentions as to the holding of the Shares so
sold for investment for its own account and not with a view to the distribution thereof; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(D)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;as
to such other matters as Agent may, in its discretion, deem necessary or appropriate in order that such sale (notwithstanding any failure
so to register) may be effected in compliance with the Bankruptcy Code and other laws affecting the enforcement of creditors&#146; rights
and the Securities Act and all applicable state securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Borrower
recognizes that Agent may be unable to effect a public sale of any or all the Shares and may be compelled to resort to one or more private
sales thereof in accordance with <U>clause (4)</U> above. Borrower also acknowledges that any such private sale may result in prices
and other terms less favorable to the seller than if such sale were a public sale and, notwithstanding such circumstances, agrees that
any such private sale shall not be deemed to have been made in a commercially unreasonable manner solely by virtue of such sale being
private. Agent shall be under no obligation to delay a sale of any of the Shares for the period of time necessary to permit the applicable
Subsidiary to register such securities for public sale under the Securities Act, or under applicable state securities laws, even if Borrower
and/or the Subsidiary would agree to do so.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Borrower&#146;s
Obligations upon Default.</B> Upon the request of Agent, at the direction of Required Lenders, after the occurrence and during the continuance
of an Event of Default, Borrower will:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Assemble
and make available to Agent the Collateral at such place(s) as Agent shall reasonably designate, segregating all Collateral so that each
item is capable of identification; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Subject
to the rights of any lessor, permit Agent, by Agent&#146;s officers, employees, agents and </FONT></P>
</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">representatives, to enter any premises where
any Collateral is located, to take possession of the Collateral, to complete the processing, manufacture or repair of any Collateral,
and to remove the Collateral, or to conduct any public or private sale of the Collateral, all without any liability of Agent or any Lender
for rent or other compensation for the use of Borrower&#146;s premises.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
8 - </B>SPECIAL COLLATERAL PROVISIONS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compromise
and Collection.</B> Borrower and Agent recognize that setoffs, counterclaims, defenses and other claims may be asserted by obligors
with respect to certain of the Rights to Payment; that certain of the Rights to Payment may be or become uncollectible in whole or
in part; and that the expense and probability of success of litigating a disputed Right to Payment may exceed the amount that
reasonably may be expected to be recovered with respect to such Right to Payment. Borrower hereby authorizes Agent, after and during
the continuance of an Event of Default, to compromise with the obligor, accept in full payment of any Right to Payment such amount
as Agent shall negotiate with the obligor, or abandon any Right to Payment, in each case, as directed by Required Lenders. Any such
action by Agent shall be considered commercially reasonable so long as Required Lenders have made the determination in good faith
based on information known to them at the time Agent takes any such action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Performance
of Borrower&#146;s Obligations.</B> Without having any obligation to do so, upon reasonable prior notice to Borrowers, Agent may, at
the direction of Required Lenders, perform or pay any obligation which Borrowers have agreed to perform or pay under this Agreement,
including, without limitation, the payment or discharge of taxes or Liens levied or placed on or threatened against the Collateral, provided
that the Lenders shall fund amounts necessary to make such payments ratably in accordance with the principal amount of the Loans held
by each Lender. In so performing or paying, Agent and Required Lenders shall determine the action to be taken and the amount necessary
to discharge such obligations. Borrower shall reimburse Agent on demand for any amounts paid by Agent or any Lender pursuant to this
Section, whereupon, Agent shall promptly deliver to Lenders such payments, which amounts shall constitute Obligations secured by the
Collateral and shall bear interest from the date of demand at the Default Rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Power
of Attorney.</B> For the purpose of protecting and preserving the Collateral and Agent&#146;s and Lenders&#146; rights under this Agreement,
each Borrower hereby irrevocably appoints Agent, with full power of substitution, as its attorney-in-fact with full power and</FONT></P>

</DIV>
<DIV STYLE="float:right; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> authority,
after the occurrence and during the continuance of an Event of Default, to do any act which the applicable Borrower is obligated to do
hereunder, as directed by Required Lenders; to exercise such rights with respect to the Collateral as the applicable Borrower might exercise,
as directed by Required Lenders; to use such Inventory, Equipment, Fixtures or other property as the applicable Borrower might use, as
directed by Required Lenders; to enter any Borrower&#146;s premises; to give notice of Agent&#146;s security interest in, and to collect
the Collateral, as directed by Required Lenders; and before or after Default, to execute and file in the applicable Borrower&#146;s
name any financing statements, amendments and continuation statements, account control agreements or other Security Documents necessary
or desirable to create, maintain, perfect or continue the perfection of Agent&#146;s security interests in the Collateral. Each Borrower
hereby ratifies all that Agent shall lawfully do or cause to be done by virtue of this appointment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Authorization
for Lender to Take Certain Action.</B> The power of attorney created in Section 8.3 is a power coupled with an interest and shall be
irrevocable. The powers conferred on Agent hereunder and thereunder are solely to protect its interests in the Collateral and shall not
impose any duty upon Agent to exercise such powers. Agent shall be accountable only for amounts that it actually receives as a result
of the exercise of such powers and in no event shall Agent or any of its directors, officers, employees, agents or representatives be
responsible to any Borrower for any act or failure to act, except for gross negligence or willful misconduct. After the occurrence and
during the continuance of an Event of Default, Agent may exercise this power of attorney without notice to or assent of any Borrower,
in the name of the applicable Borrower, or in Agent&#146;s own name, from time to time in Agent&#146;s sole discretion and at Borrowers&#146;
expense. To further carry out the terms of this Agreement, after the occurrence and during the continuance of an Event of Default, Agent
may, at the direction of Required Lenders:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Execute
any statements or documents or take possession of, and endorse and collect and receive delivery or payment of, any checks, drafts, notes,
acceptances or other instruments and documents constituting Collateral, or constituting the payment of amounts due and to become due
or any performance to be rendered with respect to the Collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Sign
and endorse any invoices, freight or express bills, bills of lading, storage or warehouse receipts; drafts, certificates and statements
under any commercial or standby letter of credit relating to Collateral; assignments, verifications and notices in connection with Accounts;
or any other documents </P>
</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">relating to the Collateral, including without limitation the Records.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Use
or operate Collateral or any other property of Borrower for the purpose of preserving or liquidating Collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>File
any claim or take any other action or proceeding in any court of law or equity or as otherwise deemed appropriate by Agent for the purpose
of collecting any and all monies due or securing any performance to be rendered with respect to the Collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Commence,
prosecute or defend any suits, actions or proceedings or as otherwise deemed appropriate by Agent for the purpose of protecting or collecting
the Collateral. In furtherance of this right, upon the occurrence and during the continuance of an Event of Default, Agent may apply
for the appointment</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
a receiver or similar official to operate Borrower&#146;s business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Prepare,
adjust, execute, deliver and receive payment under insurance claims, and collect and receive payment of and endorse any instrument in
payment of loss or returned premiums or any other insurance refund or return, and apply such amounts at Agent&#146;s sole discretion,
toward repayment of the Obligations or replacement of the Collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Application
of Proceeds.</B> Any Proceeds and other monies or property received by Agent pursuant to the terms of this Agreement or any Loan Document
may be applied as follows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>First</I>,
to Agent, the aggregate amount of all costs, expenses, indemnities and other amounts required to be reimbursed to Agent, in its capacity
as such, until paid in full;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Second</I>,
to Agent, for the ratable benefit of Lenders (in accordance with the portion funded by each Lender), the aggregate amount of all Obligations
arising on account of payments made by Agent in accordance with Section 8.2, until repaid in full;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Third</I>,
to Lenders, ratably in accordance with principal amount of the Loans held by each Lender, an amount equal to the aggregate costs, expenses,
indemnities or other amounts then required to be reimbursed to such Lender, until paid in full;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Fourth</I>,
to Lenders, ratably in accordance with aggregate amount of any fees, premiums or similar payments due to each Lender in respect of the
Loans held by such Lender, an amount equal to the aggregate fees, </FONT></P>

</DIV>
<DIV STYLE="float:right; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">premiums or other similar such payments due to such Lender in respect
of the Loans, until paid in full;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Fifth</I>,
to Lenders, ratably in accordance with accrued and unpaid interest in respect of the Loans and the other Obligations due to each Lender,
an amount equal to the aggregate accrued and unpaid interest on the Loans and other Obligations then due, until paid in full;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Sixth</I>,
to Lenders, ratably in accordance outstanding principal due to each Lender in respect of the Loans, an amount equal to the aggregate
principal outstanding in respect of the Loans then due, until paid in full;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Seventh</I>,
to Agent and each Lender, ratably in accordance with the any other Obligations due to such Lender, an amount equal to all other Obligations
due and payable to Agent and each Lender, until paid in full; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Last</I>,
the balance, if any, to Borrowers or as otherwise required by applicable law.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deficiency.
</B>If the Proceeds of any disposition of the Collateral are insufficient to cover all costs and expenses of such sale and the payment
in full of all the Obligations, plus all other sums required to be expended or distributed by Agent or any Lender, then Borrower shall
be liable for any such deficiency.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Agent
Transfer.</B> Upon the transfer of all or any part of the Obligations in accordance with the provisions of this Agreement, Agent may
transfer all or part of the Collateral and shall be fully discharged thereafter from all liability and responsibility with respect to
such Collateral so transferred, and the transferee shall be vested with all the rights and powers of Agent hereunder with respect to
such Collateral so transferred, but with respect to any Collateral not so transferred, Agent shall retain all rights and powers hereby
given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Agent&#146;s
Duties.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Agent
shall use reasonable care in the custody and preservation of any Collateral in its possession. Without limitation on other conduct which
may be considered the exercise of reasonable care, Agent shall be deemed to have exercised reasonable care in the custody and preservation
of such Collateral if such Collateral is accorded treatment substantially equal to that which Agent accords its own property, it being
understood that Agent shall not have any responsibility for ascertaining or taking action with respect to calls, conversions, exchanges,
maturities, declining value, tenders or other matters relative to any Collateral, regardless of whether Agent has or is deemed to have
knowledge of such matters; or taking any necessary steps to preserve any </FONT></P>
</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">rights against any Person with respect to any Collateral. Under
no circumstances shall Agent be responsible for any injury or loss to the Collateral, or any part thereof, arising from any cause beyond
the reasonable control of Agent.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Agent
may at any time deliver the Collateral or any part thereof to Borrower and the receipt of Borrower shall be a complete and full acquittance
for the Collateral so delivered, and Agent shall thereafter be discharged from any liability or responsibility therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Neither
Agent, nor any of its directors, officers, employees, agents, attorneys or any other person affiliated with or representing Agent
shall be liable for any claims, demands, losses or damages, of any kind whatsoever, made, claimed, incurred or suffered by Borrower
or any other party through the ordinary negligence of Agent, or any of its directors, officers, employees, agents, attorneys or any
other person affiliated with or representing Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Termination
of Security Interests and Loan Documents.</B> Upon the payment in full of the Obligations (other than inchoate indemnity obligations)
and satisfaction of all Borrower&#146;s obligations under this Agreement and the other Loan Documents, and if Lenders have no further
obligations under the Commitment, the security interest granted hereby shall terminate, all rights to the Collateral shall revert to
Borrower and this Agreement and the other Loan Documents shall terminate; provided that (i) those obligations, liabilities, covenants
and terms that are expressly specified herein and in any other Loan Document as surviving that respective agreement&#146;s termination,
including without limitation, Borrower&#146;s indemnity obligations set forth in this Agreement, shall continue to survive notwithstanding
anything to the contrary set forth herein, and (ii) nothing set forth herein shall affect or be deemed to affect those obligations, liabilities,
covenants and terms set forth in any warrant instrument issued to a Lender or set forth in any other equity securities or convertible
debt securities of Borrower acquired by Lenders in connection with this Agreement. Upon any such termination, Agent shall return all
Collateral in its possession or control to Borrower and, at Borrower&#146;s expense, execute and deliver to Borrower such documents
as Borrower shall reasonably request to evidence such termination. In connection therewith, Borrower agrees to provide each Lender with
such information as may be reasonably requested by such Lender as to whether the securities issuable upon the exercise of any Warrant
issued in connection with this Agreement constitute &#147;qualified small business stock&#148; for purposes of Section 1202(c) of the
Internal Revenue Code and Section 18152.5 of the California Revenue and Taxation Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>
<DIV STYLE="float:right; width:48%">


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
9 - </B>GENERAL PROVISIONS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notices</B>.
Any notice given by any party under any Loan Document shall be in writing and personally delivered, sent by overnight courier, or United
States mail, postage prepaid, or sent by facsimile, or other authenticated message, charges prepaid, to the other party&#146;s or parties&#146;
addresses shown on the Supplement. Each party may change the address or facsimile number to which notices, requests and other communications
are to be sent by giving written notice of such change to each other party. Notice given by hand delivery shall be deemed received on
the date delivered; if sent by overnight courier, on the next Business Day after delivery to the courier service; if by first class mail,
on the third Business Day after deposit in the U.S. Mail; and if by facsimile, on the date of transmission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Binding
Effect; Successors and Assigns</B>. The Loan Documents shall be binding upon and inure to the benefit of Borrower, Lenders, Agent and
their respective successors and assigns; provided, however, that Borrower may not assign or transfer Borrower&#146;s rights or obligations
under any Loan Document. Each Lender reserves the right to sell, assign, transfer, negotiate or grant participations in all or any part
of, or any interest in, such Lender&#146;s rights and obligations under the Loan Documents provided that, so long as no Event of Default
has occurred and is continuing, no Lender shall not assign any of such rights or obligations to any competitor of Borrower or to any
party that is not a financial institution. In connection with any of the foregoing, Lenders and Agent may disclose all documents and
information which Lenders and Agent now or hereafter may have relating to the Loans, Borrower, or its business, provided that any Person
who receives such information shall have agreed in writing in advance to maintain the confidentiality of such information on terms no
less favorable to Borrower than are set forth in Section 9.13 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Waiver</B>. Any waiver, consent or approval by Lenders of any Event of Default or breach of any provision, condition, or covenant of
any Loan Document must be in writing and shall be effective only to the extent set forth in writing. No waiver of any breach or default
shall be deemed a waiver of any later breach or default of the same or any other provision of any Loan Document. No failure or delay
on the part of Agent or any Lender in exercising any power, right, or privilege under any Loan Document shall operate as a waiver thereof,
and no single or partial exercise of any such power, right, or privilege shall preclude any further exercise thereof or the exercise
of any other power, right or privilege. Lenders have the right at their sole option to continue to accept interest and/or principal payments
due under the Loan Documents after default, and such acceptance shall not constitute a </FONT></P>
</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">waiver of said default or an extension of the
maturity of any Loan unless Lenders agree otherwise in writing.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rights
Cumulative</B>. All rights and remedies existing under the Loan Documents are cumulative to, and not exclusive of, any other rights or
remedies available under contract or applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unenforceable
Provisions</B>. Any provision of any Loan Document executed by Borrower which is prohibited or unenforceable in any jurisdiction,
shall be so only as to such jurisdiction and only to the extent of such prohibition or unenforceability, but all the remaining
provisions of any such Loan Document shall remain valid and enforceable.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounting
Terms</B>. Except as otherwise provided in this Agreement, accounting terms and financial covenants and information shall be determined
and prepared in accordance with GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indemnification;
Exculpation</B>. Borrower shall pay and protect, defend and indemnify each Lender, Agent and each Lender&#146;s and Agent&#146;s employees,
officers, directors, shareholders, affiliates, correspondents, agents and representatives (other than Lender, collectively <B>&#147;<U>Agents</U>&#148;</B>)
against, and hold each Lender, Agent and each of such Agents harmless from, all claims, actions, proceedings, liabilities, damages, losses,
expenses (including, without limitation, attorneys&#146; fees and costs) and other amounts incurred by each Lender, Agent and each of
such Agents, arising from (i) the matters contemplated by this Agreement or any other Loan Documents, (ii) any dispute between Borrower
and a third party, or (iii) any contention that Borrower has failed to comply with any law, rule, regulation, order or directive applicable
to Borrower&#146;s business; <B>provided, however</B>, that this indemnification shall not apply to any of the foregoing to the extent
incurred as the result of any Lender&#146;s, Agent&#146;s or any of such Agents&#146; employees or representatives gross negligence
or willful misconduct or in connection with any dispute or matter not involving an act or omission by Borrower. This indemnification
shall survive the payment and satisfaction of all of Borrower&#146;s Obligations to Lenders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reimbursement</B>.
Borrower shall reimburse each Lender and Agent for all costs and expenses, including without limitation reasonable attorneys&#146; fees
and disbursements expended or incurred by each Lender and Agent in any arbitration, mediation, judicial reference, legal action or otherwise
in connection with (a) the preparation and negotiation of the Loan Documents, (b) the amendment and enforcement of the Loan Documents,
including with</FONT></P>


</DIV>
<DIV STYLE="float:right; width:48%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the rendering of legal advice as to each
Lender&#146;s and Agent&#146;s rights, remedies and obligations under the Loan Documents, (c) collecting any sum which becomes due
to each Lender under any Loan Document, (d) any proceeding for declaratory relief, any counterclaim to any proceeding, or any appeal,
or (e) the protection, preservation or enforcement of any rights of Lenders or Agent under the Loan Documents. For the purposes of this
section, attorneys&#146; fees shall include, without limitation, fees incurred in connection with the following: (1) contempt proceedings;
(2) discovery; (3) any motion, proceeding or other activity of any kind in connection with an Insolvency Proceeding; (4) garnishment,
levy, and debtor and third party examinations; and (5) post-judgment motions and proceedings of any kind, including without limitation
any activity taken to collect or enforce any judgment. All of the foregoing costs and expenses shall be payable upon demand by any Lender
or Agent, and if not paid within forty-five (45) days of presentation of invoices shall bear interest at the Default Rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Execution
in Counterparts; Electronic Signatures</B>. This Loan Agreement and the other Loan Documents may be executed in any number of counterparts,
each of which shall be deemed an original, but all of which together shall constitute one and the same agreement. This Loan Agreement
and each of the other Loan Documents may be executed by electronic signatures. Borrower, Lenders and Agent expressly agree to conduct
the transactions contemplated by this Loan Agreement and the other Loan Documents by electronic means (including, without limitation,
with respect to the execution, delivery, storage and transfer of this Loan Agreement and each of the other Loan Documents by electronic
means and to the enforceability of electronic Loan Documents). Delivery of an executed signature page to this Loan Agreement and each
of the other Loan Documents by facsimile or other electronic mail transmission (including pdf or any electronic signature complying with
the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) shall be effective as delivery of a manually executed counterpart hereof
and thereof, as applicable. The words &#147;execution,&#148; &#147;signed,&#148; &#147;signature&#148; and words of like import
herein shall be deemed to include electronic signatures or the keeping of records in electronic form, each of which shall be of the same
legal effect, validity and enforceability as a manually executed signature or the use of a paper-based recordkeeping systems, as the
case may be, to the extent and as provided for in any applicable law, including, without limitation, any state law based on the Uniform
Electronic Transactions Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Entire
Agreement</B>. The Loan Documents are intended by the parties as the final expression of their agreement and therefore contain the entire
agreement </FONT></P>
</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">between the parties and supersede all prior understandings or agreements concerning the subject matter hereof. This Agreement
may be amended only in a writing signed by Borrower, each Lender and Agent.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Governing
Law and Jurisdiction</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>THIS
LOAN AGREEMENT AND THE LOAN DOCUMENTS SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF
CALIFORNIA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>ANY
LEGAL ACTION OR PROCEEDING WITH RESPECT TO THIS LOAN AGREEMENT OR ANY OTHER LOAN DOCUMENT MAY BE BROUGHT IN THE COURTS OF THE STATE OF
CALIFORNIA OR OF THE UNITED STATES FOR THE NORTHERN DISTRICT OF CALIFORNIA, AND BY EXECUTION AND DELIVERY OF THIS LOAN AGREEMENT, EACH
OF BORROWER, LENDERS AND AGENT CONSENTS, FOR ITSELF AND IN RESPECT OF ITS PROPERTY, TO THE NON-EXCLUSIVE JURISDICTION OF THOSE COURTS.
EACH OF BORROWER, LENDERS AND AGENT IRREVOCABLY WAIVES ANY OBJECTION, INCLUDING ANY OBJECTION TO THE LAYING OF VENUE OR BASED ON THE
GROUNDS OF FORUM NON CONVENIENS, WHICH IT MAY NOW OR HEREAFTER HAVE TO THE BRINGING OF ANY ACTION OR PROCEEDING IN SUCH JURISDICTION
IN RESPECT OF THIS LOAN AGREEMENT OR ANY DOCUMENT RELATED HERETO. BORROWER, LENDERS AND AGENT EACH WAIVE PERSONAL SERVICE OF ANY SUMMONS,
COMPLAINT OR OTHER PROCESS, WHICH MAY BE MADE BY ANY OTHER MEANS PERMITTED BY CALIFORNIA LAW.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Waiver
of Jury Trial</B>. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW, BORROWER, LENDERS AND AGENT EACH WAIVES ITS RESPECTIVE RIGHTS TO A
TRIAL BY JURY OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF OR RELATED TO THIS LOAN AGREEMENT, THE OTHER LOAN DOCUMENTS,
OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY, IN ANY ACTION, PROCEEDING OR OTHER LITIGATION OF ANY TYPE BROUGHT BY ANY OF THE PARTIES
AGAINST ANY OTHER PARTY OR ANY PARTICIPANT OR ASSIGNEE, WHETHER WITH RESPECT TO CONTRACT CLAIMS, TORT CLAIMS, OR OTHERWISE. BORROWER,
LENDERS AND AGENT EACH AGREES THAT ANY SUCH CLAIM OR CAUSE OF ACTION SHALL BE TRIED BY A COURT TRIAL WITHOUT A JURY. WITHOUT </FONT></P>

</DIV>
<DIV STYLE="float:right; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIMITING
THE FOREGOING, THE PARTIES FURTHER AGREE THAT THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY IS WAIVED BY OPERATION OF THIS SECTION AS TO
ANY ACTION, COUNTERCLAIM OR OTHER PROCEEDING WHICH SEEMS, IN WHOLE OR IN PART, TO CHALLENGE THE VALIDITY OR ENFORCEABILITY OF THIS LOAN
AGREEMENT OR THE OTHER LOAN DOCUMENTS OR ANY PROVISION HEREOF OR THEREOF. THIS WAIVER SHALL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS,
SUPPLEMENTS OR MODIFICATIONS TO THIS LOAN AGREEMENT AND THE OTHER LOAN DOCUMENTS. WITHOUT INTENDING IN ANY WAY TO LIMIT THE PARTIES&#146;
AGREEMENT TO WAIVE THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY, if the above waiver of the right to a trial by jury is not enforceable,
including to the extent any Lender or Agent seeks to enforce any judgment or takes any legal action in any other jurisdiction to realize
upon the Collateral, the parties hereto agree that, with respect to any actions and proceedings with respect to which the above jury
trial waiver is not enforceable, such disputes shall be decided by a reference to a private judge, mutually selected by the parties,
including, if applicable, in accordance with the provisions of California Code of Civil Procedure &sect;&sect; 638 through 645.1, inclusive.
This Section 9.12 shall survive the termination of this Loan Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Confidentiality.
</B>Each Lender agrees to hold in confidence all confidential information that it receives from Borrower pursuant to the Loan Documents,
except for disclosure as shall be reasonably required: (a) to legal counsel and accountants for each Lender and Agent (to
the extent that such professional advisors are subject to the same obligations of confidentiality as set forth herein); (b) to
other professional advisors to each Lender and Agent (to the extent that such professional advisors
are subject to the same obligations of confidentiality as set forth herein); (c) to regulatory officials having jurisdiction over
each Lender and Agent to the extent required by law; (d) to each Lender&#146;s and Agent&#146;s investors and prospective investors
(subject to the same confidentiality obligation set forth herein), and in each Lender&#146;s and Agent&#146;s SEC filings as required
by law, but only to the extent such disclosure is required under applicable law; (e) as required by law or legal process or in connection
with any legal proceeding to which Lenders, Agent and Borrower are adverse parties; (f) in connection with a disposition or proposed
disposition of any or all of each Lender&#146;s rights hereunder to any assignee or participant (subject to the same confidentiality
obligation set forth herein); (g) to each Lender&#146;s and Agent&#146;s subsidiaries or Affiliates in connection with their business
with Borrower (subject to the same confidentiality obligation set forth herein); (h) as </FONT></P>
</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">required
by valid order of a court of competent jurisdiction, administrative agency or governmental body, or by any applicable law, rule,
regulation, subpoena, or any other administrative or legal process, or by applicable regulatory or professional standards, including
in connection with any judicial or other proceeding involving any Lender or Agent relating to this Agreement and the transactions
contemplated hereby; and (i) as required in connection with each Lender&#146;s and Agent&#146;s examination or audit. For purposes
of this section, each Lender, Agent and Borrower agree that &#147;confidential information&#148; shall mean any information
regarding or relating to Borrower other than: (i) information which is or becomes generally available to the public other than as
result of a disclosure by such Lender or Agent in violation of this section, (ii) information which becomes available to any Lender
or Agent from any other source (other than Borrower) which such Lender or Agent does not know is bound by a confidentiality
agreement with respect to the information made available, and (iii) information that such Lender or Agent knows on a
non-confidential basis prior to Borrower disclosing it to such Lender or Agent. In addition, Borrower agrees that each Lender and
Agent may use Borrower&#146;s name, logo and/or trademark in connection with certain promotional materials that each Lender and
Agent may disseminate to the public, including, but are not limited to, brochures, internet website, press releases and any other
materials relating to the fact that each Lender and Agent has a financing relationship with Borrower.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lender&#146;s
Receipt of Confidential Information</B>. Lenders and Agent acknowledge that pursuant to the terms of this Agreement, Lenders and Agent
may receive information deemed confidential or &#147;insider&#148; information under the Exchange Act and other applicable law. Lenders
and Agent shall hold such information in confidence, and not disclose such information to any Person (other than pursuant to Section
9.13 above) until such information has been approved for release by Borrower and is released to the general public. Lenders and Agent
shall not use such information to purchase, sell, or otherwise arrange for the purchase or sale of shares of Borrower until such information
has been approved for release by Borrower and is released to the general public.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
10 - AGENCY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Appointment.
</B>Each Lender hereby irrevocably appoints Avenue Venture Opportunities Fund, L.P. to act on its behalf as the administrative agent
hereunder and under the other Loan Documents and authorizes the Agent to take such actions on its behalf and to exercise such powers
as are delegated to the Agent by </FONT></P>
</DIV>
<DIV STYLE="float:right; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the terms hereof or thereof, together with such actions and powers as are reasonably incidental thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indemnity.
</B>Each Lender agrees to indemnify the Agent in its capacity as such (to the extent not reimbursed by Borrowers and without limiting
the obligation of Borrowers to do so), according to its respective Commitment percentage in effect on the date on which indemnification
is sought under this Section 10.2, from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments,
suits, costs, expenses or disbursements of any kind whatsoever that may at any time be imposed on, incurred by or asserted against the
Agent in any way relating to or arising out of, this Loan Agreement, a Supplement, any of the other Loan Documents or any documents contemplated
by or referred to herein or therein or the transactions contemplated hereby or thereby or any action taken or omitted by the Agent under
or in connection with any of the foregoing; The agreements in this Section shall survive the payment of each Loan and all other amounts
payable hereunder. Agent shall not be liable for any action taken or not taken by it (i) with the consent or at the request of any Lender
or as Agent shall believe in good faith shall be necessary, under the circumstances or (ii) in the absence of its own gross negligence
or willful misconduct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Agent
in Its Individual Capacity</B>. The Person serving as the Agent hereunder shall have the same rights and powers in its capacity as a
Lender as any other Lender and may exercise the same as though it were not the Agent and the term &#147;Lender&#148; shall, unless
otherwise expressly indicated or unless the context otherwise requires, include each such Person serving as Agent hereunder in its individual
capacity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exculpatory
Provisions. </B>The Agent shall have no duties or obligations except those expressly set forth herein and in the other Loan Documents.
Without limiting the generality of the foregoing, the Agent shall not:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                            subject to any fiduciary or other implied duties, regardless of whether any default or any
                                            Event of Default has occurred and is continuing;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">have
                                            any duty to take any discretionary action or exercise any discretionary powers, except discretionary
                                            rights and powers expressly contemplated hereby or by the other Loan Documents that Agent
                                            is required to exercise as directed in writing by both Lenders, provided that the Agent shall
                                            not be required to take any action that, in its opinion or the opinion of its counsel, may
                                            expose the Agent to </FONT></TD></TR></TABLE>
</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">liability or that is contrary to any Loan Document or applicable law;
                                            and</FONT></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">except
as expressly set forth herein and in the other Loan Documents, have any duty to disclose, and the Agent shall not be liable for the failure
to disclose, any information relating to the Borrowers or any of its Affiliates that is communicated to or obtained by</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; margin-left: 0.25in; text-indent: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">any
Person serving as Agent or any of its Affiliates in any capacity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Duties.
</B>Agent shall not be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or representation made
in or in connection with this Agreement or any other Loan Document, (ii) the contents of any certificate, report or other document delivered
hereunder or thereunder or in connection herewith or therewith, (iii) the performance or observance of any of the covenants, agreements
or other terms or conditions set forth herein or therein or the occurrence of any default or Event of Default, (iv) the validity, enforceability,
effectiveness or genuineness of this Agreement, any other Loan Document or any other agreement, instrument or document or (v) the satisfaction
of any condition set forth in Section 4 or elsewhere herein, other than to confirm receipt of items expressly required to be delivered
to the Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reliance
by Agent. </B>Agent may rely, and shall be fully protected in acting, or refraining to act, upon, any resolution, statement, certificate,
instrument, opinion, report, notice, request, consent, order, bond or other paper or document that it has no reason to believe to be
other than genuine and to have been signed or presented by the proper party or parties or, in the case of cables, telecopies and telexes,
to have been sent by the proper party or parties. In the absence of its gross negligence or willful misconduct, Agent may conclusively
rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon any certificates or opinions furnished
to Agent and conforming to the requirements of the Loan Agreement or any of the other Loan Documents. Agent may consult with counsel,
and any opinion or legal advice of such counsel shall be full and complete authorization and protection in respect of any action taken,
not taken or suffered by Agent hereunder or under any Loan Documents in accordance therewith. Agent shall have the right at any time
to seek instructions concerning the administration of the Collateral from any court of competent jurisdiction. Agent shall not be under
any obligation to exercise any of the rights or powers granted to Agent by this Agreement and the other Loan Documents at the request
or direction of Lenders unless Agent shall have been provided by Lenders with adequate security and indemnity against the costs, expenses
and </FONT></P>


</DIV>
<DIV STYLE="float:right; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;">liabilities that may be incurred by it in compliance with such request or direction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateral
Agent. </B>The Agent shall also act as the &#147;collateral agent&#148; under the Loan Documents, and each of the Lenders hereby irrevocably
appoints and authorizes the Agent to act as the agent of such Lender for purposes of acquiring, holding and enforcing any and all Liens
on Collateral granted by Borrowers to secure any of the Obligations. Each Lender hereby authorizes Agent, on behalf of and for the ratable
benefit of Lenders, in its capacity as collateral agent, to enter into any of the Loan Documents as secured party for purposes of acquiring,
holding and enforcing all Liens on Collateral (and any other collateral from time to time securing the Obligations), and as Agent for
and representative of Lender thereunder, and each Lender agrees to be bound by the terms of each such document. All powers, rights and
remedies under the Loan Documents may be exercised solely by Agent for the benefit of Lenders and Agent in accordance with the terms
thereof. In the event of a foreclosure on any of the Collateral pursuant to a public or private sale, either Agent or any Lender may
be the purchaser of any or all of such Collateral at any such sale and Agent, as agent for and representative of Lenders (but not any
Lender or Lenders in its or their respective individual capacities unless Required Lenders shall otherwise agree in writing) shall be
entitled (subject to the proviso at the end of this sentence), for the purpose of bidding and making settlement or payment of the purchase
price for all or any portion of the Collateral sold at any such public sale, to use and apply any of the Obligations as a credit on account
of the purchase price for any Collateral payable by Agent at such sale; provided however, that neither Agent nor any Lender shall &#147;credit
bid&#148; at any foreclosure and/or other public or private sale absent the consent of the Required Lenders. Without limiting the generality
of the foregoing, Agent is hereby expressly authorized to execute any and all documents (including releases) that bind Lenders with respect
to (i) the Collateral and the rights of Lenders with respect thereto, as contemplated by and in accordance with the provisions of the
Loan Documents, and (ii) any other subordination agreement with respect to any Subordinated Debt.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Successor
Agents. </B>Agent may resign upon thirty (30) days&#146; notice to the Lenders and Borrowers. If Agent shall resign in its capacity
under this Loan Agreement and the other Loan Documents, then the Required Lenders shall appoint a successor agent, whereupon such successor
agent shall succeed to the rights, powers and duties of Agent in its capacity, and the term &#147;Agent&#148; shall mean such successor
agent effective upon such appointment and approval, and the former Agent&#146;s rights, powers and duties as Agent in its capacity </FONT></P>
</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shall
be terminated, without any other or further act or deed on the part of such former Agent or any of the parties to this Agreement or any
Lender. If no applicable successor agent has accepted appointment as such Agent in its capacity by the date that is twenty (20) days
following such retiring Agent&#146;s notice of resignation, such retiring Agent&#146;s resignation shall nevertheless
thereupon become effective and the Lenders shall assume and perform all of the duties of such Agent hereunder until such time, if any,
as the Required Lenders appoint a successor agent as provided for above. After any retiring Agent&#146;s resignation as Agent, the provisions
of this Section 10 shall inure to its benefit as to any actions taken or omitted to be taken by it while it was an Agent under this Agreement
and the other Loan Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
11 - </B>DEFINITIONS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
definitions appearing in this Loan Agreement or any Supplement shall be applicable to both the singular and plural forms of the defined
terms:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Account</U>&#148;
</B>means any &#147;account,&#148; as such term is defined in the UCC, now owned or hereafter acquired by Borrower or in which Borrower
now holds or hereafter acquires any interest and, in any event, shall include, without limitation, all accounts receivable, book debts
and other forms of obligations (other than forms of obligations evidenced by Chattel Paper, Documents or Instruments) now owned or hereafter
received or acquired by or belonging or owing to Borrower (including, without limitation, under any trade name, style or division thereof)
whether arising out of goods sold or services rendered by Borrower or from any other transaction, whether or not the same involves the
sale of goods or services by Borrower (including, without limitation, any such obligation that may be characterized as an account or
contract right under the UCC) and all of Borrower&#146;s rights in, to and under all purchase orders or receipts now owned or hereafter
acquired by it for goods or services, and all of Borrower&#146;s rights to any goods represented by any of the foregoing (including,
without limitation, unpaid seller&#146;s rights of rescission, replevin, reclamation and stoppage in transit and rights to returned,
reclaimed or repossessed goods), and all monies due or to become due to Borrower under all purchase orders and contracts for the sale
of goods or the performance of services or both by Borrower or in connection with any other transaction (whether or not yet earned by
performance on the part of Borrower), now in existence or hereafter occurring, including, without limitation, the right to receive the
proceeds of said purchase orders and contracts, and all collateral security and guarantees of any kind given by any Person with respect
to any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<DIV STYLE="float:right; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Affiliate</U>&#148;
</B>means any Person which directly or indirectly controls, is controlled by, or is under common control with Borrower. &#147;Control,&#148;
&#147;controlled by&#148; and &#147;under common control with&#148; mean direct or indirect possession of the power to direct or
cause the direction of management or policies (whether through ownership of voting securities, by contract or otherwise); provided, that
control shall be conclusively presumed when any Person or affiliated group directly or indirectly owns ten percent (10%) or more of the
securities having ordinary voting power for the election of directors of a corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Agreement</U>&#148;
</B>has the meaning as set forth in the introductory paragraph hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Bankruptcy
Code</U>&#148;</B> means the Federal Bankruptcy Reform Act of 1978 (11 U.S.C. &sect;101, <U>et seq</U>.), as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Basic
Interest</U>&#148;</B> means the rate of interest payable on the outstanding balance of each Loan at the applicable Designated Rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Borrowing
Date</U>&#148;</B> means the Business Day on which the proceeds of a Loan are disbursed by Lender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Borrowing
Request</U>&#148;</B> means a written request from Borrower in substantially the form of <U>Exhibit &#147;B&#148;</U> to the Supplement,
requesting the funding of one or more Loans on a particular Borrowing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Business
Day</U>&#148;</B> means any day other than a Saturday, Sunday or other day on which commercial banks in New York City or San Francisco
are authorized or required by law to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Change
of Control</U>&#148;</B> means: (a) any sale, license, or other disposition of all or substantially all of the assets of Borrower, other
than as permitted by Section 6.5; (b) any reorganization, consolidation, merger or other transaction in which Borrower is not the surviving
entity; or (c) any transaction or series of related transactions in which any Person or two or more Persons acting in concert (other
than Permitted Holders) shall have acquired, by contract or otherwise, the power to control the management of Borrower, or to control
the equity interests of Borrower entitled to vote for members of the Board of Directors or equivalent governing body of Borrower on a
fully-diluted basis (and taking into account all such securities that such Person or Persons have the right to acquire pursuant to any
option right) representing 50% or more of the combined voting power of such securities (other than in connection with a sale to recognized
venture capital investors in a transaction or series of transactions effected by Borrower for financing purposes, so long as Borrower
identifies to Lenders the venture capital investors prior to the closing of </FONT></P>

</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">the transaction and provides Lenders with a description of
the material terms of such transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Chattel
Paper</U>&#148;</B> means any &#147;chattel paper,&#148; as such term is defined in the UCC, now owned or hereafter acquired by Borrower
or in which Borrower now holds or hereafter acquires any interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Closing
Date</U>&#148;</B> means the date of this Loan Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Collateral</U>&#148;
</B>means all of Borrower&#146;s right, title and interest in and to the following property, whether now owned or hereafter acquired
and wherever located: (a) all Receivables; (b) all Equipment; (c) all Fixtures; (d) all General Intangibles; (e) all Inventory; (f) all
Investment Property; (g) all Deposit Accounts; (h) all Shares; (i)&nbsp;all other Goods and personal property of Borrower, whether tangible
or intangible and whether now or hereafter owned or existing, leased, consigned by or to, or acquired by, Borrower and wherever located;
(j) all Records; and (k) all Proceeds of each of the foregoing and all accessions to, substitutions and replacements for, and rents,
profits and products of each of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing the term &#147;Collateral&#148; shall not include: (i) more than sixty-five percent (65%) of the issued and outstanding
capital stock, membership units or other securities entitled to vote owned or held of record by Borrower in any Subsidiary that is a
controlled foreign corporation (as defined in the Internal Revenue Code), provided that the Collateral shall include one hundred percent
(100%) of the issued and outstanding non-voting capital stock of such Subsidiary; (ii) &#147;intent-to-use&#148; trademarks at all
times prior to the first use thereof, whether by the actual use thereof in commerce, the recording of a statement of use with the United
States Patent and Trademark Office or otherwise, but only to the extent the granting of a security interest in such &#147;intent to
use&#148; trademarks would be contrary to applicable law; (iii) any contract, Instrument or Chattel Paper in which Borrower has any
right, title or interest if and to the extent such contract, Instrument or Chattel Paper includes a provision containing a restriction
on assignment such that the creation of a security interest in the right, title or interest of Borrower therein would be prohibited and
would, in and of itself, cause or result in a default thereunder enabling another person party to such contract, Instrument or Chattel
Paper to enforce any remedy with respect thereto or (iv) Excluded Accounts; <U>provided, however</U>, that the foregoing exclusion shall
not apply if (A) such prohibition has been waived or such other person has otherwise consented to the creation hereunder of a security
interest in such contract, Instrument or Chattel Paper, or (B) such prohibition would be rendered ineffective pursuant to Sections 9-407(a)
or 9-408(a) of the UCC, as applicable and as then in effect in any </FONT></P>
</DIV>
<DIV STYLE="float:right; width:48%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">relevant jurisdiction, or any other applicable law (including the
Bankruptcy Code or principles of equity); <U>provided, further</U>, that immediately upon the ineffectiveness, lapse or termination of
any such provision, the term &#147;Collateral&#148; shall include, and Borrower shall be deemed to have granted a security interest
in, all its rights, title and interests in and to such contract, Instrument or Chattel Paper as if such provision had never been in effect;
and provided further that the foregoing exclusion shall in no way be construed so as to limit, impair or otherwise affect Agent&#146;s
unconditional continuing security interest in and to all rights, title and interests of Borrower in or to any payment obligations or
other rights to receive monies due or to become due under any such contract, Instrument or Chattel Paper and in any such monies and other
proceeds of such contract, Instrument or Chattel Paper.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Commitment</U>&#148;
</B>means the obligation of each Lender to make Loans to Borrower up to the aggregate principal amount set forth in the Supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Copyright
License</U>&#148; </B>means any written agreement granting any right to use any Copyright or Copyright registration now owned or hereafter
acquired by Borrower or in which Borrower now holds or hereafter acquires any interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Copyrights</U>&#148;
</B>means all of the following now owned or hereafter acquired by Borrower or in which Borrower now holds or hereafter acquires any interest:
(i) all copyrights, whether registered or unregistered, held pursuant to the laws of the United States, any State thereof or of any other
country; (ii) all registrations, applications and recordings in the United States Copyright Office or in any similar office or agency
of the United States, any State thereof or any other country; (iii) all continuations, renewals or extensions thereof; and (iv) any registrations
to be issued under any pending applications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Default</U>&#148;
</B>means an event which with the giving of notice, passage of time, or both would constitute an Event of Default.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Default
Rate</U>&#148;</B> means the applicable Designated Rate plus five percent (5%) per annum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Deposit
Accounts</U>&#148;</B> means any &#147;deposit accounts,&#148; as such term is defined in the UCC, now owned or hereafter acquired
by Borrower or in which Borrower now holds or hereafter acquires any interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Designated
Rate</U>&#148;</B> means the rate of interest per annum described in the Supplement as being applicable to an outstanding Loan from
time to time.</FONT></P>
</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#147;<B><U>Disclosure
Letter</U></B>&#148; means that certain Confidential Disclosure Letter delivered by the Borrower to the Lender of even date herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Documents</U>&#148;
</B>means any &#147;documents,&#148; as such term is defined in the UCC, now owned or hereafter acquired by Borrower or in which Borrower
now holds or hereafter acquires any interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Dollars</U>&#148;
</B>or <B>&#147;<U>$</U>&#148;</B> means lawful currency of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Environmental
Laws</U>&#148;</B> means all federal, state or local laws, statutes, common law duties, rules, regulations, ordinances and codes, together
with all administrative orders, directed duties, requests, licenses, authorizations and permits of, and agreements with, any governmental
authorities, in each case relating to environmental, health, or safety matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Equipment</U>&#148;
</B>means any &#147;equipment,&#148; as such term is defined in the UCC, now owned or hereafter acquired by Borrower or in which Borrower
now holds or hereafter acquires any interest and any and all additions, substitutions and replacements of any of the foregoing, wherever
located, together with all attachments, components, parts, equipment and accessories installed thereon or affixed thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Event
of Default</U>&#148;</B> means any event described in Section 7.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Exchange
Act</U>&#148;</B> means, at any time, the Securities Exchange Act of 1934, as amended from time to time, and any successor statute,
and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Excluded
Account</U>&#148;</B> means any account that is (i) exclusively used for payroll, payroll taxes or other employee wage or benefit payments
to or for the benefit of Borrower&#146;s employees and identified to Lender as such, and (ii) other accounts with a monthly average
balance of less than $10,000 in the aggregate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Fixtures</U>&#148;
</B>means any &#147;fixtures,&#148; as such term is defined in the UCC, now owned or hereafter acquired by Borrower or in which Borrower
now holds or hereafter acquires any interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>GAAP</U>&#148;
</B>means generally accepted accounting principles and practices consistent with those principles and practices promulgated or adopted
by the Financial Accounting Standards Board and the Board of the American Institute of Certified Public Accountants, their respective
predecessors and successors, as in effect from time to time. Each </FONT></P>


</DIV>
<DIV STYLE="float:right; width:48%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">accounting term used but not otherwise expressly defined herein shall
have the meaning given it by GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>General
Intangibles</U>&#148;</B> means any &#147;general intangibles,&#148; as such term is defined in the UCC, now owned or hereafter acquired
by Borrower or in which Borrower now holds or hereafter acquires any interest and, in any event, shall include, without limitation, all
right, title and interest that Borrower may now or hereafter have in or under any contract, all customer lists, Copyrights, Trademarks,
Patents, websites, domain names, and all applications therefor and reissues, extensions, or renewals thereof, other items of, and rights
to, Intellectual Property, interests in partnerships, joint ventures and other business associations, Licenses, permits, trade secrets,
proprietary or confidential information, inventions (whether or not patented or patentable), technical information, procedures, designs,
knowledge, know-how, software, data bases, data, skill, expertise, recipes, experience, processes, models, drawings, materials and records,
goodwill (including, without limitation, the goodwill associated with any Trademark, Trademark registration or Trademark licensed under
any Trademark License), claims in or under insurance policies, including unearned premiums, uncertificated securities, money, cash or
cash equivalents, deposit, checking and other bank accounts, rights to sue for past, present and future infringement of Copyrights, Trademarks
and Patents, rights to receive tax refunds and other payments and rights of indemnification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Goods</U>&#148;
</B>means any &#147;goods,&#148; as such term is defined in the UCC, now owned or hereafter acquired by Borrower or in which Borrower
now holds or hereafter acquires any interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Indebtedness</U>&#148;
</B>of any Person means at any date, without duplication and without regard to whether matured or unmatured, absolute or contingent:
(i) all obligations of such Person for borrowed money; (ii) all obligations of such Person evidenced by bonds, debentures, notes, or
other similar instruments; (iii) all obligations of such Person to pay the deferred purchase price of property or services, except trade
accounts payable arising in the ordinary course of business and accounts payable and other liabilities incurred in the ordinary course
of business that are not overdue by more than one-hundred twenty (120) days; (iv) all obligations of such Person as lessee under capital
leases that is properly classified and accounted for as a liability on a balance sheet in accordance with GAAP and attributable to such
Person; (v) all obligations of such Person to reimburse or prepay any bank or other Person in respect of amounts paid under a letter
of credit, banker&#146;s acceptance, or similar instrument, whether drawn or undrawn; (vi)&nbsp;all obligations of such Person to purchase
securities which arise out of or in connection with the sale of the same or substantially similar securities; (vii) all </FONT></P>

</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">obligations of such Person to purchase, redeem, exchange, convert or otherwise acquire for value any capital stock of such Person or any warrants, rights or options to acquire such capital stock, now or hereafter outstanding, except to the extent that such obligations remain performable solely at the option of such Person; (viii) all obligations to repurchase assets previously sold (including any obligation to repurchase any accounts or chattel paper under any factoring, receivables purchase, or similar arrangement); (ix) obligations of such Person under interest rate swap, cap, collar or similar hedging arrangements; and (x)&nbsp;all obligations of others of any type described in clause (i) through clause (ix) above guaranteed by such Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Insolvency
Proceeding</U>&#148; </B>means with respect to a Person (a) any case, action or proceeding before any court or other governmental authority
relating to bankruptcy, reorganization, insolvency, liquidation, receivership, dissolution, winding-up or relief of debtors with respect
to such Person, or (b) any general assignment for the benefit of creditors, composition, marshalling of assets for creditors, or other,
similar arrangement in respect of such Person&#146;s creditors generally or any substantial portion of its creditors, undertaken under
U.S. Federal, state or foreign law, including the Bankruptcy Code, but in each case, excluding any avoidance or similar action against
such Person commenced by an assignee for the benefit of creditors, bankruptcy trustee, debtor in possession, or other representative
of another Person or such other Person&#146;s estate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Instruments</U>&#148;
</B>means any &#147;instrument,&#148; as such term is defined in the UCC, now owned or hereafter acquired by Borrower or in which Borrower
now holds or hereafter acquires any interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Intellectual
Property</U>&#148; </B>means all of Borrower&#146;s Copyrights, Trademarks, Patents, Licenses, trade secrets, source codes, customer
lists, proprietary or confidential information, inventions (whether or not patented or patentable), technical information, procedures,
designs, knowledge, know-how, software, data bases, skill, expertise, experience, processes, models, drawings, materials, records and
goodwill associated with the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Intellectual
Property Security Agreement</U>&#148;</B> means any Intellectual Property Security Agreement executed and delivered by Borrower in favor
of Agent, as the same may be amended, amended and restated, supplemented, or otherwise modified from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Inventory</U>&#148;
</B>means any &#147;inventory,&#148; as such term is defined in the UCC, wherever located, now owned or hereafter acquired by Borrower
or in which Borrower now holds or hereafter acquires any interest, and, in any event, </FONT></P>
</DIV>

<DIV STYLE="float:right; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shall include, without limitation, all inventory,
goods and other personal property that are held by or on behalf of Borrower for sale or lease or are furnished or are to be furnished
under a contract of service or that constitute raw materials, work in process or materials used or consumed or to be used or consumed
in Borrower&#146;s business, or the processing, packaging, promotion, delivery or shipping of the same, and all finished goods, whether
or not the same is in transit or in the constructive, actual or exclusive possession of Borrower or is held by others for Borrower&#146;s
account, including, without limitation, all goods covered by purchase orders and contracts with suppliers and all goods billed and held
by suppliers and all such property that may be in the possession or custody of any carriers, forwarding agents, truckers, warehousemen,
vendors, selling agents or other Persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Investment</U>&#148;
</B>means, as to any Person, any loans to any other Person, guaranties of the obligations of, advances to, or capital contributions to
any other Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Investment
Property</U>&#148; </B>means any &#147;investment property,&#148; as such term is defined in the UCC, now owned or hereafter acquired
by Borrower or in which Borrower now holds or hereafter acquires any interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Letter-of-Credit
Rights</U>&#148;</B> means any &#147;letter-of-credit rights,&#148; as such term is defined in the UCC, now owned or hereafter acquired
by Borrower or in which Borrower now holds or hereafter acquires any interest, including any right to payment under any letter of credit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>License</U>&#148;
</B>means any Copyright License, Patent License, Trademark License or other license of rights or interests now held or hereafter acquired
by Borrower or in which Borrower now holds or hereafter acquires any interest and any renewals or extensions thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Lien</U>&#148;
</B>means any mortgage, deed of trust, pledge, hypothecation, assignment for security, security interest, encumbrance, levy, lien or
charge of any kind, whether voluntarily incurred or arising by operation of law or otherwise, against any property, any conditional sale
or other title retention agreement, any lease in the nature of a security interest, and the filing of any financing statement (other
than a precautionary financing statement with respect to a lease that is not in the nature of a security interest) under the UCC or comparable
law of any jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Loan</U>&#148;
</B>means an extension of credit by Lender under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Loan
Agreement</U>&#148;</B> has the meaning as set forth in the introductory paragraph.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Loan
Documents</U>&#148;</B> means, individually and collectively, this Loan Agreement, each Supplement, the Disclosure Letter, each Note,
the Intellectual Property Security Agreement, and any other security or pledge agreement(s), any Warrant issued by Borrower in connection
with this Agreement, and all other contracts, instruments, addenda and documents executed in connection with this Agreement or the extensions
of credit which are the subject of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Material
Adverse Effect</U>&#148;</B> means (a) a material adverse change in, or a material adverse effect upon, the operations, business, properties,
or condition (financial or otherwise) of Borrower; (b) a material impairment of the ability of Borrower to perform under any Loan Document;
or (c) a material adverse effect upon the legality, validity, binding effect or enforceability against Borrower of any Loan Document.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Note</U>&#148;
</B>means a promissory note substantially in the form attached to the Supplement as <U>Exhibit &#147;A&#148;</U>, executed by Borrower
evidencing each Loan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Obligations</U>&#148;
</B>means all debts, obligations and liabilities of Borrower to each Lender or Agent now or hereafter made, incurred or created under,
pursuant to or in connection with this Agreement or any other Loan Document (other than the Warrant), whether voluntary or involuntary
and however arising or evidenced, whether direct or acquired by such Lender or Agent by assignment or succession, whether due or not
due, absolute or contingent, liquidated or unliquidated, determined or undetermined, and whether Borrower may be liable individually
or jointly, or whether recovery upon such debt may be or become barred by any statute of limitations or otherwise unenforceable; and
all renewals, extensions and modifications thereof; and all attorneys&#146; fees and costs incurred by each Lender and Agent in connection
with the collection and enforcement thereof as provided for in any such Loan Document.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Patent
License</U>&#148;</B> means any written agreement granting any right with respect to any invention on which a Patent is in existence
now owned or hereafter acquired by Borrower or in which Borrower now holds or hereafter acquires any interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Patents</U>&#148;
</B>means all of the following property now owned or hereafter acquired by Borrower or in which Borrower now holds or hereafter acquires
any interest: (a) all letters patent of, or rights corresponding thereto in, the United States or any other country, all registrations
and recordings thereof, and all applications for letters patent of, or rights corresponding thereto in, the United States or any other
country, including, without limitation, registrations, recordings and applications in the United States Patent and </FONT></P>





</DIV>
<DIV STYLE="float:right; width:48%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark Office or
in any similar office or agency of the United States, any State thereof or any other country; (b)&nbsp;all reissues, continuations, continuations-in-part
or extensions thereof; (c) all petty patents, divisionals, and patents of addition; and (d) all patents to be issued under any such applications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Perfection
Certificate</U>&#148;</B> means that certain Perfection Certificate dated October 25, 2021 by Borrower to Lender as amended, amended
and restated, supplemented, or otherwise modified from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Permitted
Holders</U>&#148; </B>means Terren Peizer and Cuong Do.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Permitted
Lien</U>&#148;</B> means:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>involuntary
Liens which, in the aggregate, would not have a Material Adverse Effect and which in any event would not exceed, in the aggregate, the
Threshold Amount;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Liens
for current taxes or other governmental or regulatory assessments which are not delinquent, or which are contested in good faith by the
appropriate procedures and for which appropriate reserves are maintained;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>security
interests on any property held or acquired by Borrower in the ordinary course of business securing Indebtedness incurred or assumed for
the purpose of financing all or any part of the cost of acquiring such property; <U>provided</U>, that such Lien attaches solely to the
property acquired with such Indebtedness and that the principal amount of such Indebtedness does not exceed one hundred percent (100%)
of the cost of such property;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Liens
in favor of Agent;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>bankers&#146;
liens, rights of setoff and similar Liens incurred on deposits made in the ordinary course of business as long as an account control
agreement (or equivalent) for each account in which such deposits are held in a form acceptable to Agent has been executed and delivered
to Agent to the extent required under Section 6.11;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>materialmen&#146;s,
mechanics&#146;, repairmen&#146;s, warehousemen&#146;s, carriers&#146;, landlord&#146;s (subject to Section 5.9(e) hereof), employees&#146;
or other like Liens arising in the ordinary course of business and which are not delinquent for more than 45 days or are being contested
in good faith by appropriate proceedings;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>any
judgment, attachment or similar Lien, unless the judgment it secures exceeds the Threshold </FONT></P>
</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount and has not been discharged or execution thereof effectively stayed and bonded against pending appeal within 30 days of the entry thereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>licenses
or sublicenses of Intellectual Property in accordance with the terms of Section 6.5 hereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Liens
securing Subordinated Debt;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Liens
acceptable to Lenders, which are listed in the Disclosure Letter and any renewals or extensions thereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>the
interests of licensors under inbound licenses to Borrower;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>the
interests of sub-lessees under subleases of real property;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Liens
to secure payment of workers&#146; compensation, employment insurance, old-age pensions, social security and other like obligations
incurred in the ordinary course of business (other than Liens imposed by ERISA);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>deposits
to secure the performance of bids, trade contracts (other than for Indebtedness), leases (other than capital lease obligations), statutory
obligations, surety and appeal bonds, performance bonds and other obligations of a like nature arising as a matter of law and incurred
in the ordinary course of business; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>zoning
restrictions, easements, rights of way, restrictions on use of real property and other similar encumbrances incurred in the ordinary
course of business which, in the aggregate, are not substantial in amount and do not materially detract from the value of the property
subject thereto or interfere with the ordinary conduct of the business of the Borrower or any of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Person</U>&#148;
</B>means any individual, sole proprietorship, partnership, joint venture, trust, unincorporated organization, association, corporation,
limited liability company, institution, public benefit corporation, other entity or government (whether federal, state, county, city,
municipal, local, foreign, or otherwise, including any instrumentality, division, agency, body or department thereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Proceeds</U>&#148;
</B>means &#147;proceeds,&#148; as such term is defined in the UCC and, in any event, shall include, without limitation, (a) any and
all Accounts, Chattel Paper, Instruments, cash or other forms of money or currency or other proceeds payable to Borrower from time to
time in respect of the Collateral, (b) any and all proceeds of any </FONT></P>

</DIV>
<DIV STYLE="float:right; width:48%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">insurance, indemnity, warranty or guaranty payable to Borrower from
time to time with respect to any of the Collateral, (c) any and all payments (in any form whatsoever) made or due and payable to Borrower
from time to time in connection with any requisition, confiscation, condemnation, seizure or forfeiture of all or any part of the Collateral
by any governmental authority (or any Person acting under color of governmental authority), (d) any claim of Borrower against third parties
(i)&nbsp;for past, present or future infringement of any Copyright, Patent or Patent License or (ii) for past, present or future infringement
or dilution of any Trademark or Trademark License or for injury to the goodwill associated with any Trademark, Trademark registration
or Trademark licensed under any Trademark License and (e) any and all other amounts from time to time paid or payable under or in connection
with any of the Collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Receivables</U>&#148;
</B>means all of Borrower&#146;s Accounts, Instruments, Documents, Chattel Paper, Supporting Obligations, and letters of credit and
Letter-of-Credit Rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Records</U>&#148;
</B>means all Borrower&#146;s computer programs, software, hardware, source codes and data processing information, all written documents,
books, invoices, ledger sheets, financial information and statements, and all other writings concerning Borrower&#146;s business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Related
Person</U>&#148;</B> means any Affiliate of Borrower, or any officer, employee, director or equity security holder of Borrower or any
Affiliate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Required
Lenders</U>&#148; </B>(and each a <B>&#147;Required Lender</B>&#148;) means, as of any date of determination, Lenders holding at least
51% of the outstanding principal balance of the total principal amount of Loans then outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Rights
to Payment</U>&#148;</B> means all Borrower&#146;s accounts, instruments, contract rights, documents, chattel paper and all other rights
to payment, including, without limitation, the Accounts, all negotiable certificates of deposit and all rights to payment under any Patent
License, any Trademark License, or any commercial or standby letter of credit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Security
Documents</U>&#148;</B> means this Loan Agreement, the Supplement hereto, the Intellectual Property Security Agreement, and any and
all account control agreements, collateral assignments, chattel mortgages, financing statements, amendments to any of the foregoing
and other documents from time to time executed or filed to create, perfect or maintain the perfection of Agent&#146;s Liens on the
Collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Shares</U>&#148;
</B>means: (a) one hundred percent (100%) of the issued and outstanding capital stock, membership units or </FONT></P>
</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="float:LEFT; width:48%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other securities owned or
held of record by Borrower in any Subsidiary that is not a controlled foreign corporation (as defined in the Internal Revenue Code),
and (b) 65% of the issued and outstanding capital stock, membership units or other securities entitled to vote owned or held of record
by Borrower in any Subsidiary that is a controlled foreign corporation (as defined in the Internal Revenue Code).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Subordinated
Debt</U>&#148;</B> means Indebtedness (i) approved by Required Lenders; and (ii) where the holder&#146;s right to payment of such Indebtedness,
the priority of any Lien securing the same, and the rights of the holder thereof to enforce remedies against Borrower following default
have been made subordinate to the Liens of Agent and to the prior payment to each Lender of the Obligations, either (A) pursuant to a
written subordination agreement approved by Required Lenders in their sole but reasonable discretion or (B) on terms otherwise approved
by Required Lenders in their sole but reasonable discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Subsidiary</U>&#148;
</B>means any Person a majority of the equity ownership or voting stock of which is directly or indirectly now owned or hereafter acquired
by Borrower or by one or more other Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Supplement</U>&#148;
</B>means that certain supplement to the Loan and Security Agreement, as the same may be amended or restated from time to time, and any
other supplements entered into between Borrower and each Lender, as the same may be amended or restated from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Supporting
Obligations</U>&#148;</B> means any &#147;supporting obligations,&#148; as such term is defined in the UCC, now owned or hereafter
acquired by Borrower or in which Borrower now holds or hereafter acquires any interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Termination
Date</U>&#148;</B> has the meaning specified in the Supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Threshold
Amount</U>&#148;</B> has the meaning specified in the Supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Trademark
License</U>&#148;</B> means any written agreement granting any right to use any Trademark or Trademark registration now owned or hereafter
acquired by Borrower or in which Borrower now holds or hereafter acquires any interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Trademarks</U>&#148;
</B>means all of the following property now owned or hereafter acquired by Borrower or in which Borrower now holds or hereafter acquires
any interest: (a)&nbsp;all trademarks, tradenames, corporate names, business names, trade styles, service marks, logos, other source
or business identifiers, prints and labels on which any of the foregoing have appeared or appear, designs and general </FONT></P>

</DIV>
<DIV STYLE="float:right; width:48%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">intangibles of
like nature, now existing or hereafter adopted or acquired, all registrations and recordings thereof, and any applications in connection
therewith, including, without limitation, registrations, recordings and applications in the United States Patent and Trademark Office
or in any similar office or agency of the United States, any State thereof or any other country or any political subdivision thereof
and (b)&nbsp;reissues, extensions or renewals thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>UCC</U>&#148;
</B>means the Uniform Commercial Code as the same may, from time to time, be in effect in the State of California; <U>provided</U>, that
in the event that, by reason of mandatory provisions of law, any or all of the attachment, perfection or priority of, or remedies with
respect to, Agent&#146;s Lien on any Collateral is governed by the Uniform Commercial Code as enacted and in effect in a jurisdiction
other than the State of California, the term &#147;UCC&#148; shall mean the Uniform Commercial Code as enacted and in effect in such
other jurisdiction solely for purposes of the provisions thereof relating to such attachment, perfection, priority or remedies and for
purposes of definitions related to such provisions. Unless otherwise defined herein, terms that are defined in the UCC and used herein
shall have the meanings given to them in the UCC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;<U>Warrant</U>&#148;
</B>has the meaning specified in the Supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
pages follow]</I></FONT></P>


</div>
<br CLEAR=ALL><BR>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
page to Loan and Security Agreement]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties have executed this Loan Agreement as of the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BORROWER:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BIOVIE
INC.,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
Nevada corporation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 35%; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Cuong Do</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cuong Do</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Chief Executive Officer</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
page to Loan and Security Agreement]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LENDERS:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AVENUE
VENTURE OPPORTUNITIES FUND, L.P.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avenue
    Venture Opportunities Partners, LLC</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    Partner</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%">/s/ Sonia Gardner</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 22%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonia
    Gardner</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
    Signatory</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AVENUE
VENTURE OPPORTUNITIES FUND II, L.P.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avenue
    Venture Opportunities Partners II, LLC</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    Partner</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Sonia Gardner</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 22%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonia
    Gardner</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
    Signatory</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AGENT:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AVENUE
VENTURE OPPORTUNITIES FUND, L.P.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avenue
    Venture Opportunities Partners, LLC</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    Partner</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Sonia Gardner</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 22%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonia
    Gardner</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
    Signatory</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>bivi-20211130_8kex10z2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Execution
Copy</I></B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SUPPLEMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
the</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan
and Security Agreement</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dated
as of November 30, 2021</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">between</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioVie
Inc. (&#147;Borrower&#148;)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avenue
Venture Opportunities Fund, L.P. II, a Delaware limited partnership (&#147;AVOF 2&#148;), as a lender</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avenue
Venture Opportunities Fund, L.P., a Delaware limited partnership (&#147;Avenue&#148; and, in its capacity as a lender, together with
AVOF 2, each a &#147;Lender&#148; and collectively, &#147;Lenders,&#148; and in its capacity as administrative agent and collateral agent,
&#147;Agent&#148;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
is a Supplement identified in the document entitled Loan and Security Agreement, dated as of November 30, 2021 (as amended, restated,
supplemented and modified from time to time, the <B>&#147;Loan Agreement&#148;</B>), by and among Borrower, Lenders and Agent. All
capitalized terms used in this Supplement and not otherwise defined in this Supplement have the meanings ascribed to them in the Loan
Agreement, which is incorporated in its entirety into this Supplement. In the event of any inconsistency between the provisions of the
Loan Agreement and this Supplement, this Supplement is controlling.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the provisions of the Loan Agreement, the parties agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Part
1 - </B>Additional Definitions:</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;Amortization
Period&#148;</B> means the period commencing on the first day of the first full calendar month following the Interest-only Period and
continuing until the Maturity Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;Commitment&#148;
</B>means, subject to the terms and conditions set forth in the Loan Agreement and this Supplement, Lenders&#146; commitment to make
Growth Capital Loans to Borrower up to the aggregate original principal amount of Twenty Million Dollars ($20,000,000), with Ten Million
Dollars ($10,000,000) to be funded by Avenue and Ten Million Dollars ($10,000,000) to be funded by AVOF 2. The Commitment shall be divided
into two (2) tranches in the following amounts: (i) Fifteen Million Dollars ($15,000,000), with Seven Million Five Hundred Thousand ($7,500,000)
to be funded by Avenue and Seven Million Five Hundred Thousand ($7,500,000) to be funded by AVOF 2 on the Closing Date (&#147;<B>Tranche
1</B>&#148;); and (ii) up to Five Million Dollars ($5,000,000) to be funded between the Tranche 2 Start Date and the Tranche 2 End Date,
subject to the conditions in Section 1(b)(i) of Part 2 (&#147;<B>Tranche 2</B>&#148;). Notwithstanding the foregoing, at the request
of Borrower, Lenders may make additional Growth Capital Loans to Borrower in an additional amount of Five Million Dollars ($5,000,000)
upon Borrower&#146;s achievement of the Tranche 3 Increase Conditions, the mutual written agreement of Borrower and Lenders, each acting
in its sole discretion, and subject to execution and delivery by Borrower, Lenders and Agent of amendments to the Loan Documents and
the Warrants in form and substance satisfactory to Lenders to reflect such additional Growth Capital Loans and the other terms of the
Loan Agreement (the &#147;<B>Tranche 3 Discretionary Commitment</B>&#148;), but such Tranche 3 Discretionary Commitment shall only
be included in the definition of &#147;Commitment&#148; at such time as the additional Five Million Dollars ($5,000,000) (&#147;<B>Tranche
3</B>&#148;) is actually funded by Lenders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;Designated
Rate&#148;</B> means, for each Growth Capital Loan, a variable rate of interest per annum equal to the greater of (i) the sum of seven
percent (7.00%) <U>plus</U> the Prime Rate, and (ii) ten and three-quarters percent (10.75%). Changes to the Designated Rate based on
changes to the Prime Rate shall be effective as of the next scheduled interest payment date immediately following such change.</FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;Final
Payment&#148;</B> means a payment (in addition to and not a substitution for the regular monthly payments of principal plus accrued
interest) equal to four and one-quarter percent (4.25%) of the sum of (a) the original aggregate principal amount of Tranche 1 and Tranche
2 Commitment amount of Twenty Million Dollars ($20,000,000.00) plus (b) the aggregate principal amount borrowed under Tranche 3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;Growth
Capital Loan&#148;</B> means any Loan requested by Borrower and funded by a Lender under its Commitment for general corporate purposes
of Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;Interest-only
Period&#148;</B> means the period commencing on the Closing Date and continuing until the eighteenth (18<SUP>th</SUP>) month anniversary
of the Closing Date; provided, however, that such period shall be extended for an additional six (6) months from the end of such eighteen
(18) month period prior to the Tranche 2 End Date, Borrower has received a Tranche 2 Loan; <I>provided, further</I>, however, that the
Interest-only Period shall not exceed twenty-four (24) months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;Loan&#148;
</B>or <B>&#147;Loans&#148;</B> mean, as the context may require, individually a Growth Capital Loan, and collectively, the Growth
Capital Loans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;Loan
Commencement Date&#148;</B> means, with respect to each Growth Capital Loan: (a) the first day of the first full calendar month following
the Borrowing Date of such Loan if such Borrowing Date is not the first day of a month; or (b) the same day as the Borrowing Date if
the Borrowing Date is the first day of a month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;Maturity
Date&#148;</B> means December 1, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;Prepayment
Fee&#148;</B> means, with respect to any prepayment of the Loans:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 69.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&#9;if
the prepayment occurs during the period commencing on the Closing Date and ending on the last day of the Interest-only Period, an amount
equal to the principal amount of such Loans prepaid multiplied by three percent (3.00%); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 69.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&#9;if
the prepayment occurs during the period commencing on the first day after the Interest-only Period and ending on (but excluding) the
Maturity Date, an amount equal to the principal amount of the Loans prepaid multiplied by one percent (1.00%).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;Prime
Rate&#148;</B> is the rate of interest per annum from time to time published in the money rates section of The Wall Street Journal or
any successor publication thereto as the &#147;prime rate&#148; then in effect; provided that, in the event such rate of interest is
less than zero, such rate shall be deemed to be zero for purposes of this Supplement; and provided further that if such rate of interest,
as set forth from time to time in the money rates section of The Wall Street Journal, becomes unavailable for any reason as determined
by Agent, the &#147;Prime Rate&#148; shall mean the rate of interest per annum announced by Silicon Valley Bank as its prime rate in
effect at its principal office in the State of California (such announced Prime Rate not being intended to be the lowest rate of interest
charged by such institution in connection with extensions of credit to debtors); provided that, in the event such rate of interest is
less than zero, such rate shall be deemed to be zero for purposes of this Supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;Revenue&#148;
</B>means revenue, determined in accordance with GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;Termination
Date&#148;</B> means the earlier of: (i) the date Lenders may terminate making Growth Capital Loans or extending other credit pursuant
to the rights of Lenders under Article 7 of the Loan Agreement; and (ii) January 15, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;Threshold
Amount&#148;</B> means Two Hundred Fifty Thousand Dollars ($250,000.00).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;Tranche
2 End Date&#148;</B> means September 15, 2022.</FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;Tranche
2 Milestone&#148;</B> means Borrower has achieved at least two (2) of the following milestones: (a) achievement of positive data in
the ongoing phase 2b study of BIV201 for the treatment of refractory ascites, (b) completion of enrollment of at least ninety percent
(90%) of the patients in the ongoing phase 3 study of NE3107 for the treatment of Alzheimer&#146;s Disease, and (c) achievement of positive
data from the phase 2 study of NE3107 for the treatment of Parkinson&#146;s Disease, in each case as determined by Lenders in their
sole discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#147;<B>Tranche
2 Start Date</B>&#148; means the Closing Date, but subject to Borrower&#146;s achievement of the Tranche 2 Milestone.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;Tranche
3 Increase Conditions&#148;</B> means (a) Borrower has achieved positive data from the phase 3 study of NE3107 for the treatment of
Alzheimer&#146;s Disease, as determined by each Lender in its sole discretion, and (b) each funding Lender has obtained approval from
such Lender&#146;s investment committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#147;Warrant&#148;
</B>is defined in Part 2, Section 3(a) hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Part
2 - </B>Additional Covenants and Conditions:</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Growth
Capital Loan Facility.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Conditions
Precedent Regarding Growth Capital Loan Commitments</B>. Subject to satisfaction of all of the applicable conditions precedent specified
in Sections 4.1 and 4.2 of the Loan and Security Agreement and this Supplement, each Lender shall fund its pro rata share of the Tranche
1 Commitment in the aggregate amount of Fifteen Million Dollars ($15,000,000) on the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional
Condition(s) Precedent Regarding Growth Capital Loan Commitments</B>. In addition to the satisfaction of all of the other applicable
conditions precedent specified in Sections 4.1 and 4.2 of the Loan and Security Agreement and this Supplement, Lenders&#146; obligation
to fund Tranche 2 and Tranche 3 of the Commitment of Growth Capital Loans is subject to receipt by Lenders of evidence that the following
conditions precedent have been satisfied, as determined by Lenders in their sole discretion:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with
respect to Tranche 2, Borrower has achieved the Tranche 2 Milestone; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with
respect to Tranche 3, Borrower has achieved the Tranche 3 Increase Conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to satisfaction of the conditions precedent specified in Sections&nbsp;4.1 and Section 4.2 of the Loan Agreement and this Supplement,
each Lender agrees to make Growth Capital Loans to Borrower under its pro rata share of the Commitment from time to time from and after
the Closing Date up to and including the Termination Date in an aggregate, original principal amount up to, but not exceeding, then then-unfunded
portion of such Lender&#146;s Commitment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Minimum
Funding Amount; Maximum Number of Borrowing Requests</B>. Growth Capital Loans requested by Borrower to be made on a single Business
Day shall be for a minimum aggregate, original principal amount of Two Million Dollars ($2,000,000.00); provided, however, that the initial
Growth Capital Loan shall be funded on the Closing Date in a minimum original principal amount of Fifteen Million Dollars ($15,000,000.00).
Borrower shall not submit a Borrowing Request more frequently than once per calendar month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayment
of Growth Capital Loans</B>. Principal of, and interest on, each Growth Capital Loan shall be payable as set forth in a Note evidencing
such Growth Capital Loan (substantially in the form attached hereto as <U>Exhibit &#147;A&#148;</U>), which Note shall provide substantially
as follows: principal shall be fully amortized over the Amortization Period in equal, monthly principal installments plus, in each case,
unpaid interest thereon at the Designated Rate, commencing after the Interest-only Period of interest-only installments at the Designated
Rate. In particular, on the Borrowing Date applicable to such Growth Capital Loan, Borrower shall pay to Agent (i) if the Borrowing Date
is earlier than the Loan Commencement Date, interest only at the Designated Rate, in advance, on the outstanding principal balance of
the Growth Capital Loan for the period from the Borrowing Date through the last day of the calendar month in which such Borrowing Date
occurs (it being understood that this clause (i) shall not apply in the case the Borrowing Date is on the same date as the Loan Commencement
Date), and (ii) the first (1st) interest-only installment at the Designated Rate, in advance, on the outstanding principal balance of
the Note evidencing such Loan for the ensuing month. Commencing on the first day of the second full month after the Borrowing Date and
continuing on the first day of each month during the Interest-only Period thereafter, Borrower shall pay to Agent interest only at the
Designated Rate, in advance, on the outstanding principal balance of the Loan evidenced by such Note for the ensuing month. Commencing
on the first day of the first full month after the end of the Interest-only Period, and continuing on the first day of each consecutive
calendar month thereafter, Borrower shall pay to Agent equal consecutive monthly principal installments in advance in an amount sufficient
to fully amortize the Loan evidenced by such Note over the Amortization Period, plus interest at the Designated Rate for such month.
On the Maturity Date, all principal and accrued interest then remaining unpaid and the Final Payment shall be due and payable.</FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepayment</B>.
The Growth Capital Loans may be voluntarily prepaid as provided in this Section 2 only. Borrower may prepay all, but not less than all,
outstanding Growth Capital Loans in whole, but not in part, at any time upon no less than five (5) Business Days&#146; prior written
notice to Lenders by tendering to each Lender a cash payment in respect of such Loans in an amount determined by such Lender equal to
the sum of: (i) the aggregate outstanding principal amount of such Loans; (ii) the accrued and unpaid interest on such Loans as of the
date of prepayment; (iii) the Prepayment Fee; and (iv) the Final Payment; provided that, if a Lender has not yet exercised its rights
under Section 3(d) hereof, Borrower shall provide written notice of prepayment at least ten (10) days in advance of the proposed prepayment
date and such Lender shall have the option, with respect to the Conversion Option, to exercise its rights pursuant to Section 3(d) hereof
by delivering written notice to Borrower at least two (2) Business Days in advance of the proposed prepayment date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Issuance
of Warrant; Right to Invest; Conversion Right.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Warrant</B>.
As additional consideration for the making of its pro rata share of the Commitment, each Lender has earned and is entitled to receive
immediately upon the execution of the Loan Agreement and this Supplement, a warrant instrument issued by Borrower (the <B>&#147;Warrant&#148;</B>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Warrant
General</B>. The Warrant shall be in form and substance reasonably satisfactory to the applicable Lender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Right
to Invest</B>. Each Lender shall have the right, in its discretion, but not the obligation, to invest up to One Million Dollars ($1,000,000.00)
in the aggregate among all Lenders in equity securities of Borrower on the same terms, conditions, and pricing offered by Borrower, in
connection with any offering of Borrower&#146;s equity securities during the eighteen (18) month period following the Closing Date;
provided, however, such terms shall exclude a seat on the Borrower&#146;s Board of Directors, which may be offered to other investors
at Borrower&#146;s discretion; provided, further, in no event shall such right shall apply to (i) issuances of equity securities under
any existing or future at-the-market offering program, (ii) any placement of equity securities with a strategic partner/participant or
charitable or educational institution, and (iii) use of equity securities to goods or services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Conversion
Right</B>. Each Lender shall have the right, in its discretion, but not the obligation, at any time and from time to time, while the
Loan is outstanding, to convert an amount of up to Five Million Dollars ($5,000,000.00) of the principal amount of the outstanding Growth
Capital Loans in the aggregate among all Lenders (the &#147;<B>Conversion Option</B>&#148;) into shares of Common Stock (as defined
in the Warrant) at a price per share equal to one hundred twenty percent (120.00%) of the Stock Purchase Price set forth (and as defined)
in the Warrant (the &#147;<B>Conversion Price</B>;&#148; the exercise of such Conversion Option, a &#147;<B>Conversion</B>&#148;).
The Conversion Option will be exercised by such Lender delivering a written, signed conversion notice to the Borrower in accordance with
this Section 3(d) which will include (i) the date of which the conversion notice is given, (ii) a statement to the effect that the applicable
Lender is exercising the Conversion Option, (iii) the amount in respect of which the Conversion Option is being exercised and the number
of shares issued and (iv) a date on which the allotment and issuance of the shares is to take place.</FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commitment
Fee</B>. Borrower shall pay to each Lender, pro-rata in accordance with each Lender&#146;s respective Commitment, a commitment fee in
the amount of one percent (1.00%) of the aggregate Twenty Million Dollars ($20,000,000.00) amount of the Tranche 1 and Tranche 2 Commitments
due and payable on the Closing Date, of which One Hundred Thousand Dollars ($100,000.00) has been paid by Borrower to Avenue as an advance
deposit prior to the date hereof. As an additional condition precedent under Section 4.1 of the Loan Agreement, each Lender shall have
completed to its satisfaction its due diligence review of Borrower&#146;s business and financial condition and prospects, and such Lender&#146;s
pro-rata share of the Commitment shall have been approved. If this condition is not satisfied, the One Hundred Thousand Dollars ($100,000.00)
advance deposit previously paid by Borrower shall be refunded. Except as set forth in this Section 4, the Commitment Fee is not refundable.
In addition, to the extent Borrower receives Loans under Tranche 3, Borrower shall pay to each Lender, pro-rata in accordance with each
Lender&#146;s respective Commitment, on or before the funding date of such Tranche 3 Loans a commitment fee in the amount of one percent
(1.00%) of the amount of the Tranche 3 Loan so funded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Documentation
Fee Payment</B><I>.</I> On the Closing Date, Borrower shall reimburse each Lender and Agent pursuant to Section 9.8(a) of the Loan Agreement
for (i) its reasonable, documented and out-of-pocket attorneys&#146; fees, costs and expenses incurred in connection with the preparation
and negotiation of the Loan Documents and (ii) such Lender&#146;s and Agent&#146;s costs and filing fees related to perfection of its
Liens in the Collateral in any jurisdiction in which the same is located, recording a copy of the Intellectual Property Security Agreement
with the United States Patent and Trademark Office or the United States Copyright Office, as applicable, and confirming the priority
of such Liens.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Reserved.]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Debits
to Account for ACH Transfers. </B>For purposes of Sections 2.2 and 5.10 of the Loan Agreement, the Primary Operating Account shall be
the bank account set forth in the Disclosure Letter, unless and until such account is changed in accordance with Section 5.10 of the
Loan Agreement. Borrower hereby agrees that the Growth Capital Loans will be advanced to the account specified above and regularly scheduled
payments of principal, interest and fees due to each Lender will be automatically debited by each Lender from the same account. Borrower
hereby confirms that the bank at which the Primary Operating Account is maintained uses that same ABA Number for incoming wires transfers
to the Primary Operating Account and outgoing ACH transfers from the Primary Operating Account.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Part
3 - </B>[Reserved.]</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Part
4 - </B>Additional Loan Documents:</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse; margin-left: 1in">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Promissory Note</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    &#147;A&#148;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Borrowing Request</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    &#147;B&#148;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Compliance Certificate</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    &#147;C&#148;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Remainder
of this page intentionally left blank; signature pages follow</I>]</FONT></P>




<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
page to Supplement to Loan and Security Agreement</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties have executed this Supplement as of the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BIOVIE
INC.,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
Nevada corporation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Cuong Do</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cuong Do</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
    for Notices:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9120
    Double Diamond Parkway Suite 1400</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reno,
    Nevada 89521</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
    Cuong Do, CEO</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-Mail:
    cdo@bioviepharma.com</FONT></TD></TR>
  </TABLE>



<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature page to Supplement to Loan and Security Agreement</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LENDERS:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AVENUE
VENTURE OPPORTUNITIES FUND, L.P.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avenue
    Venture Opportunities Partners, LLC</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its:</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    Partner</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Sonia Gardner</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonia Gardner</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
    Signatory</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
    for Notices:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11
    West 42<SUP>nd</SUP>&nbsp;Street, 9<SUP>th</SUP>&nbsp;Floor</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, New York 10036</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
    Todd Greenbarg, Senior Managing Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    tgreenbarg@avenuecapital.com</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    # 212-878-3523</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AVENUE
VENTURE OPPORTUNITIES FUND II, L.P.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avenue
    Venture Opportunities Partners II, LLC</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its:</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    Partner</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Sonia Gardner</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonia
    Gardner</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
    Signatory</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
    for Notices:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11
    West 42<SUP>nd</SUP>&nbsp;Street, 9<SUP>th</SUP>&nbsp;Floor</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, New York 10036</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
    Todd Greenbarg, Senior Managing Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    tgreenbarg@avenuecapital.com</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    # 212-878-3523</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AGENT:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AVENUE
VENTURE OPPORTUNITIES FUND, L.P.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avenue
    Venture Opportunities Partners, LLC</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its:</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    Partner</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Sonia Gardner</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonia
    Gardner</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
    Signatory</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
    for Notices:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11
    West 42<SUP>nd</SUP>&nbsp;Street, 9<SUP>th</SUP>&nbsp;Floor</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, New York 10036</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
    Todd Greenbarg, Senior Managing Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    tgreenbarg@avenuecapital.com</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    # 212-878-3523</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
&#147;A&#148;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORM
OF PROMISSORY NOTE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9;[Note
No. X-XXX]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 75%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$____________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Date]</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned (&#147;<U>Borrower</U>&#148;) promises to pay to the order of [AVENUE VENTURE OPPORTUNITIES FUND, L.P.][AVENUE VENTURE
OPPORTUNITIES FUND II, L.P.], a Delaware limited partnership (&#147;<U>Lender</U>&#148;), at such place as Lender may designate in
writing, in lawful money of the United States of America, the principal sum of ______________________________ Dollars ($__________),
with interest thereon from the date hereof until maturity, whether scheduled or accelerated, at a variable rate per annum equal to greater
of (i) the sum of seven percent (7.00%) <U>plus</U> the Prime Rate, and (ii) ten and three-quarters percent (10.75%) (the &#147;<U>Designated
Rate</U>&#148;), according to the payment schedule described herein, except as otherwise provided herein. In addition, on the Maturity
Date, the Borrower promises to pay to the order of Lender (i) all principal and accrued interest then remaining unpaid and (ii) the Final
Payment (as defined in the Loan Agreement (as defined herein)).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Note is one of the Notes referred to in, and is entitled to all the benefits of, a Loan and Security Agreement, dated as of November
30, 2021, between Borrower and Lender (as supplemented by the Supplement [as defined in the Loan Agreement] and as further amended, restated,
amended and restated, supplemented, or otherwise modified from time to time, the &#147;<B><U>Loan Agreement</U></B>&#148;). Each capitalized
term not otherwise defined herein shall have the meaning set forth in the Loan Agreement. The Loan Agreement contains provisions for
the acceleration of the maturity of this Note upon the happening of certain stated events.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
of and interest on this Note shall be payable as provided under Section 2 of Part 2 of the Supplement to the Loan Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Note may be prepaid only as permitted under Section&nbsp;2 of Part 2 of the Supplement to the Loan Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
unpaid payments of principal or interest on this Note shall bear interest from their respective maturities, whether scheduled or accelerated,
at a rate per annum equal to the Default Rate, compounded monthly. Borrower shall pay such interest on demand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest,
charges and fees shall be calculated for actual days elapsed on the basis of a 360-day year, which results in higher interest, charge
or fee payments than if a 365-day year were used. In no event shall Borrower be obligated to pay interest, charges or fees at a rate
in excess of the highest rate permitted by applicable law from time to time in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Borrower is late in making any scheduled payment under this Note by more than five (5) days, Borrower agrees to pay a &#147;late charge&#148;
of five percent (5%) of the installment due, but not less than fifty dollars ($50) for any one such delinquent payment. This late charge
may be charged by Lender for the purpose of defraying the expenses incidental to the handling of such delinquent amounts. Borrower acknowledges
that such late charge represents a reasonable sum considering all of the circumstances existing on the date of this Note and represents
a fair and reasonable estimate of the costs that will be sustained by Lender due to the failure of Borrower to make timely payments.
Borrower further agrees that proof of actual damages would be costly and inconvenient. Such late charge shall be paid without prejudice
to the right of Lender to collect any other amounts provided to be paid or to declare a default under this Note or any of the other Loan
Documents or from exercising any other rights and remedies of Lender.</FONT></P>

<!-- Field: Page; Sequence: 8; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
page to Promissory Note</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Note shall be governed by, and construed in accordance with, the laws of the State of California, excluding those laws that direct the
application of the laws of another jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrower&#146;s
execution and delivery of this Note via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S.
federal ESIGN Act of 2000, e.g., www.docusign.com) shall constitute effective execution and delivery of this Note and agreement to and
acceptance of the terms hereof for all purposes. The fact that this Note is executed, signed, stored or delivered electronically shall
not prevent the assignment or transfer by Lender of this Note pursuant to the terms of the Loan Agreement or the enforcement of the terms
hereof. Physical possession of the original of this Note or any paper copy thereof shall confer no special status to the bearer thereof.
In no event shall an original ink-signed paper copy of this Note be required for any exercise of Lender&#146;s rights hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 85%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">BIOVIE INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>



<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
&#147;B&#148;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORM
OF BORROWING REQUEST</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
[__], 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avenue
Venture Opportunities Fund, L.P.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11
West 42nd Street, 9th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10036</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avenue
Venture Opportunities Fund II, L.P.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11
West 42nd Street, 9th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10036</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>BIOVIE
                                            INC.</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference
is made to the Loan and Security Agreement, November 30, 2021 (as amended, restated or supplemented from time to time, the &#147;<U>Loan
Agreement</U>&#148;; the capitalized terms used herein as defined therein), among Avenue Venture Opportunities Fund, L.P. (&#147;<U>Avenue</U>&#148;),
as administrative agent and collateral agent (in such capacity, &#147;<U>Agent</U>&#148;), and as a lender, Avenue Venture Opportunities
Fund II, L.P. (&#147;<U>AVOF 2</U>&#148; and together with Avenue, in its capacity as a lender, collectively, &#147;<U>Lenders</U>&#148;,
and each a &#147;<U>Lender</U>&#148;), and Biovie Inc. (&#147;<U>Borrower</U>&#148;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned is the ____________________ of Borrower and hereby requests on behalf of Borrower a Loan under the Loan Agreement, and in
that connection certifies as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
amount of the proposed Loan is _______________________ Dollars ($_________________). The Borrowing Date of the proposed Loan is ___________________
(the &#147;<U>Borrowing Date</U>&#148;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the Borrowing Date,</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Avenue will wire $[_________] less fees and expenses to be deducted on the Borrowing Date of (a) [$___] in respect to the Commitment
Fee, of which $100,000 has been paid to Avenue prior to the date hereof, (b) $[_________] in respect to the interest fee, and (c) $[_________]
in respect to the legal fees for net proceeds of $[___________], and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
AVOF 2 will wire $[_________] less fees and expenses to be deducted on the Borrowing Date of (a) [$___] in respect to the Commitment
Fee, of which [$___] has been paid to AVOF 2 prior to the date hereof, (b) $[_________] in respect to the interest fee, and (c) $[_________]
in respect to the legal fees for net proceeds of $[___________]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
Borrower pursuant to the following wire instructions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; width: 31%; border: Black 1.5pt solid; padding-right: 5.4pt; padding-bottom: 4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Institution
    Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 69%; border-top: Black 1.5pt solid; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: -45pt; padding-bottom: 4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding-right: 5.4pt; padding-bottom: 4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: -45pt; padding-bottom: 4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding-right: 5.4pt; padding-bottom: 4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABA
    No.:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: -45pt; padding-bottom: 4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding-right: 5.4pt; padding-bottom: 4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contact
    Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: -45pt; padding-bottom: 4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding-right: 5.4pt; padding-bottom: 4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    No.:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: -45pt; padding-bottom: 4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding-right: 5.4pt; padding-bottom: 4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: -45pt; padding-bottom: 4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding-right: 5.4pt; padding-bottom: 4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account
    Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: -45pt; padding-bottom: 4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding-right: 5.4pt; padding-bottom: 4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account
    No.:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: -45pt; padding-bottom: 4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 10; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
the Borrowing Date, the Lenders will wire $[__________] to GCA Law Partners LLP for fees and expenses pursuant to the following wire
instructions:<SUP>1</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; width: 29%; border: Black 1.5pt solid; padding-right: 5.4pt; padding-bottom: 4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Institution
    Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 71%; border-top: Black 1.5pt solid; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: -45pt; padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding-right: 5.4pt; padding-bottom: 4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABA
    No.:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: -45pt; padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding-right: 5.4pt; padding-bottom: 4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account
    Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: -45pt; padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding-right: 5.4pt; padding-bottom: 4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account
    No.:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: -45pt; padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding-right: 5.4pt; padding-bottom: 4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: -45pt; padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding-right: 5.4pt; padding-bottom: 4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confirm
    remittance:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: -45pt; padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of this date, no Default or Event of Default has occurred and is continuing, or will result from the making of the proposed Loan, the
representations and warranties of Borrower contained in Article 3 of the Loan Agreement and Part 3 of the Supplement are true and correct
in all material respects other than those representations and warranties expressly referring to a specific date which are true and correct
in all material respects as of such date, and the conditions precedent described in Sections 4.1 and/or 4.2 of the Loan Agreement and
Part 2 of the Supplement, as applicable, have been met.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
event has occurred that has had or could reasonably be expected to have a Material Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Borrower&#146;s
most recent financial statements, financial projections or business plan dated ____________, as reviewed by Borrower&#146;s Board of
Directors, are enclosed herewith in the event such financial statements, financial projections or business plan have not been previously
provided to Lenders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Remainder
of this page intentionally left blank; signature page follows</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 3pt; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
be included in the Borrowing Request on the Closing Date. The executed Borrowing Request must be delivered 2 Business Days prior to the
Closing Date.</FONT></TD>
</TR></TABLE>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
page to Borrowing Request</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrower
shall notify you promptly before the funding of the Loan if any of the matters to which I have certified above shall not be true and
correct on the Borrowing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
truly yours,<BR>
<BR>
BIOVIE INC.,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
Nevada corporation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>



<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
&#147;C&#148;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORM
OF</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMPLIANCE
CERTIFICATE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avenue
Venture Opportunities Fund, L.P.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11
West 42nd Street, 9th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10036</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avenue
Venture Opportunities Fund II, L.P.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11
West 42nd Street, 9th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10036</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>BIOVIE
INC.</U></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference
is made to the Loan and Security Agreement, dated as of November 30, 2021 (as the same has been and may be supplemented, amended and
modified from time to time, the &#147;<U>Loan Agreement</U>,&#148; the capitalized terms used herein as defined therein), among Avenue
Venture Opportunities Fund, L.P. (&#147;<U>Avenue</U>&#148;), as administrative agent and collateral agent (in such capacity, &#147;<U>Agent</U>&#148;),
and as a lender, Avenue Venture Opportunities Fund II, L.P. (&#147;<U>AVOF 2</U>&#148; and together with Avenue, acting in its capacity
as a lender, collectively, &#147;<U>Lenders</U>&#148;, and each a &#147;<U>Lender</U>&#148;), and BioVie Inc. (&#147;<U>Borrower</U>&#148;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned authorized representative of Borrower hereby certifies in such capacity that in accordance with the terms and conditions
of the Loan Agreement, (i) no Default or Event of Default has occurred and is continuing, except as noted below, and (ii) Borrower is
in compliance for the financial reporting period ending ____________________________ with all required financial reporting under the
Loan Agreement, except as noted below. Attached herewith are the required documents supporting the foregoing certification. The undersigned
authorized representative of Borrower further certifies in such capacity that: (a) the accompanying financial statements have been prepared
in accordance with Borrower&#146;s past practices applied on a consistent basis, or in such manner as otherwise disclosed in writing
to Agent, throughout the periods indicated; and (b) the financial statements fairly present in all material respects the financial condition
and operating results of Borrower and its Subsidiaries, if any, as of the dates, and for the periods, indicated therein, subject to the
absence of footnotes and normal year-end audit adjustments (in the case of interim monthly financial statements), except as explained
below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Please
provide the following requested information and</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>indicate
compliance status by circling (or otherwise indicating) Yes/No under &#147;Included/Complies&#148;:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; width: 39%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>REPORTING
    REQUIREMENT</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; width: 37%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>REQUIRED</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>INCLUDED/COMPLIES</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; vertical-align: middle"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    Sheet, Income Statement &amp; Cash Flow Statement (in accordance with Section 5.1(a) of the Loan Agreement*)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; vertical-align: middle"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monthly,
    within 30 days, or as required by Lenders; quarterly, within 45 days</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO / N/A</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; vertical-align: middle; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; vertical-align: middle"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    Budgets &amp; Updated Capitalization Tables</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; vertical-align: middle"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    modified</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; vertical-align: middle; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO / N/A</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; vertical-align: middle; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; vertical-align: middle"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
    Financial Statements</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; vertical-align: middle"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annually,
    within 120 day of fiscal year-end</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; vertical-align: middle; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO / N/A</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; vertical-align: middle; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; vertical-align: middle"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
    Packages</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: left; vertical-align: middle"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    modified</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; vertical-align: middle; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO / N/A</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>







<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 76%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
    of most recent Board-approved budget/plan</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    change in budget/plan since version most recently delivered to Agent</FONT></TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO / N/A</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>If
    Yes, please attach</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
    of most recent capitalization table: ____________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    changes in capitalization table since version most recently delivered to Agent?:</FONT></TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO / N/A</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>If
    Yes, please attach a copy of latest capitalization table</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>


<!-- Field: Page; Sequence: 13; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>INTERIM
    REPORTING REQUIREMENT</U>*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>REQUIRED</U></FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>AMOUNT</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    Balance</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monthly
    within 30 days</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$_________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining
    Months Liquidity</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monthly
    within 30 days</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_________________</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EQUITY
&amp; CONVERTIBLE NOTE FINANCINGS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Please
provide the following information (if applicable) regarding Borrower&#146;s most-recent equity and/or convertible note financing each
time this Certificate is delivered to Agent</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
    of Last Capital Raise: _____________</FONT></TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Has
    there been any new financing since the last Compliance Certificate submitted?</FONT></TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>If
    &#147;YES&#148; please attach a copy of the Capitalization Table</I></FONT></TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
    Closed: ______________ &nbsp;&nbsp;&nbsp;Per
    Share Price: $_________________</FONT></TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
    Raised: _______________</FONT></TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    stock splits since date of last report?</FONT></TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>If
    yes, please provide any information on stock splits which would affect valuation</I>:</FONT></TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    dividends since date of last report?</FONT></TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>If
    yes, please provide any information on dividends which would affect valuation: </I></FONT></TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    unusual terms? (i.e., Anti-dilution, multiple preference, etc.)</FONT></TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>If
    yes, please explain:</I></FONT></TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>




<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ACCOUNT
CONTROL AGREEMENTS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 6.11 of the Loan Agreement, Borrower represents and warrants that: (i) as of the date hereof, it maintains only those deposit
and investment accounts set forth below; and (ii) to the extent required by Section 6.11 of the Loan Agreement, a control agreement has
been executed and delivered to Agent with respect to each such account, other than in the case of Excluded Accounts. <B><I>[Note: If
Borrower has established any new account(s) since the date of the last compliance certificate, please so indicate]</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposit
Accounts<SUP>2</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Name
    of Institution</U></FONT></TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Account
    Number</U></FONT></TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Control
    Agt.<BR>
In place? </U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Complies</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>New<BR>
Account</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[_______]</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[_______]</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.)</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
Accounts</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Name
    of Institution</U></FONT></TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Account
    Number</U></FONT></TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Control
    Agt.<BR>
In place? </U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Complies</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>New<BR>
Account</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.)
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.)</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.)</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>AGREEMENTS
WITH PERSONS IN POSSESSION OF TANGIBLE COLLATERAL</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 5.9(e) of the Loan Agreement, Borrower represents and warrants that: (i) as of the date hereof, tangible Collateral is located
at the addresses set forth below; and (ii) to the extent required by Section 5.9(e) of the Loan Agreement, a Waiver has been executed
and delivered to Agent, or such Waiver has been waived by Agent, <B><I>[Note: If Borrower has located Collateral at any new location
since the date of the last compliance certificate, please so indicate]</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Location
    of Collateral</U></FONT></TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Value
    of Collateral at such <BR>
Locations</U></FONT></TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Waiver<BR>
In place? </U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Complies?</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>New<BR>
Location?</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.)</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.)
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.)</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.)</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES
    / NO</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 3pt; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>2</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company:
Please complete with existing accounts.</FONT></TD>
</TR></TABLE>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SUBSIDIARIES
AND OTHER PERSONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 6.14(a) of the Loan Agreement, Borrower represents and warrants that: (i) as of the date hereof, it has directly or indirectly
acquired or created, or it intends to directly or indirectly acquire or create, each Subsidiary or other Person described below; and
(ii) such Subsidiary or Person has been made a co-borrower under the Loan Agreement or a guarantor of the Obligations <B><I>[Note: If
Borrower has acquired or created any Subsidiary since the date of the last compliance certificate, please so indicate]</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; padding-right: 0; padding-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Name</U>:</FONT></TD>
    <TD STYLE="padding-right: 0; width: 3%; padding-left: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Jurisdiction
    of<BR>
    formation or organization</U>:<SUP>3</SUP></FONT></TD>
    <TD STYLE="padding-right: 0; width: 3%; padding-left: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 13%; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Co-borrower<BR>
or guarantor?</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 13%; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Complies?</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 13%; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>New<BR>
Subsidiary<BR>
or Person?</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;1.)</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;YES
    / NO</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;2.)
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;YES
    / NO</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;3.)</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"></TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;YES
    / NO</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;4.)</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;YES
    / NO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;YES
    / NO</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EXPLANATIONS</U></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Remainder
of this page intentionally left blank; signature page follows</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 3pt; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->





<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>3</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the &#147;Explanations&#148; heading (see below) please include a description of such Subsidiary&#146;s or Person&#146;s fully diluted
capitalization and Borrower&#146;s purpose for its acquisition or creation of such Subsidiary if such information has not been previously
furnished to Agent.</FONT></TD>
</TR></TABLE>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
page to Compliance Certificate</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%">&nbsp;</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BIOVIE
    INC.</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:<SUP>*</SUP></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 3pt; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



































<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>*</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Must
be executed by Borrower&#146;s Chief Financial Officer or other executive officer.</FONT></TD>
</TR></TABLE>


<!-- Field: Page; Sequence: 17 -->
<DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
<!-- Field: /Page -->




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>bivi-20211130_8kex10z3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE
AND DISTRIBUTION THEREOF, AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#147;<U>SECURITIES ACT</U>&#148;)
OR ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF (A) SUCH REGISTRATION, (B) AN OPINION
OF COUNSEL IN A FORM REASONABLY ACCEPTABLE TO COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED DUE TO AN EXEMPTION THEREFROM UNDER SAID
ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR (C) BIOVIE INC. OTHERWISE SATISFIES ITSELF THAT SUCH TRANSACTION IS COMPLIANT WITH SUCH
LAWS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Issuance: November 30, 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WARRANT
TO PURCHASE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHARES
OF STOCK OF</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BIOVIE
INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Void
after November 30, 2026)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
certifies that [______________________________], a Delaware limited partnership, or permitted assigns (&#147;<U>Holder</U>&#148;),
for value received, is entitled to purchase from BIOVIE INC. a Nevada corporation (&#147;<U>Company</U>&#148;), the Applicable Number
(hereinafter defined) of fully paid and nonassessable shares of the Company&#146;s Common Stock (the &#147;<U>Common Stock</U>&#148;),
for cash, at a purchase price per share equal to the Stock Purchase Price (hereinafter defined). Holder may also exercise this Warrant
on a cashless or &#147;net issuance&#148; basis as described in Section 1(b) below, and this Warrant shall be deemed to have been exercised
in full on such basis on the Expiration Date (hereinafter defined), to the extent not fully exercised prior to such date. This Warrant
is issued in connection with that certain Loan and Security Agreement and Supplement thereto, both of even date herewith (as amended,
restated and supplemented from time to time, the &#147;<U>Loan Agreement</U>&#148; and the &#147;<U>Supplement</U>&#148;, respectively),
among Company, as borrower, Holder, as lender, and [______________________________]., as lender (together with Holder, &#147;<U>Lenders</U>&#148;).
Capitalized terms used herein and not otherwise defined in this Warrant shall have the meaning(s) ascribed to them in the Loan Agreement
and the Supplement, unless the context would otherwise require.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#147;<U>Applicable
Number</U>&#148; means the number of shares of Common Stock purchasable hereunder obtained by dividing (x) as of the Date of Issuance,
(A) [______________________________] Dollars ($[______________________________]) by (B) the Stock Purchase Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#147;<U>Stock
Purchase Price</U>&#148; means $5.82.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to Sections 4.3 and 4.8, this Warrant may be exercised at any time or from time to time up to and including 5:00 p.m. (Pacific time)
on November 30, 2026 (the &#147;<U>Expiration Date</U>&#148;), upon surrender to Company at its principal office at 9120 Double Diamond
Parkway, Suite 1400, Reno, Nevada 89521 (or at such other location as Company may advise Holder in writing) of this Warrant properly
endorsed with the Form of Subscription attached hereto duly completed and signed and upon payment in cash or by check of the aggregate
Stock Purchase Price for the number of shares for which this Warrant is being exercised determined in accordance with the provisions
hereof. The Stock Purchase Price and the number of shares purchasable hereunder are subject to further adjustment as provided in Section
4 of this Warrant.</FONT></P>



<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Warrant is subject to the following terms and conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise;
Issuance of Certificates; Payment for Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless
an election is made pursuant to clause (b) of this Section 1, this Warrant shall be exercisable at the option of Holder, at any time
or from time to time, on or before the Expiration Date for all or any portion of the shares of Common Stock (but not for a fraction of
a share) which may be purchased hereunder for the Stock Purchase Price multiplied by the number of shares to be purchased. Company agrees
that the shares of Common Stock purchased under this Warrant shall be and are deemed to be issued to Holder as the record owner of such
shares as of the close of business on the date on which the form of subscription shall have been delivered and payment made for such
shares. Subject to the provisions of Section 2, shares of Common Stock so purchased shall be delivered in either book-entry or certificated
form, together with any other securities or property to which Holder is entitled upon such exercise, to Holder by Company at Company&#146;s
expense within a reasonable time after the rights represented by this Warrant have been so exercised. Except as provided in clause (b)
of this Section 1, in case of a purchase of less than all the shares which may be purchased under this Warrant, Company shall cancel
this Warrant and execute and deliver a new Warrant or Warrants of like tenor for the balance of the shares purchasable under this Warrant
surrendered upon such purchase to Holder within a reasonable time. If the Common Stock is delivered in certificated form, each stock
certificate so delivered shall be in such denominations of Common Stock as may be requested by Holder and shall be registered in the
name of such Holder or such other name as shall be designated by such Holder, subject to the limitations contained in Section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Holder,
in lieu of exercising this Warrant by the cash payment of the Stock Purchase Price pursuant to clause (a) of this Section 1, may elect,
at any time on or before the Expiration Date, to surrender this Warrant and receive that number of shares of Common Stock computed using
the following formula:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 8%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD ROWSPAN="2" STYLE="padding-bottom: 1pt; white-space: nowrap; font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X&nbsp;&nbsp;=&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; width: 5%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Y(A-B)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 36pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where:</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X&nbsp;&nbsp;=&nbsp;&nbsp;the
                                            number of shares of Common Stock to be issued to Holder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 40.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-left: 22pt; text-align: justify; text-indent: -22pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Y&nbsp;&nbsp;=&nbsp;&nbsp;the
number of shares of Common Stock that Holder would otherwise have been entitled to purchase hereunder pursuant to Section 1(a) (or such
lesser number of shares as Holder may designate in the case of a partial exercise of this Warrant).</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 40.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A&nbsp;&nbsp;=&nbsp;&nbsp;the
closing price on the last trading day prior to exercise of the Warrant.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 23%; text-align: justify; text-indent: -5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 40.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B&nbsp;&nbsp;=&nbsp;&nbsp;the
Stock Purchase Price then in effect.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Election
to exercise under this Section 1(b) may be made by delivering a signed form of subscription to Company via facsimile, to be followed
by delivery of this Warrant. Notwithstanding anything to the contrary contained in this Warrant, if as of the close of business on the
last business day preceding the Expiration Date this Warrant remains unexercised as to all or a portion of the shares of Common Stock
purchasable hereunder, then effective as 9:00 a.m. (Pacific time) on the Expiration Date, Holder shall be deemed, automatically and without
need for notice to Company, to have elected to exercise this Warrant in full pursuant to the provisions of this Section 1(b), and upon
surrender of this Warrant shall be entitled to receive that number of shares of Common Stock computed using the above formula, provided
that the application of such formula as of the Expiration Date yields a positive number for &#147;X&#148;.</FONT></P>



<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Limitation
on Transfer</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Warrant and the Common Stock shall not be transferable except upon the conditions specified in this Section 2, which conditions are intended
to ensure compliance with the provisions of the Securities Act of 1933, as amended (the &#147;<U>Securities Act</U>&#148;). Each holder
of this Warrant or the Common Stock issuable hereunder will cause any proposed transferee of the Warrant or Common Stock to agree to
take and hold such securities subject to the provisions and upon the conditions specified in this Section 2. Notwithstanding the foregoing
and any other provision of this Section 2 but subject to the last sentence of Section 2(c), Holder may freely transfer all or part of
this Warrant or the shares issuable upon exercise of this Warrant (or the securities issuable, directly or indirectly, upon conversion
of the shares, if any) at any time to any affiliate of Lenders under the Loan Agreement, by giving Company notice of the portion of the
Warrant being transferred setting forth the name, address and taxpayer identification number of the transferee and surrendering this
Warrant to Company for reissuance to the transferees(s) (and Holder, if applicable).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
certificate representing (i) this Warrant, (ii) the Common Stock (or applicable balance account at the Company&#146;s transfer agent),
and (iii) any other securities issued in respect to the Common Stock issued upon any stock split, stock dividend, recapitalization, merger,
consolidation or similar event, shall (unless otherwise permitted by the provisions of this Section 2 or unless such securities have
been registered under the Securities Act or sold under Rule 144) be stamped or otherwise imprinted with a legend substantially in the
following form (in addition to any legend required under applicable state securities laws):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE
AND DISTRIBUTION THEREOF. NEITHER THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH ANY OF THESE SECURITIES
ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE SOLD OR TRANSFERRED
IN THE ABSENCE OF (A) SUCH REGISTRATION, (B) AN OPINION OF COUNSEL IN A FORM REASONABLY ACCEPTABLE TO COMPANY THAT SUCH REGISTRATION
IS NOT REQUIRED DUE TO AN EXEMPTION THEREFROM UNDER SAID ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR (C) BIOVIE INC. OTHERWISE SATISFIES
ITSELF THAT SUCH TRANSACTION IS COMPLIANT WITH SUCH LAWS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Holder
of this Warrant and each person to whom this Warrant is subsequently transferred represents and warrants to Company and agrees (by acceptance
of such transfer) that it will not transfer this Warrant (or securities issuable upon exercise hereof unless a registration statement
under the Securities Act was in effect with respect to such securities at the time of issuance thereof) unless (i) there is an effective
registration statement under the Securities Act and applicable state securities laws covering any such transaction, (ii) pursuant to
Rule 144 under the Securities Act (or any other rule under the Securities Act relating to the disposition of securities), (iii) Company
receives an opinion of counsel, reasonably satisfactory to Company, that an exemption from such registration is available or (iv) the
Company otherwise satisfies itself that such transaction is exempt from registration. Notwithstanding the foregoing or any other provision
of this Section 2, Holder shall not transfer this Warrant (or securities issuable upon exercise hereof, or securities issuable, directly
or indirectly, upon conversion of such securities, if any) to any competitor of Company, as determined in good faith by the Board of
Directors of Company (the &#147;<U>Board</U>&#148;), without the prior written consent of Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Shares
to be Fully Paid; Reservation of Shares</U>. Company covenants and agrees that all shares of Common Stock which may be issued upon the
exercise of the rights represented by this Warrant will, upon issuance, be duly authorized, validly issued, fully paid and nonassessable
and free from all preemptive rights of any stockholder and free of all taxes, liens and charges with respect to the issue thereof. Company
further covenants and agrees that during the period within which the rights represented by this Warrant may be exercised, Company will
at all times have authorized and reserved, for the purpose of issue or transfer upon exercise of the subscription rights evidenced by
this Warrant, a sufficient number of shares of authorized but unissued Common Stock, or other securities and property, when and as required
to provide for the exercise of the rights represented by this Warrant. Company will take all such action as may be necessary to assure
that such shares of Common Stock may be issued as provided herein without violation of any applicable law or regulation, or of any requirements
of any domestic securities exchange upon which the Common Stock may be listed. Company will not take any action which would result in
any adjustment of the Stock Purchase Price (as described in Section 4 hereof) (i) if the total number of shares of Common Stock issuable
after such action upon exercise of all outstanding warrants, together with all shares of Common Stock then outstanding and all shares
of Common Stock then issuable upon exercise of all options and upon the conversion of all convertible securities then outstanding, would
exceed the total number of shares of Common Stock then authorized by Company&#146;s Articles of Incorporation, as amended and restated
from time to time (the &#147;<U>Charter</U>&#148;) or (ii) if the par value per share of the Common Stock would exceed the Stock Purchase
Price.</FONT></P>



<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustment
of Stock Purchase Price and Number of Shares</U>. The Stock Purchase Price and the number of shares purchasable upon the exercise of
this Warrant shall be subject to adjustment from time to time upon the occurrence of certain events described in this Section 4. Upon
each adjustment of the Stock Purchase Price, Holder of this Warrant shall thereafter be entitled to purchase, at the Stock Purchase Price
resulting from such adjustment, the number of shares obtained by multiplying the Stock Purchase Price in effect immediately prior to
such adjustment by the number of shares purchasable pursuant hereto immediately prior to such adjustment, and dividing the product thereof
by the Stock Purchase Price resulting from such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Subdivision
or Combination of Stock</U>. In case Company shall at any time subdivide its outstanding shares of Common Stock into a greater number
of shares, the Stock Purchase Price in effect immediately prior to such subdivision shall be proportionately reduced, and conversely,
in case the outstanding shares of Common Stock of Company shall be combined into a smaller number of shares, the Stock Purchase Price
in effect immediately prior to such combination shall be proportionately increased.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Dividends</U>.
If at any time or from time to time the holders of Common Stock (or any shares of stock or other securities at the time receivable upon
the exercise of this Warrant) shall have received or become entitled to receive,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common
Stock, or any shares of stock or other securities whether or not such securities are at any time directly or indirectly convertible into
or exchangeable for Common Stock, or any rights or options to subscribe for, purchase or otherwise acquire any of the foregoing by way
of dividend or other distribution,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
cash paid or payable including as a cash dividend, or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common
Stock or other or additional stock or other securities or property (including cash) by way of spin off, split-up, reclassification, combination
of shares or similar corporate rearrangement, (other than shares of Common Stock issued as a stock split, adjustments in respect of which
shall be covered by the terms of Section 4.1 above),</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">then
and in each such case, Holder hereof shall, upon the exercise of this Warrant, be entitled to receive, in addition to the number of shares
of Common Stock receivable thereupon, and without payment of any additional consideration therefor, the amount of stock and other securities
and property (including cash in the cases referred to in clauses (b) and (c) above) which such Holder would hold on the date of such
exercise had it been the holder of record of such Common Stock as of the date on which holders of Common Stock received or became entitled
to receive such shares and/or all other additional stock and other securities and property.</FONT></P>



<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Change
of Control</U>. In the event of a Change of Control (as hereinafter defined), this Warrant shall be automatically exchanged for a number
of shares of Company&#146;s securities, such number of shares being equal to the maximum number of shares issuable pursuant to the terms
hereof (after taking into account all adjustments described herein) had Holder elected to exercise this Warrant immediately prior to
the closing of such Change of Control and purchased all such shares pursuant to the cash exercise provision set forth in Section 1(a)
hereof (as opposed to the cashless exercise provision set forth in Section 1(b)). Company acknowledges and agrees that Holder shall not
be required to make any payment (cash or otherwise) for such shares as further consideration for their issuance pursuant to the terms
of the preceding sentence. &#147;<U>Change of Control</U>&#148; shall mean (a) any sale, license, or other disposition of all or substantially
all of the assets of Company, other than as permitted by Section 6.5 of the Loan Agreement; (b) any reorganization, consolidation, merger
or other transaction in which Company is not the surviving entity; or (c) any transaction or series of related transactions in which
any Person or two or more Persons acting in concert (other than Permitted Holders (as defined in the Loan Agreement)) shall have acquired
by contract or otherwise, the power to control the management of Company, or to control the equity interests of Company entitled to vote
for members of the Board or equivalent governing body of Company on a fully-diluted basis (and taking into account all such securities
that such Person or Persons have the right to acquire pursuant to any option right) representing 50% or more of the combined voting power
of such securities; provided that an issuance of equity securities for the primary purpose of raising capital shall not be considered
a Change of Control under this Warrant. This Warrant shall terminate upon Holder&#146;s receipt of the number of shares of Company&#146;s
equity securities described in this Section 4.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice
of Adjustment</U>. Upon any adjustment of the Stock Purchase Price, and/or any increase or decrease in the number of shares purchasable
upon the exercise of this Warrant, Company shall give written notice thereof to Holder pursuant to Section 12. The notice, which may
be substantially in the form of Exhibit &#147;A&#148; attached hereto, shall be signed by Company&#146;s chief financial officer and
shall state the Stock Purchase Price resulting from such adjustment and the increase or decrease, if any, in the number of shares purchasable
at such price upon the exercise of this Warrant, setting forth in reasonable detail the method of calculation and the facts upon which
such calculation is based.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Other
Notices</U>. If at any time:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Company
shall declare any cash dividend upon its Common Stock;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Company
shall declare any dividend upon its Common Stock payable in stock or make any special dividend or other distribution to the holders of
its Common Stock;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Company
shall offer for subscription pro rata to the holders of its Common Stock any additional shares of stock of any class or other rights;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;there
shall be any capital reorganization or reclassification of the capital stock of Company, or consolidation or merger of Company with,
or sale of all or substantially all of its assets to, another entity;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;there
shall be a voluntary or involuntary dissolution, liquidation or winding-up of Company; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Company
shall take or propose to take any other action, notice of which is actually provided to holders of the Common Stock;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">then,
in any one or more of said cases, Company shall give Holder, pursuant to Section 12, (i) at least 15 days&#146; prior written notice
of the date on which the books of Company shall close or a record shall be taken for such dividend, distribution or subscription rights
or for determining rights to vote in respect of any such reorganization, reclassification, consolidation, merger, sale, dissolution,
liquidation or winding-up, or other action and (ii) in the case of any such reorganization, reclassification, consolidation, merger,
sale, dissolution, liquidation or winding-up, or other action, at least 15 days&#146; written notice of the date when the same shall
take place. Any notice given in accordance with the foregoing clause (i) shall also specify, in the case of any such dividend, distribution
or subscription rights, the date on which the holders of Common Stock shall be entitled thereto. Any notice given in accordance with
the foregoing clause (ii) shall also specify the date on which the holders of Common Stock shall be entitled to exchange their Common
Stock for securities or other property deliverable upon such reorganization, reclassification, consolidation, merger, sale, dissolution,
liquidation or winding-up, or other action as the case may be.</FONT></P>



<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain
Events</U>. If any change in the outstanding Common Stock of Company or any other event occurs as to which the other provisions of this
Section 4 are not strictly applicable or if strictly applicable would not fairly effect the adjustments to this Warrant in accordance
with the essential intent and principles of such provisions, then the Board shall make in good faith an adjustment in the number and
class of shares issuable under this Warrant, the Stock Purchase Price and/or the application of such provisions, in accordance with such
essential intent and principles, so as to protect such purchase rights as aforesaid. The adjustment shall be such as will give Holder
of this Warrant upon exercise for the same aggregate Stock Purchase Price the total number, class and kind of shares as Holder would
have owned had this Warrant been exercised prior to the event and had Holder continued to hold such shares until after the event requiring
adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Holder&#146;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 1 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable notice of exercise, the Holder (together with the Holder&#146;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&#146;s Affiliates (such Persons, &#147;<U>Attribution Parties</U>&#148;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, the Conversion Option set forth in the Supplement)
subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any
of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 4.8, beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section
13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the
extent that the limitation contained in this Section 4.8 applies, the determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable shall be in the sole discretion of the Holder, and the submission of a notice of exercise shall be deemed to be the Holder&#146;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to
any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this Section 4.8, in determining the number of outstanding shares of Common Stock, a Holder may
rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&#146;s most recent periodic or annual report
filed with the SEC, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the
Company or the transfer agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder,
the Company shall within one trading day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of
securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which
such number of outstanding shares of Common Stock was reported. The &#147;Beneficial Ownership Limitation&#148; shall be 4.99% (or,
upon written election by Holder which is delivered to the Company prior to the issuance of any Warrant Shares to such Holder, 9.99%)
of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable
upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions
of this Section 4.8, provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common
Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the
Holder and the provisions of this Section 4.8 shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be
effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented
in a manner otherwise than in strict conformity with the terms of this Section 4.8 to correct this paragraph (or any portion hereof)
which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements
necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor
holder of this Warrant.</FONT></P>



<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Issue
Tax</U>. The issuance of certificates for shares of Common Stock upon the exercise of this Warrant shall be made without charge to Holder
of this Warrant for any issue tax in respect thereof; provided, however, that Company shall not be required to pay any tax which may
be payable in respect of any transfer involved in the issuance and delivery of any certificate in a name other than that of the then
Holder of this Warrant being exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Closing
of Books</U>. Company will at no time close its transfer books against the transfer of this Warrant or of any shares of Common Stock
issued or issuable upon the exercise of this Warrant in any manner which interferes with the timely exercise of this Warrant unless the
Company at the same time is closing its transfer books for all Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Voting Rights; Limitation of Liability</U>. Nothing contained in this Warrant shall be construed as conferring upon Holder hereof the
right to vote or to consent as a stockholder in respect of meetings of stockholders for the election of directors of Company or any other
matters or any rights whatsoever as a stockholder of Company. No dividends or interest shall be payable in respect of this Warrant or
the interest represented hereby or the shares purchasable hereunder until, and only to the extent that, this Warrant shall have been
exercised; provided, however, that if any dividends are due or paid at any time on the underlying securities for which this Warrant is
exercisable, then upon exercise, the securities issued to Holder shall be deemed to have accrued dividends and be paid identical dividends
from the same time as the outstanding shares for which this Warrant is exercisable were first issued (or, if later, the date of this
Warrant). No provisions hereof, in the absence of affirmative action by Holder to purchase shares of Common Stock, and no mere enumeration
herein of the rights or privileges of Holder hereof, shall give rise to any liability of such Holder for the Stock Purchase Price or
as a stockholder of Company, whether such liability is asserted by Company or by its creditors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment
of Charter</U>. Unless Holder consents thereto in writing, Company shall not amend its Charter prior to the exercise of this Warrant
if the Common Stock would be adversely affected by such amendment in a manner that would be more adverse to Holder with respect to the
shares of Common Stock issuable upon the exercise of this Warrant than, and substantially dissimilar to, such amendment&#146;s effect
on the other holders of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration
Rights</U>. If Company proposes to file a new registration statement under the Securities Act for purposes of effecting an underwritten
offering of its equity securities for its own account or for the account of any other persons (other than (i) a registration of securities
solely relating to an offering and sale to employees or directors of the Company pursuant to any employee stock plan or other employee
benefit plan arrangement) and (ii) a registration of securities filed on Form S-4 or Form S-8 or any successor thereto), Holder shall
be entitled to piggyback registration rights, and Company shall afford Holder an opportunity to include in that registration all or any
part of the shares of Common Stock issued upon exercise hereof, provided, however, that the Company&#146;s underwriters may limit the
number of shares included in such underwritten offering if the underwriters determine that marketing factors require a limitation of
the number of shares to be underwritten which may impact the number of Holder&#146;s shares of Common Stock eligible to registered in
such offering.</FONT></P>



<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rights
and Obligations Survive Exercise of Warrant.</U> The rights and obligations of Company, of Holder of this Warrant and of the holder of
shares of Common Stock issued upon exercise of this Warrant, contained in Sections 6, 8, 9 and 18 shall survive the exercise of this
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Modification
and Waiver</U>. This Warrant and any provision hereof may be changed, waived, discharged or terminated only by an instrument in writing
signed by the party against which enforcement of the same is sought.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to Holder or Company shall be deemed to have been
given (i) upon receipt if delivered personally or by courier (ii) upon confirmation of receipt if by telecopy or (iii) three business
days after deposit in the US mail, with postage prepaid and certified or registered, to each such Holder at its address as shown on the
books of Company or to Company at the address indicated therefor in the opening paragraphs of this Warrant (or at such other location
as Company may advise Holder in writing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Survival
of Certain Obligations</U>. All of the obligations of Company relating to the Common Stock issuable upon the exercise of this Warrant
shall survive the exercise and termination of this Warrant. All of the covenants and agreements of Company shall inure to the benefit
of and be binding upon the successors and permitted assigns of Holder. Company will, at the time of the exercise of this Warrant, in
whole or in part, upon request of Holder but at Company&#146;s expense, acknowledge in writing its continuing obligation to Holder in
respect of any rights (including, without limitation, any right to registration of the shares of Common Stock) to which Holder shall
continue to be entitled after such exercise in accordance with this Warrant; provided, that the failure of Holder to make any such request
shall not affect the continuing obligation of Company to Holder in respect of such rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Descriptive
Headings and Governing Law</U>. The descriptive headings of the several sections and paragraphs of this Warrant are inserted for convenience
only and do not constitute a part of this Warrant. This Warrant shall be construed and enforced in accordance with, and the rights of
the parties shall be governed by, the laws of the State of Delaware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Lost
or Rejected Warrants or Stock Certificates</U>. Company agrees that upon receipt of evidence reasonably satisfactory to Company of the
loss, theft, destruction, or mutilation of any Warrant or stock certificate and, in the case of any such loss, theft or destruction,
upon receipt of an indemnity reasonably satisfactory to Company, or in the case of any such mutilation upon surrender and cancellation
of such Warrant or stock certificate, Company at its expense will make and deliver a new Warrant or stock certificate, of like tenor,
in lieu of the lost, stolen, destroyed or mutilated Warrant or stock certificate. If at any time the electronic original of this Warrant
is rejected by any person (including, but not limited to, paying or escrow agents) or any person fails to comply with the terms of this
Warrant based on being presented to such person as an electronic record or a printout hereof, or any signature hereto being in electronic
form, Company shall, promptly upon Holder&#146;s request and without indemnity, execute and deliver to Holder, in lieu of the electronic
original version of this Warrant, a new warrant of like tenor and amount in paper form with original ink signatures; provided that the
second, third, fourth, fifth and sixth sentences of Section 19 (Counterparts; Facsimile; Electronic Signatures) will be deleted from
such new warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Fractional
Shares</U>. No fractional shares shall be issued upon exercise of this Warrant. Company shall, in lieu of issuing any fractional share,
pay the holder entitled to such fraction a sum in cash equal to such fraction multiplied by the then effective Stock Purchase Price.</FONT></P>



<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations
of Holder.</U> With respect to this Warrant, Holder represents and warrants to Company as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Experience.
</U>It is experienced in evaluating and investing in companies engaged in businesses similar to that of Company; it understands that
investment in this Warrant involves substantial risks; it has made detailed inquiries concerning Company, its business and services,
its officers and its personnel; the officers of Company have made available to Holder any and all written information it has requested;
the officers of Company have answered to Holder&#146;s satisfaction all inquiries made by it; in making this investment it has relied
upon information made available to it by Company; and it has such knowledge and experience in financial and business matters that it
is capable of evaluating the merits and risks of investment in Company and it is able to bear the economic risk of that investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Investment.
</U>It is acquiring this Warrant for investment for its own account and not with a view to, or for resale in connection with, any distribution
thereof. It understands that this Warrant and the shares of Common Stock issuable upon exercise of this Warrant, have not been registered
under the Securities Act, nor qualified under applicable state securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rule
144.</U> It acknowledges that this Warrant and the Common Stock issuable upon exercise of this Warrant must be held indefinitely unless
they are subsequently registered under the Securities Act or an exemption from such registration is available. It has been advised or
is aware of the provisions of Rule 144 promulgated under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Access
to Data.</U> It has had an opportunity to discuss Company&#146;s business, management and financial affairs with Company&#146;s management
and has had the opportunity to inspect Company&#146;s facilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Accredited
Investor</U>. It is an &#147;accredited investor&#148; within the meaning of Regulation D promulgated under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Additional
Representations and Covenants of Company.</U> Company hereby represents, warrants and agrees as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Corporate
Power.</U> Company has all requisite corporate power and corporate authority to issue this Warrant and to carry out and perform its obligations
hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Authorization.
</U>All corporate action on the part of Company, its directors and stockholders necessary for the authorization, execution, delivery
and performance by Company of this Warrant has been taken. This Warrant is a valid and binding obligation of Company, enforceable in
accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Offering.
</U>Subject in part to the truth and accuracy of Holder&#146;s representations set forth in Section 17 hereof, the offer, issuance and
sale of this Warrant is, and the Common Stock issuable upon exercise of this Warrant will be, exempt from the registration requirements
of the Securities Act, and are exempt from the qualification requirements of any applicable state securities laws; and neither Company
nor anyone acting on its behalf will take any action hereafter that would cause the loss of such exemptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Listing;
Stock Issuance</U>. Company shall secure and maintain the listing of the Common Stock or other securities issuable upon exercise of this
Warrant, upon each securities exchange or over-the-counter market upon which securities of the same class or series issued by Company
are listed, if any. Upon exercise of this Warrant, Company will cause the issuance of the shares of Common Stock purchased pursuant to
the exercise to be issued in book-entry form in the names of Holder, its nominees or assignees, as appropriate at the time of such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Charter
Documents</U>. Company has provided Holder with true and complete copies of Company&#146;s Charter, By-Laws, and each Certificate of
Designation or other charter document setting, forth any rights, preferences and privileges of Company&#146;s capital stock, each as
amended and in effect on the date of issuance of this Warrant.</FONT></P>



<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rule
144 Compliance</U>.&#9;Company shall, at all times prior to the earliest to occur of (x) the date of sale or other disposition by Holder
of this Warrant or all shares of Common Stock issuable upon exercise of this Warrant, (y) the registration pursuant to Section 9 above
of the shares issuable upon exercise of this Warrant, or (z) the expiration or earlier termination of this Warrant if the Warrant has
not been exercised in full or in part on such date, use all commercially reasonable efforts to timely file all reports required under
the 1934 Act and otherwise timely take all actions necessary to permit the Holder to sell or otherwise dispose of this Warrant and the
shares of Common Stock issued on exercise hereof pursuant to Rule 144 promulgated under the Act as amended and in effect from time to
time. If the Holder proposes to sell Common Stock issuable upon the exercise of this Agreement in compliance with Rule 144, then, upon
Holder&#146;s written request to the Company, the Company shall furnish to the Holder, within five (5) business days after receipt of
such request, a written statement confirming the Company&#146;s compliance with the filing and other requirements of such rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts;
Facsimile; Electronic Signatures</U>. This Warrant may be executed by one or more of the parties hereto in any number of separate counterparts,
all of which together shall constitute one and the same instrument. Holder&#146;s execution and delivery of Holder&#146;s counterpart
signature page to this Warrant via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal
ESIGN Act of 2000, e.g., www.docusign.com) shall constitute Holder&#146;s effective execution and delivery of this Warrant and agreement
to and acceptance of the terms hereof for all purposes. The fact that this Warrant is executed, signed, stored or delivered electronically
shall not prevent the transfer by any Holder of this Warrant pursuant to Section 2 or the enforcement of the terms hereof. The electronic
original of this Warrant, and any copies hereof, shall NOT be deemed to be a &#147;certificated security&#148; within the meaning of
Section 8102(a)(4) of the California Commercial Code. Physical possession of the original of this Warrant or any paper copy thereof shall
confer no special status to the bearer thereof. In no event shall an original ink-signed paper copy of this Warrant be required for any
exercise of Holder&#146;s rights hereunder, nor shall this Warrant or any physical copy hereof be required to by physically surrendered
at the time of any exercise hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Remainder
of this page intentionally left blank; signature page follows]</I></FONT></P>



<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
Page to Warrant]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, Company has caused this Warrant to be duly executed by its officer, thereunto duly authorized as of the date of issuance
set forth on the first page hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BIOVIE
    INC.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 27%; border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 70%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cuong
    Do</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO
    &amp; President</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
Page to Warrant</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGREED
    AND ACCEPTED:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 4%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 36%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 60%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HOLDER:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[______________________________]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[______________________________]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    Partner</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[______________________________]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
    Signatory</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORM
OF SUBSCRIPTION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(To
be signed only upon exercise of Warrant)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To:&#9;BIOVIE
INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#111;</FONT></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            undersigned, the holder of the within Warrant, hereby irrevocably elects to exercise the
                                            purchase right represented by such Warrant for, and to purchase thereunder, (1) ________________
                                            (_____) shares<SUP>1</SUP> (the &#147;<U>Shares</U>&#148;) of Stock of BioVie Inc. and
                                            herewith makes payment of _____________ Dollars ($________) therefor, and requests that the
                                            certificates for such shares be issued in the name of, and delivered to, _________, whose
                                            address is ___________.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#111;</FONT></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            undersigned hereby elects to convert ______ percent (__%) of the value of the Warrant pursuant
                                            to the provisions of Section 1(b) of the Warrant.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned acknowledges that it has reviewed the representations and warranties contained in Section 17 of this Warrant and by its signature
below hereby makes such representations and warranties to Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Address)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
                                                                           <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.3in; text-align: left"><SUP>1</SUP></TD><TD STYLE="text-align: justify">Insert here the number of shares called for on the face of the
Warrant (or, in the case of a partial exercise, the portion thereof as to which the Warrant is being exercised), in either case without
making any adjustment for additional Common Stock or any other stock or other securities or property or cash which, pursuant to the adjustment
provisions of the Warrant, may be issuable upon exercise.</TD>
</TR></TABLE>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ASSIGNMENT</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the undersigned, the holder of the within Warrant, hereby sells, assigns and transfers all of the rights of the undersigned
under the within Warrant, with respect to the number of shares of Common Stock covered thereby set forth herein below, unto:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Assignee</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No.
    of Shares</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>



<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EXHIBIT
&#147;A&#148;</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>[On
letterhead of Company]</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference
is hereby made to that certain Warrant dated November 30, 2021 issued by BIOVIE INC. a Nevada corporation (the &#147;<U>Company</U>&#148;),
to [______________________________], a Delaware limited partnership (the &#147;<U>Holder</U>&#148;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[IF
APPLICABLE] The Warrant provides that the actual number and type of shares of Company&#146;s capital stock issuable upon exercise of the Warrant
and the initial exercise price per share are to be determined by reference to one or more events or conditions subsequent to the issuance
of the Warrant. Such events or conditions have now occurred or lapsed, and Company wishes to confirm the actual number of shares issuable
and the initial exercise price. The provisions of this Supplement to Warrant are incorporated into the Warrant by this reference, and
shall control the interpretation and exercise of the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[IF
APPLICABLE] Notice is hereby given pursuant to Section 4.5 of the Warrant that the following adjustment(s) have been made to the Warrant:
[describe adjustments, setting forth details regarding method of calculation and facts upon which calculation is based].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
certifies that Holder is entitled to purchase from Company __________________________, at the Holder&#146;s option, either (i) (____________)
fully paid and nonassessable shares of Company&#146;s _________ Stock at a price of _________________________ Dollars ($__________)
per share or (ii) (____________) fully paid and nonassessable shares of Company&#146;s _________ Stock at a price of _________________________
Dollars ($__________) per share. The applicable Stock Purchase Price and the number of shares purchasable under the Warrant remain subject
to adjustment as provided in Section 4 of the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executed
this ___ day of ________________, 20___.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BIOVIE
    INC.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>



<!-- Field: Page; Sequence: 15 -->
<DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
<!-- Field: /Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>bivi-20211130_8kex99z1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>BioVie&nbsp;Secures Up to a $25.0 Million Debt
Facility with Avenue Venture Opportunities Fund, L.P. and Avenue Venture Opportunities Fund II, L.P. </B></P>

<P STYLE="font: 9pt Segoe UI,sans-serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B>Reno, NV, December 1, 2021</B>&nbsp;&ndash; BioVie
Inc., (NASDAQ: BIVI) (&ldquo;BioVie&rdquo; or the &ldquo;Company&rdquo;) a clinical-stage company developing innovative drug therapies
for the treatment of neurological and neurodegenerative disorders&nbsp;and advanced liver disease,&nbsp;entered into a debt facility with
Avenue Venture Opportunities Fund, L.P. and Avenue Venture Opportunities Fund II, L.P. (Collectively &ldquo;the Avenue Venture Funds&rdquo;)
providing up to $25&nbsp;million with the initial $15&nbsp;million funded at the close on November 30, 2021.</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0">&ldquo;We are pleased to partner with the Avenue Venture Funds as we prepare
for a catalyst-rich 2022, which includes anticipated top-line data from both our Phase 2b trial of BIV201 in refractory ascites and our
Phase 3 trial of NE3107 in Alzheimer&rsquo;s,&rdquo; said Cuong Do, CEO of BioVie. &ldquo;This non-dilutive funding provides us with the
capital to take us through several key clinical milestones and to support continued advancement of our programs in additional indications
as we initiate a Phase 2 trial of NE3107 in Parkinson&rsquo;s disease that is expected to have topline data readout in the first half
of 2022 and initiate a Phase 3 trial of BIV201 in the treatment of hepatorenal syndrome-acute kidney injury.&rdquo;</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0">Chad Norman, Senior Portfolio Manager with Avenue Venture Funds, commented,
&ldquo;We are excited to be working with the team at Biovie to help bring forward new and innovative therapies for patients with several
unmet medical needs.&rdquo;</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><B>About Avenue Venture Opportunities</B></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0">The Avenue Venture Opportunities Funds seek to provide creative financing
solutions to high-growth, venture capital-backed technology and life science companies. The Avenue Venture Opportunities Funds focus generally
on companies within the underserved segment of the market created by the widening financing gap between commercial banks and larger debt
funds. For additional information on Avenue Capital Group, which is a global investment firm with assets estimated to be approximately
$11.6&nbsp;billion as of June&nbsp;30, 2021, please visit<U>&nbsp;www.avenuecapital.com</U>&nbsp;</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><B>About BioVie&nbsp;</B></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company
developing innovative therapies to overcome unmet medical needs in chronic debilitating conditions. In liver disease, the Company&rsquo;s
Orphan drug candidate BIV201 (continuous infusion&nbsp;terlipressin), with FDA Fast Track status, is being evaluated in a&nbsp;US Phase
2 study for the treatment of refractory ascites&nbsp;due to liver cirrhosis&nbsp;with top-line results anticipated in&nbsp;mid-2022. The
Company is also planning a pivotal Phase 3 study of BIV201 in the treatment of hepatorenal syndrome-acute kidney injury (HRS-AKI) in 2022,
subject to FDA&rsquo;s review and authorization. BIV201 is administered as a patent-pending liquid formulation. The active agent is approved
in about 40 countries for related complications of advanced liver cirrhosis but is not available in the US or Japan. In neurodegenerative
disease,&nbsp;BioVie&nbsp;acquired the assets of&nbsp;NeurMedix&nbsp;Inc., including NE3107 that inhibits inflammatory activation of ERK
and NFB (e.g., TNF transcription) that leads to neuroinflammation and insulin resistance, but not their homeostatic functions (e.g., insulin
signaling and neuron growth and survival). Both are drivers of Alzheimer&rsquo;s and Parkinson&rsquo;s diseases. The Company is conducting
a potentially pivotal Phase 3 randomized, double blind, placebo controlled, parallel group, multicenter study to evaluate NE3107 in subjects
who have mild to moderate Alzheimer's disease (NCT04669028). An estimated six million Americans suffer from Alzheimer&rsquo;s. BioVie
has initiated this study and is targeting primary completion in late 2022. A Phase 2 study of NE3107 in Parkinson&rsquo;s disease has
been authorized by the FDA to start the first of the year in 2022,
and related compounds have additional potential to treat certain cancers. NE3107 is patented in the United States, Australia, Canada,
Europe, and South Korea. For more information, visit&nbsp;www.bioviepharma.com.</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1.5pt solid; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><B>Forward-Looking Statements</B>&nbsp;</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><I>This press release contains forward-looking statements,
which may be identified by words such as &quot;expect,&quot; &quot;look forward to,&quot; &quot;anticipate&quot; &quot;intend,&quot; &quot;plan,&quot;
&quot;believe,&quot; &quot;seek,&quot; &quot;estimate,&quot; &quot;will,&quot; &quot;project&quot; or words of similar meaning. Although
BioVie Inc. believes such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations
will be attained. Actual results may vary materially from those expressed or implied by the statements herein due to the Company's ability
to successfully raise sufficient capital on reasonable terms or at all, available cash on hand and contractual and statutory limitations
that could impair our ability to pay future dividends, our ability to&#8239;complete our clinical studies and to obtain approval for our
product&#8239;candidates, to successfully defend potential future litigation, changes in local or national economic conditions</I>&#8239;<I>as
well as various additional risks, many of which are now unknown and generally out of the Company's control, and which are detailed from
time to time in reports filed by the Company with the SEC, including quarterly reports on Form 10-Q, reports on Form 8-K and annual reports
on Form 10-K. BioVie Inc. does not undertake any duty to update any statements contained herein (including any forward-looking statements),
except as required by law.</I>&nbsp;</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><B><I>For Investor Relations Inquiries:</I></B>&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%">&nbsp;</TD>
    <TD STYLE="width: 67%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">Contact:&nbsp;<BR>
<B>Bruce Mackle</B>&nbsp;<BR>
<I>Managing Director</I>&nbsp;<BR>
<B>LifeSci Advisors, LLC</B>&nbsp;<BR>
<FONT STYLE="color: #00467F"><U>bmackle@lifesciadvisors.com</U></FONT>&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1.5pt solid; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>bivi-20211130_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://nanoantibiotics.com/role/Cover" xlink:href="bivi-20211130.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://nanoantibiotics.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>bivi-20211130.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /6Ips7xRiXgen8uHZH0sSaCDmbPtzpN22ekhtWp9fUkKXysjI5ygbSQ841gWEasK -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:bivi="http://nanoantibiotics.com/20211130" elementFormDefault="qualified" targetNamespace="http://nanoantibiotics.com/20211130">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://nanoantibiotics.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="bivi-20211130_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="bivi-20211130_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>bivi-20211130_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>bivi-20211130_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bivi-20211130.xsd" xlink:type="simple"/>
    <context id="From2021-11-30to2021-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001580149</identifier>
        </entity>
        <period>
            <startDate>2021-11-30</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-11-30to2021-11-30">0001580149</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-11-30to2021-11-30">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2021-11-30to2021-11-30">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2021-11-30to2021-11-30">2021-11-30</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2021-11-30to2021-11-30">BioVie Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-11-30to2021-11-30">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2021-11-30to2021-11-30">000-55292</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-11-30to2021-11-30">46-2510769</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-11-30to2021-11-30">9120 Double Diamond Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2021-11-30to2021-11-30">Suite 1400</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2021-11-30to2021-11-30">Reno</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-11-30to2021-11-30">NV</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-11-30to2021-11-30">89521</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-11-30to2021-11-30">(775)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-11-30to2021-11-30">888-3162</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2021-11-30to2021-11-30">Class     A Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-11-30to2021-11-30">BIVI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-11-30to2021-11-30">NASDAQ</dei:SecurityExchangeName>
    <dei:WrittenCommunications contextRef="From2021-11-30to2021-11-30">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2021-11-30to2021-11-30">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2021-11-30to2021-11-30">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2021-11-30to2021-11-30">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-11-30to2021-11-30">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139691548817752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 30,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-55292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BioVie Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001580149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-2510769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9120
Double Diamond Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Reno<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">89521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(775)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">888-3162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class
    A Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BIVI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MY400X%8]T?PJA/1P>,-VZT)8FL&B\\=B45V_&KU:LM+] ]RJ_T,V-B8#LEI
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MJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%
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M?^:+X3]>?P%02P$"% ,4    " #W28%3!T%-8H$   "Q    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( /=)@5-I&(I!
M[@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( /=)@5.97)PC$ 8  )PG   3              "  <P!  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ ]TF!4W+S)T%.!   W!
M !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+
M 0(4 Q0    ( /=)@5.?H!OPL0(  .(,   -              "  9$,  !X
M;"]S='EL97,N>&UL4$L! A0#%     @ ]TF!4Y>*NQS     $P(   L
M         ( !;0\  %]R96QS+RYR96QS4$L! A0#%     @ ]TF!4ZK$(A8S
M 0  (@(   \              ( !5A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( /=)@5,D'INBK0   /@!   :              "  ;81  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( /=)@5-ED'F2&0$
M ,\#   3              "  9L2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     )  D /@(  .43      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="bivi-20211130_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanoantibiotics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="bivi-20211130_8k.htm">bivi-20211130_8k.htm</File>
    <File>bivi-20211130.xsd</File>
    <File>bivi-20211130_8kex10z1.htm</File>
    <File>bivi-20211130_8kex10z2.htm</File>
    <File>bivi-20211130_8kex10z3.htm</File>
    <File>bivi-20211130_8kex99z1.htm</File>
    <File>bivi-20211130_lab.xml</File>
    <File>bivi-20211130_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bivi-20211130_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "bivi-20211130_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bivi-20211130_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bivi-20211130_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bivi-20211130.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "bivi",
   "nsuri": "http://nanoantibiotics.com/20211130",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "bivi-20211130_8k.htm",
      "contextRef": "From2021-11-30to2021-11-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://nanoantibiotics.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "bivi-20211130_8k.htm",
      "contextRef": "From2021-11-30to2021-11-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://nanoantibiotics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001520138-21-000754-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001520138-21-000754-xbrl.zip
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M@OMMF%+6<R+=_2"9DVW?I.Y?)76'Z5+7<%V?.??*7F=LGV]UOS5;OQ??6EY
M]F:@6UT)++%<>4-[F 0&;5^S!"X3-.3\A<%KF#I2A:VO=<9$PX@<)[HAMWTF
M#@U,1<L0>\,L0%2$I4=ZCG7K]8&%!S8&T-0E.NMR4QX%3/XF@X5B)8RRIR(%
M>*I42Z7UM0U$V-:NB!C"UC K\(*-9PIQ*UERC-K)J2F#)=A&CEHFX:#(/9-^
ML6'S*TN@%>>?>L *ZVM3O'#W.:*PV['H="#[I.O.MO?M].OE>>^T];QA]AV
M/5AMKAIU5IQY&EU,O,U3)UE0&U(YD:1NXC-)O#[H&F8PS0-=8UK"K/@N$ZT
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M!5I>9Q[E1D*7!W4H=RISF:6<R5XEP<*CN;,Y)E*MYI7Y2:3)%*_(%JP$:,*
M<U.>+!7[&3Z8;[<?)B !VX+&J$?CU:YQNF0QAPU$Q?1F![D#0GH]2'#B->Y;
MNUUN,,SFE;=W1<XYW -&%@BV2-;7E.T'GX.6>SLX<OR]G.!=? -%EJQ@\<$M
MYO&G*JD-3CO<D!.)J:FWON9*>&0UZ/R%);R2N#L2' 8 P0ON;<,"\.DMI3GW
M UC3UT^)G2',I?:HH\O]AJX8.]Q7Y_%/WA$#1O(QM2=JA\:RD$R" 227=<>(
M';FL#FZ6".G#"^<B%PU =>6W<+7)JI!)@@K48,#7)&IO;M<+NUW55^-V/?AS
M%5&Z,XB6\3-8DSKN<"_D%7RZZ,U=6T;IR#+AWZ#OUM=F..C9;]]<,MI?XW<R
M'_2]\<X2+I-_HF8-F$-">F;-A(-/UZTO^OF\96!T>^M)&#V<E  \N[).<PZ<
M7F=#+9:S:FD[JU8J[YZFT"GI.WA[3(</>2ZZ=&;[AHV4XF\EW_<&"^,*-_<C
M[-#5.=2]HNBZLQ9#%]'"S(GD+!:U0Z00/W9\[_G;Z!1O]C'G=:<I^2*\?B5K
M<)Z-8NI3&5S]5S'XT]"5K"5:$KMG'\'O*\_NRU7M"UJX.SF@)#D "[4D:E;K
MOHX519=(,EK=:%<+V#^J7&[-E%/'OY2"SV/</HWSUZ^$J]4GFDW,(_Y[E/"3
MT74Q^5QP4R;.0VT[O1=PAPJ,7S)Z1]5DZ:UJ,NW6KY7]*@8$-ZW&\5FM?=FL
M/_^QGU?U%<HG7?,8GE=?7PNV#X*3Q;&CBO=N7<B=N6;RRD?=-\9$HSZ>%!<[
M+O*BDV"CP074RDMIL-2ZP_K4Z)+.6)XK%OG)H 661OBX]R#&H[[7MQS^>\F'
M2/X->V)XVD3?F=U674E@Y]UQ^3H_%+IJ:6U8$#[^D%$?C:NGZ._]QOG71EV"
MT3@[6%ZZ[UE2["]*YH@%*\JS9BP?#\]J@5/:7BUX-I<)SA_BO55 Z,(P[(]W
M7BA%OS"(!;<@P?ID4=-DY(J9^IB<\,&;[EL9_INSA_:$KQ3O).\W63D8)3-*
M8-XX\I_.D>*CQW=KRC\#V$&?LVY0&CPY>=?M<HTYJ\N-#\PQE65:Y0_FE^8G
M>@H=2Q]CBT+?&QA335L,)A9:C(STT2YI'(H?KHO;^]?BFPWRNZMR==B/?1H=
M_;RLG]S^K'UI7A:^G-^.?K2*ZJ_2MZ9]V3QV6OM'H^/_*UJW[1_M3\['7S>=
ML>%>7FK[5J=?*+!"_>!\9#>N[!M6+Y_<#K]_KUY<J?S\DM6/CMEVIS<^ZCJ'
MIPUO^^J7]D-5JH7"5LVLG1SV+HV?GRZK^YLGJJY][1O66;/<<-FGFFT,-IM-
M]7AT5*W^^.V.OC:MH5Y7Z-%P_^<OP^@I6[]I\>?WS;'^@QJ5JO+EXX_C3J/_
MV::'A<:/^J]>2U7.;SYN:\K^)?O"CX>7;=[ZUAYV2U>E3ZJY[W]7SGY]_'S(
M^@7K=ON271IUB8[_!U!+ P04    " #W28%3;TBTJHO(  !N^P0 &@   &)I
M=FDM,C R,3$Q,S!?.&ME>#$P>C$N:'1M[+UM<QM'DB[Z'1'X#WWVSIX@(YJT
M9%OVC.6C"(JB9AA'(RDD:B8V;MP/#72!;*O1C>T7TMA??_/)S'IK "0A:\8@
MC8W8L0B@NZNJL[+RY<DG?_[;Q=_?O!B/?O[;V<DK^F^"__OYXOSBS=F+G[^1
M_]*WW^C7/[]\]^J_DH\7__7F[/_\QZRNNI^2IT\677)1S$V;O#4WR8=ZGE6I
M?) F'TU3S/Z#+J1+WV][W?-DGC671?53\N1YTIE?NZ.L+"[ISZ:XO.K^X\7/
MK]^]O0AO>C3+YD6Y_.FNV_)OV^)_C(R"[O3RQ<_G+\Y^-=.^*^IJ/#JM%\N?
MOSFG):!OOL%SZ#_O=WX>_[N:M(OG=PQX4I?Y;QGUU%2=:;[FL-^\.WD['IV\
M?95\/#O]].'\XK^2D[]^.#O[^]G;BP<WF0?Z#EYEG<G'HZQ-ZEGRMKXV\XEI
MDN^>I,FW3[Y]^N"F\T#?PL1T-\94#V[<#W2Y7YZ_^\?YV7AT_O;T^,$-/AN/
MWIKK+,^2:=TLZB;#T94^N&D\4-')VO'H?_\_3[__\?G/GUZ\K)NFOC'-S]]\
M>H$/__Q\_Q[^7>^ARA_<F!_H4I_\X^SM)]*6])^+3Q_.DG?OW[_[</'I[?G%
M^=G'Y/4GLM_.S]/DS?'[XX<G_J1-7YDRN\D:DY3%O"!K*%ED35>9IKTJ%LF!
MV^PG_WCW.OG6;_7#!SA94EY94IHJA\YZ8(-_H+MGKZAV2%'] ;34M:EZ8[74
MC\\/']Y<H:3R>5$5;0?C]MHDV24]):&=1"9O69+'VF2E?GA05$G;3Z^2:;;(
MID6W3/Q2X >!OGYX*U&)9VY5]NIDTZ2K+TUW1=_=%-U5(F=42E>X57BCVMXN
M@UM&,\7:EKC'E1G^OMV\;K1R_^OH*'E=F#+_*7E/K^$YS>"_>U--,?+DZ$CC
MB3^_.O^'70=9LZ.N7M!/OEUT=A6/)G77U?.?DA_PV:1NZ-GNLY=E-OV<T*^3
MMBZ+G)9V70SNI"FR,DW^9LIKTQ73C-8SJ]HC7=35-^0>S8-YLC*2)U[_O:=)
MTR36S&?2F.SST<3,ZH8FO>!%"&_[PYHI8M[A')P<A2IW\,A@I;_!4LOJ/@3A
M_>,%]W[#B'_IVZZ8+?7#@G8@;OCD^%E1?<UI7%P5I%S?U%G%6N"CF?8-5.;)
M96/,'.HT1S@PV1 -3(HVF2SY4@U8)=8#3@[HFMS,BHHN)RT%E?*Q7RQ*N6WX
M[<24]<WA84K"<3G\[EY7\@#>J$;<^F)\ELUQ=9[:?Y"6I5LVINTP_91TK+T%
M_JJ;I(:*O2E:D\SKO)@5=+]94\^3CM:;5##_-]*C+U] E6*AW=I"HR*OH%HU
M6?1-VV<T2KK^YJJ87M&;D4EEN*3%Y_/L,YU^UUE19I.2G^06G X%W'Y&YT")
M=WA);ZOAB2YY(+0#YJTJ^RHO$"1JD]9T)!4-G12\6/0^XS$F?.34E<&DYZ3;
M@M5L$\.)$GF$'X=_&3P+NK.-2YFUCZ"+&S,S#<Z+X^0LHTN"5T:#I:W0T6/8
M5_%O I/'LVCX-"\8/Y#1-0](^6<W15G2.Z='9;E=!;(G>I5NFB$?F&NO;^F%
M7F6=_Q*B&JP0_?]R_9CIK;1%=5D:>8<R7]TJ>"D8=D&O]F##V@\$.$T,EB>0
M6%H3^5?R%20V@3D9F@+R8AKZ+1:[E07X^>6+P*0*A%D$&2)]>%<4=?=5XR/1
M\"=3VGPY1'!)LA**' LD7NJ,7GA]T_[TX.>Z]I711 (S;48ZLOOIS=GKB^>T
MW_/NZJ?O__R?Z_/2O]7HV##IKSMEVHLG'R[.3]^0ETN6=H+-=_[VXNS#^P]G
M%R<7Y^_>_HM-JW_++'^OO?CM5Q90>EM/CY_*;.[SOZ]@JLA)?0SPQ4LRV.Q!
M'A@Y)[2AIW3$/'W*A\"JV<-GWU5V;?B+N<DJ4@C0YG3HPH-<F*F>"'10D!FR
MJ%O3NM/4Z?C?0:E_[3?PJ"3IV_M+TGD%FZ1H.S*REBI+YR(GYAHB0B\;1DP1
M_BZV5)KZNFC9:-3?!@(FELH:RVGURE@TQR-KE]%SNX9.(I),%D.^4D21'TB_
M:DQIKME ;LBASZ:R,1[^R_RW1%?_[<?1MWH<7?SM+#E]]_>_GU_ TT\0 $ H
MX.-CF.\C4B??;G,PT3$$;-Q\7G1B_+]\<4R[>O(+.0[L3&SR-U?.%/5HUCNZ
MN 5[M6WDZ89^"]FT^(=\1$\]+6LX7 E@3**6:CT4IV4/.YA_=4$W+BH&2L@O
M"P1 Z/'T_$O\O6CH@F*!J/*\[DGE5'5'[N[4&'<//_WC9+ >B(O@@HQ4UG5=
M7N.2*7E1!5Q#^R-Q2]VD\MK(1>Z<9E0@QM^8"?^*M6M+?RZR(D]P>/=8-?69
M6?4VB+NVC. *?7*Z":G8>9:3+JV\3_JRIW^8MJ4U6";M52::&-HW2Q!OG_?S
MU948A P&[BDMT<*)  DMZWB>C9EG!>R.)%XGQ++;%N^>;_]'4></8!ZL%+:P
M,=[6'*,YNRYH1%.\:9;7Y\D'$MBEUQ->6IW(&;E&(DDDGG0!AXMP2W)8ES;8
M!4'BE  42: X4BN+7=V1I#J9172$A99^SGD2^3D"%3\\;V&9)/2<# -IC+5.
M,+3CY+V7>U8?I(MH8_GG1N.W0^08D6'=U :V^'A$ZUW1J%?V#D]0(C>7?9DU
M)>W#Z97)^Y(3>DN)L[&ACBFX]9K-2-/J<O4=O4[R ,@EF!2=G46VH-G10F 9
M9Z0G6M:1XY'5"78-:)XD9\ODW<(@N49O#2$#K%G6!I[!JE.!,77UL7^[X?K)
M[(,O,' .0>D^)T&A4;!Z#@\ :PVRA@LUF#Y_VC<-FZ;TMT07\6F;T1%P1>.=
MP%IE>Q,1L8/BV!RGR:>*TZ,?$1DC58>$8=.N1J@TR[(:+6 ]?&>XX*%LZ._N
MOZ'?-S5MR;[!KL:A("^#1(3W\<-7<(](41]DA_=_KWA])W0LER8CC39#0OW@
MV6%D#4 W%C4;#ADV%-RPW N &$T2.'3V4&AY'="UK'#U<"?E4M0Y:PB.,[>T
M9O OQ>(C:Z5?D&%"&U[U &WO@A1?6Y-2S8N6C"?8:H>QM<B13.AH5ENJ(0+%
MS)948Z:&9JC1[B!;<M,4'9DGUF2"7D:"8>+FZ RLY""+@MY^&3[(M</@MQQQ
M*S_S^IO3]I.V(V>VH(\D08-$!JT0B>"G%V>_7A50YO+,E_;FGU[84S TNORQ
M$.1C8'NV"SCS.)CD&[QI>C$S,GWI;*.CK9[-BJF<IG9E4DGYR#TYFY!<D>DY
MQ\LL6F]@BOGJ'IW1H3%?9%4A3^=W+_J^J# QL;5Q25Y/>XQ;/VGU;8I$-"22
M=45GZ=(^*1V/8MO=31)GYT%[Z*(%>//X>XK$E\][K;R&8UR)9 _6W]T6B?O+
MFOY*UU^%2 6=VUC4P,GA\!PMI)>:NEK=#6Z5\MZ0C9\P8@4II2IY^M.3)\GB
M>$X&1X:C=HISJLJS)N==SXFI@Z=^<XY'L-7=YAP^:J^5=V8>T,J3+;7R6_)G
MMQ*.@:Q"!,@6]KN9K:*6MEK+5AR;4-X;7T YYNR(^2CR][1QQJ._X-'9K8_F
M/3Y\=JB?1>S9DX<RWVQM;\AH%Q7M_?F<_&:Z-6D$_RLV:/>ROC/S8,OR^VW"
MT>).L2%)+J-$#9"'=UGJ%=>#')JRF/+KMU[3-Z0$PX/P9=:2H)X[7TTNK/O.
M:7H?S9AD)1V")G+H[+%'AUE#FCHG<5M:G^Z5:6E)&0WS@8T?&W&*=\!Q<CZ[
MWU/%'X7T:[2(?1YZ&IV5C,+ADT^G$HW+C6B6]64GPR&7JBCE%K1>L[XL4\[M
M]@T?PM[QE)S/?N_LS#QX[SS;;N]4T-\P',>C=W.8L?GC=<D>X"SXE?ZPO3H<
MCW@OGV;EM"_9/I:(6:S7:&.7-6D5MD>G=)9>:K!IAMBY>"QQD-UAE%9B'GEQ
MC26>-,GIF[.3#__GY,T;&OV'%W>A>K]]GKQ;L!'Q$];EH^%DW//D'UG9_RZ@
MWSM>T1>A?H_"%;!S?YY<+!<TQ9,FFQ33Y\G;;&YD?=[6F/73"*)KK\(W1SN-
M'_XRD,QOWXQ?%6*,T_25^I>!7SS5#24(!_+RIUU/AW&..(<ILP5B&VHL3&BK
M288[^>Z')T?TDV1I,O**)=I(^X^.W!9G[%5Q*>ZMW96R%=G!-B8,WN*(EQL^
M<S=,R, UXU%/CR:3H8)7*(EX&;2S@6GT]806C =/QC'=UCG,PT>W^NP6%D*6
M-)K80DZF=;EW'C99%/SM GFPSJ:+ @NKS&[6P -Q,XX\/\Z3YD'.@\^:'[?"
M%,%J'(\B&SPYH=/AG0@:NX:,=X6;YBS3FRM3<0!#(_LL)V&,; :_];+@;*>(
MB21?(\&Z;+*IT7!@>V@-[@EVA#-VK6E=-#;<@L"5FL4%%H/&(F:MRY4@9SF=
MFA))# Y.K=K(*9*OB[IGM.R<UO&J7!Z[G6:'@@W&IGD1N!&YH5>1[Z5^9^;!
M4O_G^TO]&WK_X]&IJ,ECB#S\-!]I:#DF!P4WSSY#@"&V*YDX?&\#@*I.PSU#
M*I0A\JSQ75@=IPS'%*M UCS0 ?*6R=/M 3*3BVF33+EHX=E_'MK'V8'0/DR3
M22^X!,38Y:%_>O;D^,D3R>#3!! \9%G.35E4L$0Z>P=@%E#[$3Y80_+R5^ZC
M\>TZ0%9N9DVV]$'9A:D &H2CBY=.QZN&)VE<.:.ZK,\;#$9S@<<^+4F[^'-5
MW]"BXSQC+21YA&"<C5G06^##-?,18TQUSM![&D##[Q Y1UFW:=&050"'G,Y"
M&FW1=D&P%D4N''E?8S9'#YME1:.?NJ>2BBCF<@.-K[6=CMQF,UO:%5E1Q6L*
M5:I+1+<M>PF)>1%Q(!C:">72V1/' 0Y&G7LK3'CDHJGI+K!?K(TSS["2-W5?
MYH*S:[MR:3$Q=45&1\'R\'&XS*P/R3#0;"S<C;K'$\PO?5Y,W>@%IT*/M#/#
MO:64AWZAY00BCV$"V.=I!9W"#Y&H=FZF)<Z>#%(FI]5:M\:*N49<^.Z1#2@6
M$8X3\ROMIJ*U6UM^RR-O]84BSBBH5QD[7:D3VNO]G9D'Z_V_;*'W0[P'N=<&
MU1"MF#P.X;$2.&1WV0$62*V06 "L($((^8FD; ..A;YI"E:)2$+BN0D@4*()
MV. .@^4SFS%5':M)1 >AJ)P3+Z,2/%F;#+-2BZUFY8.4=HM]P>QXV#I%LB0G
MT)8TU:J8X;&&M!7Y3[J7Y%6X!?$N6HTD7TOGWGADGV-Q+_O]MS/S$*#HD_MO
MP+\V&1" I%5=<:D5R/9Y\KJPEL%KR4G3'XS3T:/N7TN[N'_Y_WJ<R45-CA7>
MO''(.&_,B"MI&@8(:%I$C;8A3"VPL],@NTF"1+KH$D+6RKF=.F,5N488:!-3
MF5DA0FA/="XW**H> M=:P;0>'RNUP'@\=1P3'*JA2RN)=]J2T0@]X"W9G@RF
MAM:O]=;0 N!=!'XX7EL ,DCZ=N:$OW7"3Z9/.VV*":OF>!2_&W)M8ZPT"$Z6
M9M;I)[$XND_^=?$_9Z/Z-&(]Z11V/)0H2>>QV=VPVR"54JL8CUD1N2_K7A8Y
M,!\W?<=N%:U",94"Z/!-(D4G$!].[[6MZ5R@[I69='6C'!TTQ!L^,#&*@E8G
M:_:AN%V;QY<@/LZK\4C].*L!AX+*VLU*Q7IE-9"JD$E 4S,)CFW2WDDVJ:_-
MB@H=CQ;J<D,QJ3ZEJV]7J8'3ES)L>S VJT<9L ;01SODI^&(&V"F)F\5> 9<
M'&KG-0S)%F#*/YQF[55*.ZN>?N9ABB$[KRNS5+QQ4]-ITBW%EY1K*[E673V:
M$AX Q2J%#CIF6++J=<()'8]X"01\$.A[OB4&G@ZL:0R-/ZK(CL6_W:3TO04'
M!! Y=J5<8"4^! >1)5(O[]; RN#^BF,M47H,3J*P'IG)+]!*DH7429R"5@K
M'KU3\*>/]\A+LW&,\0BA&P'7>=D8(/^0[&!B!8?\;J%I-6I%9[_#[]'23LJL
M^ASBO%/RL3B<Q:I6'\\X3@2Z&-X=##2GA;D(2TUXAD4 _EM;A"3,&#9T9073
M[0CQ2:99WXJZGM3UY];A1)![IQ=W<X4XF Z03W3/0!%K>/7:N&9QQM$:M04:
M,^/("+]_WGVN/I)O>YQ\6E@(RU2![Q)]S_O&CE[M&!4<V!7)F2WHM,%O%Z1/
MU1#!B60C]%@D.S0M[ SVA$ O/0@GF-B!AV6Z0*0PD7'LRL_C$/I /J@ U'<1
M%GXMO,P5Z=A( %W4C<]2R$(P*(D7%6W;^X'%=R;Q+5!B8&=F !0-(F<LT"J(
MLJ(BV!J@M-$CV>4=HG#8(2(1_'!\IHZOUJ'ROO;+ZX&LXY%%&,/^HWW.T>/&
MOCGC]K_J&#L)9Z>LTZJAE'CTE(NHZ2^\&L!20GS2(-+J_7J(=*G%&!(G$[OT
MNN;U5]VYSC:R&T *[2X1ME93"EF:#&NJ\;5,7R[O0"#[W)VLBO?Q0 0RJQJ/
M-V$2M^T"4\W>'A^%-^=!5)(/$IW-KTK2MQ(%]?0L 'Q?%[5@+:SXZR84U;%:
M!)^< !C-(0]WIES;,IY[KX!,J],Z1*, ^#5[/=[@R;K][>*M5F0LM)WVI,9I
MW4L?2E?!:*+PS8]'""NM"XVNB\&F464E?1/9&Y/?@PAF;YYN-D^G6YJG/AU1
MM '@7XHYR99LZ[(7;&Z%\*@[9+FHH2P$K+O>QH&415Z]$Z34^7%\H/#W4,5+
M&""TA0HA)[!*UIE8/HLR.*I@]3$&>LDFFTU : 8FC,+Z&&@(3W;IA-V1YOOU
M6WE,HIMO6^&$Y%7H%+&)%5<5W@J6"VH=M1IF&,?Z:G"Z[_;(N:,7W^Z1<[\;
M<NY^<=G8)?5VI_D5UGJ+&T06:&PHD$6W9CO>EMA=V8',WX>R153WLN>-V&A6
M:15PR79Z#I[@8M);FRYXJ-K%S(B&HN=IW3<"9YC8XD?>_6$A@L/(>3_J4.'V
M; 5BZ825-UXA<5O99?4%.(*=\B!]G86"!*OI52TPE-S,*]C\M;_?'\:4>A#,
M+R'3S7?*=//A[/V'LX]G;X5X[2-3W?SSY,.'D[?@&W\,L_Z][(FO+(;>J@W1
M/2 )S1H)?68N<+="*&.R-65O<%D=^TDVX%4=J#(UAU\5[93NW2-V],:0@FFX
M<H]^_$B9&!^@OJ)=_MU6A'T]O<QWS656%?\3UF\$.,.H2Y-$1&NY0(^':YIC
MSG%2!:F1!%W6=9ZX<C)[9#),VPGJ+WU3M'EA@TCBQGON7?6A<HR!G_K?/3U(
MJD)KCH[VTRX^!HMV]=F @&>NMCMZIJ/DP(,GKEZ9[J)W%YBNEH(B4%]([#0I
MZZF@=G4#W>"DC7PZB;JU=3!JB>4@[!@4C4\$BCA5M#P?P5GR=QS_!>A@3G+$
M8TQRML^=[=8\>*=M039THLEU$>SQZ!_8-;"8(+AGH!R8&G(SP(0M>_#"40?P
M3M" [W*3J3N $:YGNFZ$-+JHACF[\6B!OVB^W@CD3><P <J?8!'VDF::E;25
M),XZ3 )&V9I9O*^QJR;+(RB#U)XN'+UDR -.'R Z.XF5RL:M QT%E*C%>L5$
M$(YF>K46Y+E+@/DZ5K]< 0$VJS/!.TP*T2&!41L_T-CW5@HC&W,7\UNQ0(NB
MT;CL@3]K%;9LVZ#0&YIDU>>F7W33):)*Y/Q><\1(\HN:/6?5F;$:<"!F>;Q=
M"$'8U1ZS)B%1J$13P9U0"@Q/>Z>?6PQ>*7!2I*2ZY1_&?'\ \V!ELP41TFD]
M7Y0%!%%90$Y\0<L;DJ/!*0_.A2E?8G*?Y@ZKJXJIJ5J.=(IW*>6;.$=I5_2M
M9+,TERD[JC(HXH+/VH$_Y ;.XW(\LN<VYRGMV1T<Q#C#376975J%HQ4Y\)5I
M@=B5;JW.F/5-5;17%NQBFNL":/DH/>NC_:LQ6OCBR(K*P)GTD+8XJ81 \>3.
MZI6B"$Z8N^65U0IS-8,3/-D?X#LZ#]Y36U! @.KD5(^\6T_H=.6(#L_@]<?U
MQF-U4(U&&RE-FKXD#TX(^.312C$(:6VD^BRU(2E90!+?U'=TX"_9*.^D>,@V
M\!@8_D (+.6P'GZO9]@$U6G\*$OPIWLV@#CXFA@_-=XJ]S:#AYLH2?X9[F5[
M'.IIQF&H%1#+'H.X*9)Z)="$$,KS3PDKN(8>#M%%RZE-S: ]O8&Q#G)$1AK+
MM.2K)4&?A1'3 ':S*F#HU&.%2P\6BQ]I+5"';GA5ET!SL>&X ICT"(P@:&F3
MW?I ;^\*\A+%<WNRJIV?!VOO+4A(H+W?D"Q<JL8\+;-BSH;$>P&^H<& 4^N-
M$8X;TB_^DB[[-9GBLM2"Y=CP8!-AT7-Q>B798)2/J/BXVL#(<8#A0=J/U",T
MYF6&G>"U: C^3</PP](:/M:*TJRT,Z0DJ@>OY;K(>\YIUXZ*U)%%IROZEXOF
M0@4LM &X$CEQZ<^$F6IQ7DQZ-2C8OZ"IM=B7R<F>(7FWYL&[9@N>EU-ZR203
M$A?S12]T(ONBE]B7L+K74S8&P/(P=P3E36+]BYP:5AO##@K\4P Q.8A "K^O
M$%) /5K!G;4<U.@2Y,U [0T5^BKXDZ$=4;J-OG$UPUG1*# D Z2).=Q2"PF>
M6UM$86!M:O&0JQ3%?O(.7[(N//#7DY/W0> >AV3;V=K>"+L?+2-',E)0HG/%
M62:7<,U%$[ *D_;:.R&[/@_>D%N08> 8^]A/VB(O,E0S*A?&VN1/&AE30N\_
MSWZI&9M9WU0>/^ON:(^+S'8W0?9: E]HTNL\$LUDNW-',,9[N=J9>;!<;4$W
M<59=%TW-H'=D'4AQ=-Q"E^VAFHT,;\D(9#]@%  [0@''=Q!1LEAL5E*A,++'
M$,=0HA%PD(JLI'7=&835($BRN);"P1VW3[7L=>2NSH-E>8L2>NC((>18)/EM
M[2#(I.=6RPYP%@N8.;?Y1%]VN9>(G9F'9+FW*.I^W0-;Z0$,5APJ%_%PN J;
MYFDLM@+A VY$LZ:[PS"*Y\YA-N*49B"ZL1BNP:UA\4J?&[),$1O)^<_4%F>Y
M$5J,?&!/0S@SVU0/Y[(1%G:8IHNZ :.<_?&@8HIK^! [E_P3HMT5*<BKK)R%
MCNH@M..JAP?S#BIK?+C<6<QM8(@/GA6%;;R5OC$ DTB[OY5:P6?'WR:V*B/P
M,;;Q+T G$3@8R:I_D6IE!O>SO[FJ2]NO*:H/1*XBZ#C<2=>1U+ZKEG]!7C%X
M<8.W,V/CS&;]9YF4W-3SHI,KG/O!7[FJ,849=,*VI^T1Z<(H^R*L/%<FKO'-
MC;T@%3]?27%6V(<LT89K7[)T0IOR&3LOVM)D_/K]#N#<*U.P>>E6*5CM9/*E
M,.3O]S#DHQ??[6'(NW@\;8'"^BC4X5/P_<3'T =SF7$WY(C38<\RLDOSV)9E
MY *UB]K25"'IMN)H3;'\E./$6A^\4O;QWF&]WQ0&-4D'Q6'D:7%@B81(ZGJE
M#%XZJ6@ 8,C5(8;'04'W&10E%6UX=%:U/#(LY]3#W]=S>HLKL8A1B5(Q5A#W
MD*/>EUPCSM@DI,#Z^:01\CM..R%RYNV/3\<?T>>AL\MPT61@O&P^)^^X00R.
M&_[-:;U8"MV;?N$C[#A58Z3]++NN;4R$J?6:7%*@D5$Q6/*]6[ S\]B6SN(#
MIR^Y^/N]DDPRT>:%EF<[6X;Q7S5S1FAWOAO-FOLT3=Z+U=\.B!;";D+K"I(_
MV)K<\>B]+69IQ++TG88Y"H]6>V+H;0I)VR^4-2X$#C"/!)EO[G%NRBOTC!M!
MYIS4BD)!@B,7@"WM"]0VTC--UNCR1&30W,CS@^T1^MXSE&Y('XU'DC]BOUQQ
MB(J7G&:+;(H_! G<-=FTLQZ[9(WI$J"4>#!:@+_?J3LSCVTK>]_44X4<1.51
MLEWOBGX[1.I5869A8S$^$=+D')2B78WXI6Z<-#DC_VKAF]YZ%D.Y2$ZI!?D)
MHB0\"MV#PRVC<Y;GJ#4[0(:*Y/JFLB2NJQ46[SVIPJGWU?=RNS/SV+:LUS=!
M@].F/,[O@@*ZKI6J.@N.EH-G$$B'C^TK$IRL]8X<MH/Y8X^L)L1ENA_SERZ@
MCH*?O2@^Z'F(D[E% 8(SA9%8$=N9;N\L9SGJWS#05_.*#W^1'M'+WIK(TM<,
MTD9GO0#2>'F_N<,W<\4PE$QW%31P!V]0P">YL-+2.6E)+=PZT3\#'81@IY,U
M9Y_U'-B$3T=N+'Z4A14Q;4"09BL>+%V-[>P0Y/)\?-.ZSK6T@Y8*ZA 4Y<DY
M8+9Z?*TBX]V\6T>GPX,0<W:_!W9F'E]"5@@RUZ$9&#@O%3E%97V951[NGR$+
MW GO>FZNV4!<-#7.7H7]0:+FAB0*&!SIB<L_8C8U>QOGFM'#$C-?E/72Y"E;
MC?@$>P*?9I9\#+EI^ZM!HFD&9PID1HM:DCPJK5>F5/ZZO<CNZ#R^A, (V6M&
MF4*8//P4R&N-! =D/P[?#MVN\%.+/KU%[CWX-!4LV>K/QZ-XG\@1@$P1G"6M
M=Y#MH5$&^=!5DMGZ X0L>KAC&TH76MNEE9G2<A//)&ZLIVF%/6K_/UZX%N><
ME>,,GBDLL^<:A.\>_?) YR%V_A:U?Q]D<]7-$O5*%A(E2:/(K:1#C)7(O*B*
M>3_G'L7,GAB6\9&B.?MP_O%D)7;)< ,YLCR]+IUH590EX&N/R?VUW>(BC(V@
MS/',J->]@]%ZF!=CNY:*%./QL%7(_=V=B)?%9W "1?#U%;5&ZHD>;O6H1[=+
M_YO[E/"MP"H'V7BID6&X P*7E1)F0W.V'58559 @H%UZKNPLT8_TQPJ_)/VK
MOQ&BVN&=DOA&6MO-+]5DE=9%XL]S?\FI7#(>G4@!P=._?/]D=4Y:@^F[<P *
MS9F:1#$IS-8P!\R$*X50=:;-SG0(+O: DF) ]UBZI$C9FNWC4="AB?XY)?G0
MJHIIUC3<KDDVH-(H'ZR?XP=WHK3)!;L2G^S47]9\NLR2OS*+;MVX<.%KDW/J
MYX.!+T-C^;BD]S8_W%09NS'L[DIFV5D"HU1K:\7#Y[Q&,Z8WV01-H/74:Q.\
MA0CFB""-ULV9=5M@K]@?DV+?H@!5Z7,E<1Q)*(<0%T+Q@&BURY5 ;-C4 VBV
M:%J%5N$K)"]=^,^3XI*IEQ=M4/(3N.\!#X(D<%LF,[-JDP2?T6=!0@E:G7G3
M8N[J",,U9*N]N,-T1?I8RF4M,[KT]27ORB>JO$<OTV[,K&\Q ^N@(;G>%(H-
MPS)82FD!O%]CR['"J^7NEFV6DVFW$ L/.=ZTDE**A4-Z<*[1"+-\ [J-B%I'
MJ*,] P<7TVO_=8$)'J$70RO#\\EJ2>[[,=RUM $_.)\"C$G0TURC(YH9E#BQ
MJV$[0 E_PZ6XAW1%P33K2N'3D$PHG\]XE.4P-Z2$]-KX]^$KZF263H8P0'Z1
M51U"SB\;I/D\\7M1.1)^QPK.S:E\==]>]^W,/$3W;5&^N4IH04[H$<K3>MZ?
M7#"PQL9E(1;4)JJ/;86RTUE"D;Z&4QOHW*.IOS][KQ&!_'@4,,BSMN"SGCQR
M6LI$AY:\A^YD5HJ3J?8Q^%3Q%?^7[I/#ZD5KAV8IW\?8@2!_OV8\K>6V(GN2
M?3X% :_8)\>#:E)KMB,&>^FR_"%0^=KX)@:ID@K86E+[5XI<**S<E!41[6TF
M,N<HV;S0&'.@SR20O'1P5XP4G3#2Y+*860;-SI)Y7 /6:?V,A4(+II9>#!&[
MF0*9'!9 FXC2.-C0DP8.Z%[4:2+WDDEUHL)S9@L(7RPC+(X CLK=Z<=V>&*;
M1G HG0N>V-AEKH>>#L:I@+:J3"B*$.OSE$4MDQ/=F+(4^/"B1FAG"NH=R['@
M)M0)DEEL8%INQI)C<OXBR4);NW%--8V7''1,O?%8]Z'^=_8]3XMF/YNQ]I<G
M /+BI 4_^&K(W6=[Y.[1B^\?,7)WM^F#A\J.=H;7&G1=H$(RQ?^GTF;'?;%6
M2;"XT)YJS;_!W-BSK+,9L44]^\>^N2[H:%$GZF)-X<^@/">L3QG2I++GPJ4P
M'I3;\A.,UBLJ-U#8L67I.G3@RO'(>SX/_WW<2ZX>!&]PR);\O;(EG[Y[^^I<
MB)+??S@[/7MU]O;B,<SU$6F#[[?AOCUU#;8X!?N: P78E)[=*PAXV'9:VG?#
MEE4Q@LM=Z1G7R647@SQ7_@<-$P1=O4CO3$W.2D/J/Y +IDML4=OWQ]\*IG5(
MR)R&$7;AP2MG15E:T[J+.BD%3PRXN?#L8M&%_=UMZ:(MZT/S$FD\A\(!NELZ
MZ(>F@P.^V1)+2C9<^>/)7J^E BU<.;Z*BQ?[JC7E[\ =O??*OP[*Z(/A;CH0
M+=XR=)C9&E/VEQ8N3]WX7ZZ$Y5^Q/ZEA^95>M([J]!Y,N %N@H'"JY6J?Y0S
M]@',8ULXSSF7!,&#EQ+JC[8;KN5 &3(.:SU58[I,C"XG6_+#I16MN-1#_%[G
MD)L-<JFX'90MK9&SE:ZAI!'G $6$FT)*@'U37SU@.&RIS][+Z\[,8^N2!13=
MC4?O%D7E:/79I) /)&E):O+C' +RYLU[5F<?263F2/22N#Q/_E;?0$F^.7YS
M?'K,$20IY=.CDX-"$?NUK?*9"W^+Z_#(P#,8$7H&QPT??9O5^YWFOAFF[4[^
M\%_O8Q+3;2H43H5H?3QRNDM$]93D--"*,?LZEV I0[LS%R,U>6".+TEB3TC1
M3DL)'9[&ZOD\(H3GE,\20>W#5'H3*8][=]74_>75FO(>;VD(-L)I[MACGQC6
M\Z1K4UM(I]P.4,C(C+:.;2W?ESCLTCP@RV:;PNJKH@T"*E:0>X[)D;2V4>@E
M[/0UJ(&QM+=KRI<=U*.=7AERATSK)$D<(M*\&;Y2/C[DA3CZ([=RW8'#LE#4
M*D9 IFR*N+ZMV[3^F;)U[(Z _H9@XX.5Q]D6\JALF=7E>#2DRWQ=E.*;LY8]
M<&EP@V9T2L0\D]]L/GT#+_K0Z;!/IZ>6-=*FL]0DG;JZ26A85W O#=%[!I,)
MYY\C:=;TEFWZ"UD-;[@.!A$V$K?MI6T+5C8R'H'X;LL=_F"%_7(K_ZPS)>A0
MN<[GO24L_F@9+<(X-XIVJR2\(KGE@O6];.XV5=E!8PG<'9G;G^DD5E?;N%&%
MJ4A]FJRA0U65)U1<60!J\$N?7\H)[COHB,K*?N6?)*U>&9F%C$MC;1GV VN]
MT^\]IX&K!&X$]94RR>4S<Q>GZ(,#_%XZ>R^5.S,/2&6QA53^M:YS/M0%TQRX
M-AN"45P%PP(6=Z<;."M>F&(34,FK(;;=H'/>VLX'H;_F" QF"DV*9%Z:9CFT
M2*JM[$(X>-1W+Z\=KGLOOSLS#\CO+UO(KR)"-6I_$73\$*1I=-(.\C<A$!8!
M*-:C%6*SJ#M;+H2[9EIF@OQO%1>[*J33;%%TS&Q>3S^G$M45#!<=[D4'*)0^
M"Z!Z)F]B1\EERW;/(]H+(@GBYZVL1O*N!=89*%$]Y]V7H385YHJP18:5I\+_
M'" = )9<=V^2Y[^;G!9G&MSUKTW=+Z3_XG56D1B2,O7?:IW,STR$L.?;VYUY
M0,;*+63LG4#R!P'.C[UK"NM#F)+1MN#0P HDM63#,.MCYZPEN<2FQ_$MD/3.
MW52KG%K-2T85#P__C3PBR?I^FYZN P3)22E]W=IM 23VN..PI#77X-0R(E2A
M)3']8HSQ<,QM:^$EP+OO818[,X]M819@!/AZ-/;,;%YP/(YK9)U3,9=6@&'Q
M#.0N=='PNYC,HQ1['3"3:Q8H^6Y#_'USO)VAZ)PGEY2-I&\&=9CPR;40,PO@
M)6&_>Q<=Y0<?]%6)NM0U_.P![_M22L$,9U7)*RNXVJ&2;CNI[UF*V@N^5<";
MN'HO6^5UUV22P5Q<7FJ'VO'^X4#&6P%5L%U7JF]/K[+JTK4=6%<+ST5)^.0J
M4U#YE]7YZI/V5NN.S6-;_(A38" %9Q-ST+19LBHL!FL:G66!!M3KO;<.+;@[
MZN0KBX:6)'U)4=(/^Z*DHQ?/'G%1TH/.QFT#ZWE;:RC:\Y^M5QA9Y=-KN,AF
MH!U006Q S;#!2T$Y>F79I^8.[^#JX ,812NW9U8 AX=XM(KGX<UC6X"-?[>P
MNIE!0H ,[>:S*:H6\'+'LL4@+P6/-7';G"$OA+C%6DR!_J.:)@[B.NE:W(,Z
M%X[+GTQR#&%CAL\%=#:T/G+$6[(QN-U.SI0/EFN#*Z [(QU\%L*CF]3J\1?L
M%\F=/,4N&?H2%K"Q3&XM8.DY(L+KARYSCVGO? $82,$1MBW5-C9=>EOWVE6Z
M<T>_!%(N[()OF!K:C2)LCH5OZ-PF5U8<SWG-G"DP- !'6R".'F>%[%-6RSC^
M*#+Z(&K[PCK&9UK'>/+Z]?F'OY]<G/_C+#E]]X^SMR=O+SX^ALG^7JKE*TO?
MJ[YAMX]K1 R96"LI S[3>K+&2ND.']1 (7Q'*N2=BSO'7;>+:GI5(R"&T<\K
MYGCR/ST,B.<1L/H=@L;[TV;3/GZV36TKF?(%DJK^@)"3AHZ>^0(Z'5PMKJ5D
MQ;\.L<;U;)\PV)EY? G[^PF(< +Z8. J5JBW&D<5&O!D!2VRO#)@4!!W,Y&6
M/,Q0#*/^$CTMX^;.VO=DM8\//7%.5@;3JOD[7G+^P%-5-F3XF)DUP\%P^YL8
M#Y\+JD^8%;/I?_=%*P79(<1%DQ[3>CX'X 0D/'6CLXQHGQH,+3=DPY<^/"]T
MS0)$=4GE <#_5C A)X^%UTQ^QT2BG "Q_@/T/#M<0;?KU;'B27MO80?G\27D
M];R%R=Q?D/NLN2;(C[3.(_&X 8.@1P]JVM@3U C=8;#' UY(SX!V[WU%VWA/
M);J;\_@2GOD+Z$/-/EG#D<0G2"SCSV%R>7=>^A^Q^&B;"+#3(%-."-J8;:F=
MU%RSDS64<*MMS5"^&13V=$E)6H..*5) !T^?'"9YMI0J)CZ:^'<*8VZEFHB,
M ,<T<BB\*-?67Y'CC$>9^L,ZH7.1M%+17H6,@96Y26V+*I34":PA"P28U2/3
MB/(\PFD\"N'=MOCH@8KZ-F'IE<.2FXV+'HNLO"9HEB+!X%XI:9;)+W5!8@9U
MUS?:SJ4R#0M2&')+DVE3M^V1-%+BK]FB-I?%%)XW<S"F &+1=IG4:FL#%8(Z
M%#:!LZI':4@O-]>.3!P U[Y'KOY.3_T]Y?<C.J>WB1D[P79-A3IVQB 4@(H(
MA$M(".\2$M\282\INS^/;:LOG:1\["=MD1>@O E*)=%\07!L4VY5P0 C3E;M
MW_G.S(-C?%N@CX.,TK"\_)4DCX+2L369(Z8MLMDC)AL&%[;T,%F#*+KK%LQ=
MYTIR)49R6TUD0&L0(IGMI()^@$$HY;DOZ6 ?-@I7R\!I'82;:9!&6Z%=T/$;
MZ;;A[K2HVZZUD2ASC:(H7R"@#;!O#.TR9'KI[YN;F^/63(_)\4XUS>O#0..1
M_C1,?X, NBRJSXDB(@+4%C.6NV([NT2TL&5A>MBR>@LLU14R;\H@8#FC[9WV
MT=N=F<>VT5N4Q3?%?#QR^SL9;N^+]9)KVWB&W=$7#1C0#:C6NRO:A7Y_!1 )
MDEHVA,&4W_J.]YG4ETK59UM;@G5+6>ZS2DZ+@"&WEH!G=DW[GT.:I"[0O$&\
M0FV,4> .!]]9US&;R7<TIRIWE1(\YI7$]GC45UF?,X?^)"NE[/_*F"Y ?^M=
MI ,$K6:=QUTEK*OK[U14TWIN_*)HF_GV*B'GZB;XW((HQR.Y<6++%ED?H1V2
M>M<KW:S<RM,KP<]H"R_)*TBT,1(C3*(1Z[L3!M I.I-[@O>_GIPP8]AX!*.P
M57:$C.'C-3DF7)WIGG@K-Y)G0KH7+!W3S8JF=*U .%FY>;:N)"4H)( INK8F
MU'5Q#;'\B"0<M(?!2AM=(WS*Q7ZV&'2R! ME%_10Z&1WQMT2_[MG\BJ&LO%N
M6[\O!(X1'8>Q((,*>GDT@XMW\/VS4)@E?1M*\ZQH0=VOCTZ3@W ZV75=Y#:,
MD=?]I..NB[?N6C<ZUW\L9Y]2A CSWM<,/)!P_W^1'C@ZPV[>K/1/[J=;T>?A
MBK0Y;XD;@]J3@Z??WJYHUZBF\0BZ*=7&=*P>+'?E<,^R"M4K4_5.138E<69B
M-9VNZ-HT4*]T?PD%PNH9CR#9G5!ZQ+^QFKGUJ'89\'V49LP==U:TE6E.YJ12
MF(>13SEK>>8&S4@--^US%VF_#^5-@H78FE(\[3#>)%U5[C2 #_ Z2&*DN=_/
MGUZ<N/O^_,VG%]+;#S)PJ+7Z_GO["@;T1%^.@/]QCX _>O'#HT; [W9C#E_I
MSVQCK$9H,^*8\SPDW!E9^B[EVB7(-72+OS:_9HZZ;+)DQ>=W#RD2%#$&'9-N
M,=_(*B*A;E&^U4&9. J7R+(@Y;9ZZ1JJZ[PV4>_0VPRHX,@7Y]S:K&R/LS5>
M3'L$CF/#DHV>:@@NS8>A 6\#!^#0X)D#_>K!$%SC3K^BV3B>^$+K137;!"-D
MUF10]HZT S]A.)ORW(N4/SO^ED[,"*O&B(U571=)R Y9.'M'=\LL=-C3;97\
MX^UO\!BS=5S@TRM@=V[UB<:C@(E1".>O'27XX2U%,'0/.K?/I-)%N_2>VH/[
MTXLUM3$'673D;UB+P?G/JD!:)-),+YT+C@H,9FZ2KG%Q&G^E/EQ:=]KB@CPL
MCPZ630EY2)VU=8J^-]*GF7O?\'4*@K*1)^O<:8\],0-#6%BG]>6-+:&0*@]P
M(,1$D@%M:BK]2H5JW7HUL(!C;;DV\F$5W6T^U'!BJQ1%9&:J]2KKT1C4<'!;
M8MRWI9.&%#CIS^5Q<AZBUIB4V*:\(9+^%4=4R%G9UNL<3:>?;1&(L,>.1Z_V
M4?M=FL>VN(R_.GR6%/:RX_Z!#^XA1E=T7"OQH92IN?@?RM3@O$ ..PM;;&H#
MPHH#%XN@Y9*D7Y>1Y'/X8>V)'T?66\X=<>(:T4'O>Y)T @XB'=<1%6<B+R ^
M)1:([0L3)XR7<*3DV6'RTB)+7GEEGBEWJ/+>6I0'-@GO??W\)K,==W)P>LLL
M+Q77&C'4VK:66('!I.A>AB?%Q,N^?3L^9W4D\1NM,L.",DW4KPJFH;T\I]?!
M>( (57 O]-U5=LUA&IONMU_L=_7.S&-;"(IR3)W[]-(*R]0 $.P/!Z&4$AX6
M'&\X%?'?U9K$O8#LS#RVA7*P#S@>O<^FG\EE=P1W*_W!0BD)W2KK+25PE,RP
M4(=[[O*9H>G1VRH&V:]R*1NVO?RA$4DIMQ:7[L5%)_6YA7%)4&9V#-7]X.P)
M;I7:^]#A551]AW],ZPK9 ^41<@@7=L1]+6_0L_VF:$TZ-"QUOFY0J[XV&?4
M8V'YK@W:%H=VM_S<OY7(W'X.H][FF_%=B@^NZ+FDY.7O^%2I#&<(.O<6[ 8/
M%ID9X)J:WD9EFV!EEHI5BJ);[3FO44\Z4Z5&HE6TVM!(U1@I.>9(QM !RP6?
MZIY4> 7<,08XGP ,^5S6?=T,E4WLEAGS0..U8R7&R8@\LYBC($G)EQT4AV1-
M<VMH&5V67W.9$B*Z0HJ\6L>Z+GIBA)+>. ZG7-V.WPTLN3$&&03]2C/K])-8
M.[E/_G5QM;C!1&5H+[998U/$K6FT9VE&PVXJLSR:@CX;DEQ<DTUT"7^0?RN5
M[5>T?"4*9JH9Z"*8O0YN75-(NZUH[PLH@O,(2]D*TC4Q[Z<,5,I[Z8#-?==]
MR_,RNPE,*+[305$<DJGJWSF)4I"B='1=+K1>KVX7A6OB4+TDR;*1+";N"W@>
M#WG<],#B,%G_0)3ON">*1@%[&8*2==V('@G"".3PMG$#O'TE]8.9!V.SOKO_
M<?__?I ]E?-!3U?_?WLVKEV:![_/[^__/L\0,T,62$EU_FZ)/)C<U2K0E9/9
M7I5:K(0+%]IC6 PG=F)Q(K6VJ>6\L"PH[@B-E#8;<8/#W6(GV([K/ /$<[ZI
MY1[Q6+]<\PGV&Y.+.[U2$&)[<]!\F;[^IFXTEL?,)V+Z*<H#MR>EBF'> -TB
M#60 <_D5C/8FWVNUG9D'[X)GVT#3E!Q;=\&[B=L#GXU9:$^6J0FHN&VYJM0-
M*QO/<F%:)7.?TE1IK(V+I]-LZ2/Y6VS]\+!4(3?6<2D\?_@T:\CZ:%H;7LF2
M14VFQ%(\E*3);)$QQZ00>^*0E!S<)WI<1T&Q! ':2\1N_,6GS&O_C_-SC$^N
M?4F>N<.F!>SB/5E&J=Y7&4>='Q-QJCAKI>@4DL6&/BU,K3#7^W"7)R&7NG"7
M,WWJVF9BAQJ:\"^*%PO>FXM%K^^P<S>@050:WP8EZ&WGP:U9%7(X\<,U7UN#
MJ"9;&K/2D()F1O<E<XB#>D!\V8%M[)@F37^"M([,B?R:JFBO?&B=)3.XN0Z]
M7]35@(_)=7T)7-Q*C%:ZL:#V= 'W^FUGYL'Z[8?[ZS=--BOI)N?[)5#CC_N<
M! $1Z4E=?VY=ZS0;:N9+4FL4,/"6!6]=+G\#/LGESZ=!2M"QCWEGR,G@-B'G
ML/5+@NNBXKA-#%+/!6@J5DEB:%@U;51VEK)+HZT_=8]WUEG2K2D8@!6V-=M#
MJ5MC,RVX'NX :AJ\"+^"EX)A;0=/K?-'FF.A\3 )4C&QA"CT/WV;/GORA)>7
M5N?IMT><J%/ J%7$]+LM>;,/&>RO#UZ%:ZB-5!A]_3QR8$](@S7FNB"994,/
M4(M4[;'/QJH3_MO0'.@?V3KTR1IQ@_LID)2=V:A_P)KL9\<_?AGB@;?TF^S&
M]=OUT1&H#+3")8/ @6W.JNNBJ>TV?\.-<I,&_4?32"D$\1/;>I2QT U;&-*)
MM)%8:.OP3[])A:3WTB$R%#<]%[3QO28YOK0*&Q" TS)5_R$@CIEE10FJ^(Z+
M$VQXB<L@H3O^H%6Q"O[<'OKYYSWT\^C%CWOHYVX).:O8/]]?Q5YDOQI-*7%.
M-GE3T)LN.8>O\ HR0-9%.<YI#I/.Y Q+N %R,N_I-2[TYTYC=7A"4)VX67ER
MFUVZF]A[(AV,\*E8K-A]T$^YK,J04P2PNS JMQX)I:HO<TD6F"4",[(A&5*&
MI%H5XLK.Y8)&VQDA]LI)3[:^P]I RXIWY+AIPZLULJ4A))ARC*0JC>(N%#D1
M+@Y]VI&C1:=7T*XF#NV/1QS2XG#X'L&Y._/@S?:7^V^VCP#U(A$2D,.<TG:H
MD*T\3O8A[UV:Q[9UJ.SSXE5J@M:_X^<(-:G_)=V<7]6L#P2)NC'1Z"/0-F+N
MJ;)=#!'W"<1I$'*FD32YEM:TF>#0[A]Z3DG[TCV=-QT_!T_VK'KE,G1B;QBF
MUG) #<"%(@=(<SSBL2T:9)_)3"#U6]]4PI^9E,5GXT+G&EAJS?"Y9.?/>CR,
MX7)QP#^.@N$WK:8&!I5&+OJX&L[SL8N5&O\P[!_5@&9P@J']/]B QJ9JT%22
MKIQ#'?9_/QZ//B&0%JPB@WDMVVC6K48)M(!1\QJ.?NH*"8[ SY!*3^N;_(_1
MV((K2*,Y:"Q2/H+\,H:;;N+"%VG4^NE:SW0-:'A7?Z6KO3CW()_JVW;MMU=N
MY8+ED;-<_;Z5LE<='E\?C)"%0@/CW&=*8SX?D"O",,B8D0HZ@5!"-/M2VT]%
M3])X.2Y^3P]"7;=8 85B.]FNT+)O6TU+-UD?ADF^5A1F/-HV#+,W%W9F'MM6
MN;I.#7R>7!1=:>3X>$LRUJ(U==WX3<U"CT^#KG1K&CPX>)ACZ4@JQ-T"]MH,
MB*%)5W. @D6\;J -E0_6M%,AQ*DUN>1246T;4<M-@+2#9L\$D'W#^#<H5%#E
M%XMU8P'$V#449>@'IAU5/'#@ _?W>L29_+06=/O*7)+.S+JH&0#CH_E;F:Y+
MLK0 +9O<QDTP A1QE$:0VJY)A>],84\"6A!H!SU@0#>[WVT[,X^MRZL8JLZL
M/&\<Z6/#$0_9=?\D&:S[SM,Y?O>$:ZNTID8.ZXT4X3\E9$UJ"2.32AJ))0:'
M(5WN+0@Z5*4":UA8Q1+JR!X1[QOR-F*$6<!<Z4L$LS8J+!14Q$H727%>45Z(
MX5H^3!H0[1R#<@HI+,CRO.%(9<B1&4PGK$T$DG%>7ZM5H_ ("]\LLT57+\ !
M. <=H<V( KRF@P_N*L<R!_B3:\3?@MSTGYX]29\\>7*8#J*N,RZA;Q9UXUXK
MIE.:2TXQ-3W8!?=%0KLSCVV+A%Z9*4#0P!FQV]/*CCWI- DHK.&N:Q#0TLV<
M*X9FQ:]H5HKK0:N 3EX>08UE^*S&>FYPMN),&9 '_-[THE\5]<KER;1.9W3.
M+_@(YCW&R@)';"NVB&XTV-HY5Q9;BUUQRJUVFQ*ZF&CM][ML9^:Q;=&.ZZ>B
M7IDX1IR9?U^WBM>-#P'9AY]:.3\V10O,;"8U9S69FPXBY0*L<DY,/U?U36GR
M2T6>V'H(VO6N11D[I#9!EAQPC7-<./Q/_NFP3M@U=>9P1*JH*5B]0'4+(BJ%
MM]9=DL-+9V!)CRKK)K<P;.LCTF@7T5)T='@RN=2&@_&.0S%Q9^*AWX*X[Y^>
M/N$M"+/4'\!TG9H;XY$%#A2-5OU]*3YIE<*!9LRA*QO$@+O9.$R:IRI(GAW_
M!<4W05/%(-80O%+C7YT N*+H"1C>N""EIS_>VX7"%39L(-<T88P&."BGSOSB
MCT=K OH%,YLI&,K6HF2)R,J@XCA\0I-,: X&""@ABJ5=5R%!T,-2*UP=AZ*G
M["TDI&\9%X-] %16VSI&Q+OGO083(_$P[#()?T21'L7,0E/W>V6\4_/8MD .
M-?'L@IYXA4<B_T'>L ]UB09^%[:T$DUG0[^KI4Y2ALQXFXCMA0GD>_C2Y!,S
M+J<Q$Z9#:"SE,GW>R]9WCREH51'ITYXVS%I:RV;1^PZC<ZQ4&:#(<%BKE52C
M\M98N<0Y 5*(/'RLLB[LY7UGYB$=NIYL87UHH"L3EDVH<?JHGG.8YY0\<H3"
M);STND<)_D635>V,E1SM 'B@)RY6QI:!G$,2NRXX7H2X%R![=)QIX>8P\OR^
M*1A]_4Z*!Y!A411DNN):)RN>-<H!F[J_O-HX](.(V.ST;T-+I=-)M;Z5:H(P
MN>R290!Z!%MCBT[#?<G!K>7<0@\7]+AIL=#PNS71GXO#;8^_<(5\ XL!K8R&
M/BKMGF;;0KD.&G>NGF67>FX]?AH!%V_&ST<VW..@LU 2VCAG-C&7K!1/_R;O
MLA7;+D,G# L'U.-_8D"K)RF)C0/;'8WQQ6#!!ZL<MNC?=U)UQ=$I25N_$/4
MQ)]DU-^+0+MDH;<Y!X6%](N&&3)L.D_J=#31%U5H;L[OZ3>TBW 0:OJ5<V?%
M?-(K;MY&)$)8#'RCOE*:KC;*$T;&,S>PE+OO$))UWSHV:AW[@[:.?7OVUWW?
MV*\F>[]GWUCE4/[7](W% ;KO';LK*HDV\@_;](X-@9#'B B_?'%>T1$2(R1A
MKT[DI>?@0C-+WYC+D$''&<B^(=NI9>"'R-A:HMKML<I_V6.5CU[\>8]5_MT2
M"Q[7Q:"J1:'@7^/R#' P3!MU\)IPE2K_EFZUD:'ZN>""F2.[+"20ACH(^%UX
MXF6?P:- -!>7S^=U+M%2[<L0T.7P+D5WAX4F,L*^#K:&D;6\!'PM[F#?/F1G
MYO$ES9]#18T8OH*I7+.!H LR!Z"$UPG&/L!8B):[C*&+XX,%V#373 955Q:B
M1^X[^=82/GL$B_V8A&;;=L,;A(;.<*"@.#@)])\V\9; C3)7!:A4H:CZ^=,+
MFS+YX?A[Q'P>P:(^)N'8MEMP+!QA&QEYX6O\##YNI 2G)@_"@?\>P0H^)DG8
MMJ?PQWXBJ98.^/=7)!6/8"$>TPO=MG-NAK:1D6NWCIM$T( 6Y"]<U,DK;?'<
MFDX)M#<E"A[!VCXF&=FV"6VL_BW F!N. 5 2,Y5.2RXRH3/&-? R,P88<%1*
MLD$QS+A5FIRXV,!A0N H75Z"KX\+&C7;,Q[9'&S?>2A'QTY-1VOP"-[58Y*Y
M;=O9;K!'Q=ZPZ%?K>Y /#OS(4'Z>W28_R5Y\'L@\(#Y76XJ/1DD*6_=LV=8E
MBA)&KR$>MOD$*:SH*!PZ-A$:[(?CIX]@<1^3D!2_2<<P_W^EM'6ND+(Q\Z*?
M[]V6W9D'WO0O6[YI,4/%=]4C0T#=I/0'>;#&*)DQQ[TDCIL.^DXKGC'0%*ZC
MEQX^!W_Z]AD7;ZPY7TC4<,# 37[X;^,Q2=7G+:7*TUBDH.-RY8F6#ZXR-UGI
MV0)G<;.X83-SSLD.K1/;7ZD0Z:)O ;#=)1K5W\#Z]3#%Y(?C;^\O)NS>*%_J
MJ99>LC$+HLNVGW-$5:GUV'0%828W!Z$+.;TD^+%AJH8A8+!@F/ ?^!^FRE0Y
MVT3AFX)ZA9&H P=, .O5<GC3@7'$R+46_GY([L*WB*D)-CB!-NDP'@V>?QS
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MY=4SRK:N&6#*T2;$Q]J'O^&"D0G,%'L)C]$Y-%%OF>ALT%3S %PB15]845'
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M_!?H'D",G)G2+V"_A[UC:<<6@G97VYT4A_U,>+0"2@J7\U%:"5&5PCOB2$7
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M/5E+VX_K?K?WI2U[S;,S\V#-\^?[:YYW4@?Q4M^DJ)FS"D1FEKW'M7*DG3I
M^?NB%-8M]G.W15%NCVZ,2 K9DL8H5Z1,<?9*VNL1@80",%('::@C; ^?CUV]
M%[^=F0>+WU_N+WZO+<WE>,3H08W)DUA(6^X3.1.E3_'K#-T&:YMM#Y/M0:J]
M+!-'GBDH6]6YPD$0QBYRR_40!G(]&(9#_4X!+^FV)1-RN@!NC'M\GW56E5X
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M11A5.9JH$[*H%(8QTTKG7+V!V?FKA- J2+2CJL'"R;5UFM^-M/MVYZC_\IJ
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M9#FX?TZ$-XF13]%C<!1-:/R:41W>=Z6>M57W6^1OZ'W[4G$:A/CHKH3:Q;W
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M?7$\36! ,B$N@R/$;K2A-_NOWG?2*YD;!:SLYQY:S[$'\QP\QU:(3"H-;H[
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MX<$>IB>VY",,_20=G8$EX9_;Y_DET@R-J\ND@/=&294@VQ/]"/Z&SSYF>!*
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M9.F81-+@D)8795-DT<P>)@82,G\-AAL.JI84/?N*E#0B_!<K#F 8KZ!@M+*
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M3+O2869.]1<R7T)BA>("OU)@729R3&,0\ D,YU,RR^&*9JGY=CQ&*20WGP7
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M:M%XF9DF?RN5E,9"<V#.PDH6(+Z@"!;3SJU8< E6SH^8&,6Q26&X&P#2MS>
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M]-"IOJ$[8G]:!9LV[BG75#75FCW,TX3Z][W._B6E>+K&\4_^#_03<V\\%E%
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M0&,<P*WN8H57*Y-0:SS,'/7Q+"7V>$)A573A'/_<S?7&H@=-W1)LG#?;Y;/
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M)Y?7G0^=HX/KD[H7W")U6:I;+"W$>LZ6O,72PH-=]R.KSGJ6G5A>DP]PYB[
M^]N&S?AL<XV_RIIYU>7RZW9>B[O[LW82?66++XZ?XI#.\G9?.$0D!RHKSHYC
M#23%Y>7;?K5L9S#V$@T"EWU)3^D&)@K-P%JFK=44FH$]+JD_V U,S*X9&!//
MD[N!B2DT Y-.C&ZZL9Y@W/'L^4W!Q/-Z@GU>H)Y@M?/YZ3;<\=YA,HG[04CT
MF ]"OU6%2'G3-2SK[C5.&ASVBR3L.$'H8CX+(RL2/1,ZTYB-*3>Q>9.=Q5;T
MZK<F#Z@OCH(=AJ?\ /EA5WG!G>D5H6'X=%DZHL!X)Q@,/4TP8QD4\KJG(:"P
M*T"V2&A#V-, :(3]\26]J]+_>.F2\A?^DV@$LVS M+U:LS&^"Z5+:(N#. 8*
MS<>T2A,FD$[D!DY"<:S$S<U,7+LE5#<!_F6.T2&7+0=1Y5 "&,B3<**7A,23
M'D&*]]1$! % U!@,I3]"&,HB;W-!_S#K$);F<N+"&$Z-AP /983M/) ?.LJD
M$7!7$W1.^Q%P>\2@KH3?*+7$ @H4XV.W.Y.1<:<C)5P=F;AA>.H.+EB MMG
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MD%[@MF$7*HRPA;V*G%!W,8HZ#?1N-BC2F\(6BZ^:E]( [(%T%?4Y WHW&Y,
MCH4E>X>O2W&32-PGA(+WYKP+YRLI)/*1%F4E.T/!VSD(Z\CM,D*L([<G(K>'
MTG5!I%BC;JITL]I/4+QZ/WY4+]!7]MG+VOR*=<VN-"K&EKY_<(&3H*81SQ-0
MSR(D?"&VZA])J"-@._F@>8[2Q=]!SAH0:R2N'=Y(7_]7VB*S[TEPWYH4W!=I
MIS>V%F6GC[(KBC<8MC2]C&85U;T@*Y]MZ/I"+#*-;L^D@?2866A9\'#WK[J1
MID.K7WN #\W^Z)@U\#,"_A7-O@04/&V9<I[9 PO ^)\G]CR+BI=KIYZ@<2P\
MUYOV;LS">U:O[077M@3WP<+<K=5C#TL+_"N:?0DH>-K<;OX9+XO"YVOI;G'V
MJWJ[\2HEH&5>VQ+<#0MSSU://2PM\*]H]B6@X&ESNWGF:GTUAZ\%L%H JX64
M5[^V)6#?"W,55H\]+"WPKVCV):#@:7.[>:8#+B#I+<+R:C&L%E7JM7V%&%;Y
M1,DZ,KT$X)DF^WW:/_GGQ>G!V<%UAW*/2B-"YR ES"JG?6Z1^O4>U7M4[]&<
M]ZCR%]YTP>8DX6E"_?M>9_]2#20FBH;-!B70Z8A2?3G]$+-/I.>-Z/!%UY/^
MG[LB FADG(2*'^S!!1O<19A&]\=\-B#+(UZ*^@OV?W6E@^E7.BA)F)I?I8-/
M3%:8E/K7OVQLO]L]^3($$I*4_HJ?_+@K^DJBMB%6(J4X)W?5)JEJW_$22KCE
MK-TAYX;UQC-U<:2WNU&6L&L_Z"5(NJ[VN-V2(X<ZAM5R4AGE,=N,6_O&, F'
M080TC2G()@DWTC8IC?)PRX$0VGRD_2R/#?-X_2#FY.%AJ&YUD$28]MQ+0E]'
M_5S7I\>J/#Q2Y^%M7>=A;7^[JG4>*G)57MF+K]F@FP]P]RC+,S_*\LQG<A?2
MSZUYE'*H]70<;UZ6RJ-SW.:SOWVW_>P]G2:(GU4X8J#B,(%K8Q0D8=1Z&17F
MV3BU0W++0B?L;RT\A!M3[STV[0&W=TI'7"",?&5,X[!S_KESPF!USH[:B\TN
M%I0 %Q:L:=#N[$:I$6NNE#YZN+[+]*R.\_)@O^0\KQ!WTQMKZT5O+-*97Q"3
M7_/);[[HR5_KV%-<1NE_GE!&:<D8S11\*0]:D,UG)F@BM>WF2E#.U9OTK3:7
M>:SU>6>Z7#6GI_&_VE\R?7])"6><G[_D(PS9;'254%^4@SX+T1U-N"B.^EKU
M +%\Z3M:>N*\U].."K-*I_RROL6"H/35-[H6WC'.SM*9\(CU_$'+.2[H\/SX
M-UK9+]<?3_?_/U!+ P04    " #W28%3*O5_1GQ"   6W@$ &@   &)I=FDM
M,C R,3$Q,S!?.&ME>#$P>C,N:'1M[7UM4]O8LNYW5_D_Z.:<V86K' 8(R223
M[%0YX$Q<-P-<(),]-35U:F'+H!U9\I9DB,^OO_VVWB39X 08S&A.G9T$I*7U
MTJM7K^ZGGW[SX?37CV_;K3<?^KU]^#/ _]Z<#DX_]M^^^9'_A-_^*+]^\^YP
M__?@Y/3WC_U_/AFG2?%SL+TU+8+3:!+FP4%X%1RG$Y5T^0?=X"3,HO$3>!%>
M/5KUO=?!1&7G4?)SL/4Z*,*OQ5,51^?PSW_/\B(:SY^\??/^\.#4;?;I6$VB
M>/[S=0W3LWGTOR'WX\G;TP_]=NNDO_?I>' ZZ)\$Q_VCX_Y)_^"TOQ^\^STX
M_3 X"?;ZQZ>#]X.]WFD_^-#[K1^\Z_</@M[>__LT.(;'WA\>!X.#W_HGI[_"
M>T'O8#\X.#P-/@]./P2]X+=!_W-P>M@-Z*E@[_#@H+]W.C@\H >@?Q_ZP4GO
M(_0"7]P?G)P>#]Y]H@?@5\?]P_==:I(^C.W2QX_[O\"3??S\IX/]_C$W8X?1
MVSL-#M\'VZ^>/8/7X=_0M7UX> .?^\=_;>_^]/K-I[?^"V]^_/06?_7R=:?=
M@M[V#G#%<=#.<Q][GT\V@Y-/>Q_<G_[:^UWZ%IP<?MS'L9X>]PY.WO>/L8L#
M&DO0>P<3N]?'CFWT.MP(#^2XAP/N!AOO.O#9X/!H< #_AEZ\APG[='#2_XAM
M]'"J?X57>B>'![UW'W^'7N_UCT[AKWV88GCTUR/L].F'WFFU]0!6$OMXW)=U
MV_]$;\'W^O_J_WIDI_S]\>&O,JTGO<$^K,P>+RLVWCLZ^@BB@)^LG1P<^\9>
M)W@W.(2EAV[O;0:'V.SGP0FN].G@Y#T^.SB%4;UW^DH3UMO37<7!?!ST#D20
M\)%VBV;_S8\H_;!+C]9@?_TC.<NGK]>JR_NJ"-NM=!P,\GRFDB'\XB"]#"=G
M818\V^H&.UL[VVLUH+M>@V&8%&%VFSW^W#N&W7#:;L'^//ITO/>A=])?I_ZO
MWXR??.C!N4<:]^3T<.__@I)>I^ZOWX3S^=!NX0&Q3OU>OYG>^"V-1NV6&D.[
M%4W^HK-.0[FGTU1^&"6C$!O<VGP>);=J=%]$>;LU##/X6 1O%A>J"/[XGZ7_
M_=D-5+ ?QNI*96$01Y.H"$?!5&5%$F;Y133M!FD63,,,?H&_47D.0\J##6/M
M?DCC49@Y5FZWW1K#.Y<JGH5!%@[#Z#(<=8,H#V#841%#*T4:3&?9\$+E83#.
MTHEGUBD8\J4:J6"89M,T4T64)L[W]M+)5"5S]X,PTC#H3:=Q-%1G<1@<S% 6
MVZV-BS +HX1%=!2.HR0<=0(P0<:S.)[#*",84#(*DC2!<85Y3F_G%S 5.3Z&
MS<KG\%,O7N?XSPETYZ1(AU^"#7S [9CY574ZABJ_@+DN8'AFZ-,L&H8XN?S-
M(/S/3,4X.=@N?^)(/WM$S]:.:#/@-0#QFP<JSM,@_!IFPPC>*D D@L\JRU12
M@/&5P->Q(S&,%=>5^YZ$!:P.&V7<Z>!,Y?"BRN$;^3"+SF#-(AA:.*3%V-XX
MZP1G89Q>=6G^W*_@4.(8?@NOAA->ZPMU&<)/PL1T#!0'M(?+$$![^6QX(9^$
M?^'@^U^GD:P\VHWUX^[JJ8)=!:(%RUC(RIK/X!3#..$Y^L8(VMH,3KU)@;_C
MX'F$PS1)9)!747'!6PAWE()??DQ50N.%>9AE43$/>N<9#A*^33^>@0CR/POL
M;Y%V@[,46@%1"B]A]/CY ']#;6_ ]"IX>@2[H]T"D2L4[3!H*3<MP0]H@Q2P
M]6FX\"?+NY$[ZI;IB94\61KG2=M!^U07MF@^Q3%?AO$<I56!%)]KN>^B$)RE
M699>A5E7!(U^&&//,Q: ZY3,IO,&[)KT/,0)XBG63=KQT&.YLX4VVZT]-8T*
M4*?_BQ(%VB@/9KB\+!:RB8L@Q6:O4/!%1G!-:Z23!!*G9A*J)$K.-_(.=% $
MG85JPJ^&@3^],#TRJW8RN\$LH1V%/P8)0BT?7*6S>.1T*(/-'67AW5\S[_J4
M>22'I1$W>VZT6WQP.%L(Y8/7-:%?X5:VYX-W&(A6IR,$Q7)&PIZ>H>H J3J;
M!Z/H,AJ!M 4;7U'<] E#"LZY%\,61#_.=7LJV$_C6&5P%/_W=8]V\.OH!%IT
MKC12^5"&850UKE*[Y2]313#_^_GFRYUF\1[(,$YF9_^&@[3=@A-$3*4\V-U\
M1L?3[N;+KG\4H;5V%CJV"AJ'R9R/>C!:*N=^,)OB7[&U*!G&,](ESW_>V@JF
MFY/-8.-(#<'P']*S';+V*M>RDLE:,K,\FWHV)<LLR_C4A@^+28#]C(H<3:MD
M&$W!8DW'8S1.X>>OMG>V0#'-4 GN1VA)@*5WI+(O5PI,B9,9W"Z"[=TMZ,UQ
MF(!Y));^RU?/=[:##1@TM$&6&AV<09P.N7<J-U\G(W=TB6>JF+UP4%^!.0:S
MT6&=ZDSR-$O!OH[G[18,(\UPFL6P"X/W:3;!%V#=\.R?\I>*0@TOQ+2 08]F
M8$\.X=MQ:*PS$"KY*TW25,W)Z$/[$8QK7#O0M] (Z%G1\>H<#(AS\H#6VO5X
M0Z@]9? 75Q?1\,(?%OSU+,3EM](S"M$NTD:/&L+M:83'B1TOS 5,&TIENX6C
M2\=H"R^X:6@SI]*C^G,.KR\YRS^*RGB6T0*J$>X]MI!S[L#(NTNT6[OE-2OK
M,U(&_^?IT^!]%,:CGX,C=1Z^AO?_,PO)B[P=/'TJH;8W^X/?]%9F7?"T2*?P
MR,ZTT-KA*9CD13KY.7B!/P/3%KIO?O8N5C 5\'20IW$T NUPY+<':L/56$?0
M2_AFS>?/LE!]>7H6P@)"'Z?49[=++VIZA-U<]9/.Q/R(,\.3L8[JD]T7CH0[
M\H22. 9[)[U"H><+ $HH6-NCB!3MSVM_?#R24W![DP=R6_]+QQ0KN=?MEC:2
MR?QF3Q<<$6'^&M0":V'4F">DJO X:XRC;QO&]NT.8D-U;K[BG^@VC3?M((S%
M&P/J8*)&(9X^* "D%(:QFL%YA<XH?808#U5W@5-*SDLZO13Y:8*4#WYHPG@W
MK"$&9E2-)=9%/Q4>\Z3>:SU6*(;X3?P#VIJFF?X*/KW@#KEQ-A,W%KX&WU5#
M>0MF@U_JB#D@UJ/V)8Z<LU@;$[7G^F06%Q'<>/E*6GO"PR#=EC>MX8=>$%@8
M\HHM&8;M%'>H?BE0?Z/98/V$\$-QQ<$_Q+A3?/W.0K1G@O0JD:Z"D=ANR??M
M77H8ISGIAK-9#J90;AR*Y'I#KY[84K1 $V[)L?X<]Q#Y*T=A'%W"Q+*UIPT]
MDD2<9;<7F\&)?UY9<XN,3)',G>ZB6<M39^(<+ZKN 1A-8416U5F:?GD*'<GF
M*%Y#JP9'Y&N>H&/4=;'AVK%!G;/G$J,#Z-8GX[B88X]Y8K1%[?CJY1X O]2V
M9M=9'I AYUK@.\O!YOXZ#9.<35 T2F$959XFM/MH/[%#EQ8X.K^ 2T463F%N
MV/%)\NE(CET6Q\4-XMG_.@RG%0/3:@="'935 QOK)"N.1Q[^)9X\=/7""CA2
MOF#?546\:Z:$5W&(!U:,V\89#,H3C&$X*W@GR#I#9Q+0JOHI6"3Y*\E+''V!
MB8.;D]WD9RK6YZ'35]=(KW801%;?Z[P%-M-@UW?1RFT& Q,?L2(<Y;Z\NJ(9
ML&2&<+L*<O9N.+_&);6O&NF/I&=P**5PMU&%WD[>9U6NEP6]K&$NPJ,U2.(T
M"+>P"'Z?:=<P*/A$34*M4O0[LK=EU] 3\!%G4^(=4,EWG!>[9:.5(FK2;70-
M*WU!,_K@WBV46S[:'X=]<K:"?2)+32$L.$AG%-]A=42W$W>;RQE+?@%]?,A6
MK3V>Z^P;56O?H,23>80A&]=S=(UETN5HF/'KE)621&PY]'6MUQL](S/<!WC>
MGJ..<R]JN.5GL;KWN]F]B#@#)/?Z'S^>'/7V!@>__//)UA/Z]U%O?U__N_=Q
M\,O!/Y_L(?;U^,GJX[Z*1L7%S\'+'XRO8HA^_VD.O=-_>T+.@#>GQ]\")6:$
M\GYP?/@9Q@%=W3&]G*H1^ABM?P)]%G ,%N'3?*K0]Y*D5YF:\I2M-)Z='^X:
MU/$O=\O^T[M1ZH4\W7?&K_TV=0ZA;>T06FFD=1-UB4?>4,5ZW/P=,RW/[WQ:
M?M_H/7W7<:< _N?X6P5HT8">5"?V.^7F;F>E5S\A/](>7ULLJM50KD8J:RR]
M/BR!VUM;/ZRR+JY/<ZO&ITG=NQ7)@D^@6#DBM;+6>?:">D.+_!W-[&YM/J>&
M;@^9B[?WGSTA_);^W;&4+5:I9$@'*_QWK6%1[P[8K.S3V]FC3^GZ23O5$^BJ
M./\]=VW-7EP@;=X&7;KMO,WDMQ:'XUO=7M5SW^F'MG+PHV"8[)0[4V]B/MW9
MN5T5\/ORS77]AD%[7=_:2^ C!X!7!\&TKD/W^F'1?G !V3#>+O2/X)VXW!^X
M'SLP1'-#UC JQ]FB0)94;$&*I?A?9],WT&YQFX-@T_]MHY/^1JM\SS>)9L??
MQXZ_XV.RMWPGHX\:+\>,_A7_=*QRV'29(DS'"#:0 :[ZVR2L1LGO:I/L//OA
M1EOD^0_-#FEVR&I9.LMW2*UG#'Z34 QD/(:#Z6]W1CSHZV<_UF@>5V$Y@0<O
M<T!\]11%0U@LN_U1\2F-K:H-SCD0M,M(!6,US"/H+WLTS[3?$8-@MM5Y!5T4
M'*0%1C7R0B6D;:$]C'&<:Y<]NNDSE<U]?[T?X(G&-P@Z@JV$6MW\E-5Z. Q'
M[":N!HT]9VP63N#K.4RC Q&DZ*R.*]\LJMQNU4*VNKRC>#NAPQ?:?H5@0E4%
M$RY(R]#Y .6<CVZ@9J R%:G'>$YN99SR=%: (1OR^F*<F_9U:G,-=*X(^;79
M2*U-90ET\HAKKU9CKA71ZQK0GA,"JV &+5C ,9:_QRW.$,"S]#+4'O&N"54Z
MT73%2'2]HA16DN<=:2O+S!S!7SD)0Q[10DKOQB;!YU\,ZEP56+?S.CB<,K@*
M=8%,Y.O@-\SL@E_?#^[N>UR$-SS4G[JSH,?_.CB=3V&8O4R=1</7P8&:A#Q'
M!RF.?,>#WNFW\#=/&US@;1XN.[</*/MHHK($DSZ%;9^/.?&C 8P]B)#;2H Q
M'SFJD<L^N(9T.D*K0*\7LMYT((:,'B$4A!S_ BD-,"\.4VFM >"@>!@.XCR-
M6*8(M$["6AV.K@3.F)#!X]$B*+:)!EMD3F](,6)FF;%)@B7LOO^"FRT7]!%C
M<4%'L\6^.)"2&MP&G*(^H/LJ(N0*!J )OY:E<+[@42AS%Y8OI-APV8-+@#'X
M"TR'^L(X%^P6'VT.%BE?B)PR(/N;+TW5PA.X5WB>4HR:@&<&$F4^5K$8=@*$
MXY4!'6C2$4!)4#?FZ8UAI^NZP,8P=C!^](1IJPW=7P3HJUL5,2?,>M#0%SG*
MR"E';]F9U&]V@U$$)DL1$T0,-JG\2_(Z8";!.,Y9 ;K&(YNVR;SC9:-0U@G8
M<>-Q!)+,Z6J2IFFL_'*F9!=M^_/H,K+)I-KDDR_ZUJO=P)S9H.>-\$!A40B>
M0#800G)@<XQ&&5K6M.75UZF:(W@-%1+#BK!U:ZOA>X[X<J*M&($:N&%[X=PV
MT)+*0ITBK27!-I5C_N@&MJ=10#B))J^PTT!\'L @5H+XH ;U\6D&F$@)G%&G
M="'<B*).5:]21I/E)=!8/4S.F>%)5=11#%B%<0Z?HXQLD"SX 'RA%LEIT]<E
ME5M+:$7':[0?81/Y7(3.0??Y'Y2@"ML!<\*'.N&:=E$WF(39.8&>0'60C2[W
M%.@)7L)51BGN15=.V@U)B;8Q",LA(9BH)7>U'6Q76BB?%7A!A!L^!C,<,)_5
M0N6#-,,KA7[@>!9C MHNTA? H-5D"N_"([:;T03SV@J=)Z:".(1E&)$G LX3
MC%R 3M7801_J!(N4H$Z*M+L"YUG>E_QOW1%'*BCOWQUAK*[RSN/$3#UH+]8:
MD!:";=,?X-_+S(37]?7@L/+*X.#T,/C\8;#W@1CX#I$UKW_B/@+]..XCC=_Q
MWN"$//!VR#>B2KQ%MD.D=/HFNL/@-MD.H1??2'<8W ';(?1F=;K#H&$[_&OL
MC^'*$./JY8VR!O!V!Z=ISF?,U04F)Y62@_&T(H]4X=Q \/0Q9@P;S5<ZN<!-
M[\;K$67Z!!MP5(.Q O=CM%NH.W0<ZQ8[[ Z-"KXNXO7:6"^5FTK-+:5TO^&D
M9'WP*SG?Q=E)QR13L"P\[*_@MFQ"1'R .R91V9(0\XM1T^/ VO?<CX[N"%M[
M(5[O<=:LRQQ9>^IZN-@:H;F]YNB'RYD.AR1S9[XY%TQ,3<?QW6YIJV;Q=S<D
M#8UMQVSFI(54GLW"6!5./&04Y>Q:%K>T>;K3%:M4) >G@YSD-$OI-$KD%;1V
M\S#NVB02&!=\(Q_#F-)L[L< +NCFB5(QX;@/I=_1/'C3C8MQJ<#TQ)F$\6U$
MEQVVRK0D6ZN.OT:B5T!/QOR5\MQ2WA-]EK_I?NX:KT+@3; Q;:NI1SNEH,GM
M[!EB:5OJ!J!$QB5^ !-QL*U87X"8LNC)"HNH2#,)>!B&*)]\X#Q-1\%8X?83
M6_]=JC![;]QN[5,'TBQWFBAYMNAACXM"@D=R;4!@!!(^%"$-()><"FFLN6P_
M""_TL]OWVG-6-[E6X?;VGIC>CA2"\H_A2,LN3>3,2?\V(H9*-5'ZW)/SC74-
M[,(%83POY<^]0).:*2-S;I#"B,>D;#U]W'0I;HHL(VH&4IXAQ5D7V1.C$5XT
MZ:/=I8R%["! =R.K+1S0%+UP4PH'2K?2L;WV7]C,N+%X<BG947W%)8VC4#RO
M0YB6<TQ]+)VD.%KJF3XK-^T9H*D_%D_X:)9I_0EF3)2.=):A3<Z]P526Z7-L
MUB5.,N=$X9A(;BFJ;.=7$IU0:&ARQ8\*A^I40OD\.ORYULTUKMC0QR=(IT-R
MH@RIR[Z7%[DV\QF2Y43$5U@317;ZB,[G62)2YXIEUW@L/&L&$Y0EH1>C$R'3
MXJG<N!YHYTC<V8QY=2'>]"8Z8,\^[B$\/>0@M1F9"9@$(*9\R(/,SK)00MY\
MVM1O/'_+N9F]POBG3X3+*(W-OB?KU5I78$P%Y+D]G\7BQ>*3"Y^324%S+:=3
M&G\X2D%8BFCHSFOX%79!<B[GKA71NO[&Z(X:E2:(3G@.?\SU_' S#-.%\<]B
MA#3@/IZ[E#G+$@4W%I%S[@;:?$6[-1*W=UJH^'K8@C8;-*VONZ05^:=XQJPP
M]I"^2U2RSQ?K5T*@N&V0Q)KG:5VJ+RR.CE"7ID5MY,BQ<R@IFWY21&2&V]4N
M]ZC+BX3*?HC E14FDYIR]_.\[.GM(8 PYE<'B4-WZX7]1%<5DM]?804KL=!"
M9PJ/CY=M8RL+4Z7)>2WS;%J3S,W2Z8S;E\-VJY8Z\#I0R;,&/\+XD6<-?N1^
M+-'=V[=$>T9'DXI:2*!V8'2$:Y)^'^>:T6F.XBL%DPV S8E=.\=*';&@M)D.
MAQ01Y2"M)CZFR$[IN/$NM;N;P2<"U9%OZF8GF+D'U\/OR+#D4ZB$Q--I*UWM
MP*EKG0B5D>H&0S/&?V![UJV?:)>N59ARYMI6K5TRZVV*)I-PA,'QV(+W$67H
M3\@BSAUWA8UO1R@(ZUJNCH=(1#3#K,371K-AH4UT0L4N',?RV6I 40_"-;"[
MN;W:A7EVAA(ACBB"YYP)B4J@U1:KI(&PX?C$-2X$).>VX.: W)^NS;;(EDQ0
MZP1P[U.%R1=C%[(@3;YQ4\G%P8[-ZCM"*1&HA%^!2\]L2'ADY@I$&Q!^SM0=
M-&!2>M</QO%5F8\-:39)&])(\PG\HB8S;O% J1O7CG3HK-K"D4;)$)VK</E8
M<QE_)!MU9Z6-NB_ "S80VJW!^'HR8!0J]N/4\,B)-]I*,P,\:OT&3A2$_??&
MS& ZEX5YFBY;FJ[SP=PS(+*UZ/GNFJ_KHQ#.E:"U+%:2DM4-5I"KJPOV 7"F
M1S7XEH6>C-?#%;UK.NI9.L>T2X8$=5S"G9I.:K]G9EP"I%'/V(C%][H.\9N+
M 5)#\@UQ0&=<"O2 %76EYG20:;R4'?\(XT71V8PN\6LN)X]#V%=!_9'_6JBZ
MHA&#=>>*14_SK:-CANF\+%HNS=9\EA['4J\"L/#TFMV_J#H$OZ?B)<K-)<_<
ML,*!<M$1#4':<1JAI3WN,L[RZ6Q*T,H8JVAI@'+7-? <^]B%5FK7()ZS=/B>
M"\1Z@WM&=)5+?+KL0U<^YM->[W(7.PKODW>:>$VUI<NTC'*!9/IM!_H.]Q).
M;^LT.N_>P5'H9N8((%XFB%V3;@WD(1$7BP!K:$&[M1ZD$IRY/OF16%-=?&N=
M*Z/JM'>L2O)%X/>[;E*HRXS((1"S!3&^#UI6(!_T.AW<E"\Y(12UL4*PQ?).
MY9E9M%==<A*,>0E("GTNFD V)WYI0F /.R+E$KYQ"4/964[)+1[CL&8JMG@-
M-4*\%.&7K0F/#VJ*8\%AE!E.Q1#QB8P770!*YKARS'&* NIL5C<&!V/\49-6
M%UR\H:0)ZR;8BSNN&@S8;8(!' S8;8(!]W,O?[;2O7R/KAFBT9(B2V/C+B/]
M>:F55L!/!O9!"M NJ%I83X?NI<SK*\Y(J. K[C/'):7#B2YRBS9VQ<LL-6/<
M,I,3]36:S";59TV4M9QC3\>_KB #PV0*;_4%FV97F$YO01>B8V38^ '/2X>4
MH2C0ZU/^:_WKFG^!('A:<U;6@G248>PV8 7K>_<&2">#Z83-#\S#0C+0O%J8
MJN-,!JS+5!(E;6.$(KUY@V>=CL.Y/_R2I%>@M\_#*I*FC"3$O!B;:0(]F&C<
M@3YA-W2%(G/;[1@F>X?)RX)XW.-7,"-19K&R"X1#9_@9M@N=,;GI1:K]97+*
MF_&(L,@9T1^3ST$AG#&.AL@HW_6NW"X\5;(LO70=, +PIU***8=I=[=/-W",
M:(2:N(E*>E5>;#[7#?AICJ_%/D!G<YJ=J\1D3'F)4CJ!BOP7\CT7>*H/=+WL
M(/B$&R&,47;):91TA(.*Q(#^D#_J-D(0T"QBW4 H7IVOJZ08F?X,(TV.&$..
MBWJ5XA\3I(SFG^8$^Z =C0/!2*!WV3@RD_1!3! &I#A5-\LSU?$<AN)C8;(6
MIESA;"TCF%U)$KWBZF-#V<NLM!+%5R!_'2L/XE8HYI26C1 *#W3J&KB7:1%R
MG=X)%4PSYI8 5S-JZ1)$$#YYCM>AA'Q!Z6CN-HG()X;J/1U%,1& <%G;#<Y0
MK=>1)=>8"X^R2Z27Q90N)?<617;%6^5N1>J,@TKK^/F+S[=^,.NM26QT- .F
M@MC)<-XMXM]V[[7%8FFH=N04Y9$9=PQ$@Z[+H@GBP!R47::8,EV2#?TL?:U[
M4$;J#MAJ70._M*\.)!,P&:UFNO>PN.HCD^S@J8E3+\#T^#4M*@-<%A=_UL1C
M'L @=C=W5[+[C@4:^I<0@C0+6+> SU=:P ,B&B#U9;$Z;+M_T@G0-X6IZ'MQ
M8J.LJ#Q'H?Q=#KMED(YVZP8^%S_ ?([7<YWEH*FRQ,RTY5EJ^5IW&&+$+W4M
MB)VLP[H\9D.WUO]Z$9U%A=AH/5U'W"^)V;5W%F%KJR(;AQ=1. [ &(!C(3(5
M0@EQKOV*G/OTC8 4 Y6J6Q&=M]*]V=+HLY;Y.&^P4#X;!;E.36V<45BH2(R4
ML+A(R9\#5[JA0)!-QS'U*7<PQ0(5<A_%(I]-2/^!#&)W\\5*&N@0-VN[Q8I(
M@']^6+_)\'\ @U@U&,XY+JS!1AC)D3"Q%Q&4!)\B]YRRZSY5CV.]5XD'+UGO
MY4OMQ(UM$-'X8HB["@[%Y? ![5&Q+OYVJQ&I!SB(5>/.KDB!721,G5XF&=RP
MX6Y<J*H,5$6M%#"K0',XI$8Q9RMHC(U9]YE_'.(S6D%\Z ;@1.;YZ&'GB>]_
MY,PW'VI@?#W:W5+"MI('K<+OQ(Y+U\V%8=LN>3+1*;O(ZQJ(TQ4E5IRN>'E0
M"8N@.#/7?/4>APB&WR."P64:SY)"98+=L_^$XPQ$B<%P01S]9^9(U55$@.NG
MLZDC6:\;*-6#&,3&^-N/-$IU%7Q4RK5D3?:KX J$R,2R0;*+(J*@PXQTA_4Q
MI^[I5TY27/>)7E.\$2=0<,0C=",).>(F"4U3Z\_2])CU;JLN92S##3D.D61U
M^SDRYN?L4BK1?B36OU<%Q>!/L$2V%^V14LQ,U9\1N1#!;8P>0R%-;"S4HCL]
MH[QLJ;$AQ57BR07%X09T#PG^6*)+)8B=H?8I1PWKX($U<<2NQ$-=%=MN+=2Q
M3KQ49^@SIV2G4I_I>SL&>J#2L\7*O]*Q[B(!*/E"W94GL@,*E2+0B594&(>G
ML<*8<\]RSZ(<4KP5(W#9R*=EMBAO77LWTD%+%>>IL Y;QV)ETNJEADVEJMAT
M%PCO(E1736$"=LG>:(2Z.&]EB+5C_/ZNI98Z@4$#/N9VG)81M88[B;%Z4L'#
M)KW^M?LEMRO.; ^K@MV>-V W!KL];\!N]^.Q_FDUL!MG>[=;?4KWMBYKO&/R
M/A:UYR9,+DJ3]/C0!"B'R>6YU+"Q*J5$F6;8@$%1&$H3=+M1%A'H5,H+<FA>
M\-(QKOT-@W+QO;&*,D35<:XEP8 <8!IY6?SJ,E9WMEOF>,#*AW2Y99[_0K"O
M43*,ID+C(9$D/18ILF.1) )LPK/))TI#[)$-;_F!*XJ:B0>GBL^KXB"6I-9*
M,)-FH*;<C-OSFC-2L,S+IP%4;2J+#,T5..'<MNZ)&$:8D8![&6U&CE@Z$^!0
M&&#@+V<J'<>(K')C^FPP&G5")H$Z/X=3#P^S1:7%/%*7KKC+<%Q?HF3DS+JM
M<BF\,(3'2:\P#(IH1J]'7''3%&\R:;T6.TH5$2P($J%+43*SUQX/EP>WZ@@.
M:<9;FB88[L>%#?ZZA/WUO!?=M0)^N9("]J!)H(:U*-MJ-0Z!B'^O01TGRHV@
M;0MCUX0@K3)05E%EN@F&"GJE&MSV:F]R91B?2/Q74A8,&B,AENH06BM+OKM!
MD_%#3D=R!S$K47I'V]N+@7Z%]: ,=L-GI;*_,6Q,NKI%+M-DCB\?$DD=06*#
M=#8-%C5JSK_QTB\%&P[,#[YKP+&]PMXYCU2&)K)#Z81% ?AP.PN3$/GDR&D"
M:HB2@+X.P]PB&,T3P2&HJ2R_B*:.2'FXS;,P3J\ZF\'[--,P/=..O3AH+"]-
M[PTJ$Y?[:#/)/E@>0O02._."/ZJ9 Q%9SN()G3.RBHROJ6ZSO)I*F>302?+1
MUWJ+RR @/58P['*1&.H63#QVBR]:UTZ+RP$G7'>VEWCQK%#S44% (B5+4J<H
MX(+-B7"?:R;>"FEI^N$7=;-OG :V:UF)6PU;=RL6IK TT%O)X_9[6UO-PGKY
MF!K69&Q9&MC82&]7GC4]X()U/K*>C*$9* J&(2/2QM(B.8T%)4)<JWN@IRI.
MS]-9;LH V;=LF4CA)KSAM)/(WFC>-X,^%ZGR-*",K(JQ9T)+?_]ZH-277:>/
MT VC%FS&I\"0&--:-@.-HG^V,>KH!>OKR[[FN2:1G<4B-I:%D<@<)[/XG/'I
MMB EQK=E9SE9#^7),^422U!Y#^ LJ^2^4@>O(G"[7YWK1%<RO7YPTCK2K:<Q
MT\WD4P0M:UH".I\1.4>SX.9E(/] %%=FER8#NP%G?,K:U3TU%PI>%7?\DD]&
MS3[C*S#RN(<"YO>)XT7B21%MD,N29XNR!JM[M4:X2^2/, 77JW5.L#2!@ 4*
M+< [H=M!(ZZR%7 9T,,SS$(WW*F]SGK=8/M/0-MJ)51C.)0+FLJ254[R=NN[
M)S:XC7GE+-?OF5BW?UV324S>KE(!M&OL"2E7Y&Y0)^LC@<&>@0ENAHY,]^.Y
M'"/C*)NP58>> C6<FWNI-\V4?Z<A#\BIZR\"73W9;&4;#9&F,[JZX8X)8;^3
MYN&"K,Y*NQ3FMZSRVJUZG5=G:I55-?3&#2OXML7UW%5=:^\3!CA#3966@;$W
MX, B)N&QI.E!I[#ZBK/,VKB=I'E!>14@5TSO' WYQ$MFA%) (6RW6/T9J_FD
MO]>M\;%R,1?%\27=Z PD:(CMI3-8'Y=6SW$^8?D4_[U2 (%?<8H%\*7:K[Y5
M5WGN.KO.F4I!F^-K^NMX-<IH'OXS"W/)'A4-Q8:COVV$&AOC;- U6A^L(ZUW
M"[8E%98QN0OU1\WQ=X->%R7B6V2A2C2T,2S3)=Y 7.HVUH)K'RUZO>&%J+>%
MQF'7X64I\1>4[:V;V;=Y)*<P1SXXZ]Z%9Z\T U>T8U#<0W%P\?7N&@WJI4#"
M_.UNOGKU U)Z=26-0(M2*%77<;3:*:4#Z1(\L7FH6JH\)Y2;N(6_U.<!LY6:
M&[D^0%]A3SHFZEHG4^4 O3=/;@KO$E%P>W4M4?72.QW/NNX^/6JKCGN"A.JF
M-KOC)E=HZS6MUOL@%>YGS-VDR0A[*AX^IF#.>?J7I:K9R3?$-G<R^\OOT1=A
M/#+:U;GA\V5E8<T_M%DE2"]>4+J?@14[Y_"F61ZQ]JZ;0D.^?H9FM"ESSUY4
M;.#%-NA?5*8.V;F(QY(=Q#)5,Y"IRM1YIJ87+D5DDA?93$B\HXE<03&C$6T,
MS&--0I=YC')K"32,T0S2\BDFVL[M26G8=RJS1[FO6<81#J]#F@]0VW_"$-]N
M>04N1J&>(\)Q4?YE3K</\W%=W_C:R9>KL+VBL-*AP <;34QP9*[EL'5LJ0#:
M@'G$L5^.(X I$<\Y %#R%]H;$2^-_7=><T4JKQ()&'L"H#7L 'HL+"N+ITY6
MC/B^:"*^'/%]T41\[X?F^/GM<YT/D#^LW3I57VWPP3TCG"*YG.N][- HEB36
M6;6)?E7C[.,:-#;GL1KXTZX6J4BCOGJE<%G7V:SU;G"17L'!FDFIL6H@I<2A
M,<43 G.VH&$_E]+)\BA!N\PM@N"PEY82P08WD*Z;CYBY >D[]8;I?, JURX[
M!758#OJ">+\6<*@+T8OVPC;\W0]D&"]N?W_N,?L-;8MWB'KTZUZ1%012DPAM
M,",@\3ID9)2QDNH<#LJ\\"_!9;FR]7/J=SG8-4PWF&:E@,;2G2]@4C&'Y!*#
MAQ*65\\=VP=&$"\.;^J"C=Z]7@QNP@'0#,#SFC&H9AK&0H'FCJK9/@]D&#_=
M_O8Y2-NMWYCRY)B3HEPS%@3L8P0V30PF..^K@Q3],><UEF7E&'.L?[)$D5T0
M7W5X2#0S(TFLB;T37MB0V5!]0TO?*::I?^9,PA"'8/.^-$[3E/G2OH)T+%3+
MI1*,+EZKW9JHHB"8IT>E? 7'3Y[BV5GMCVT*Y\@ 87.^2S#]CD-?7WMREE0-
MN\/,RVY),IRV,^.SJZFA83RL?-]CYW^:L*E?0B/4,K*1NQH!/):[<;38B(C&
M7E8HTUN/N((<%^USZ=P3B9*.\$[#D3N/+4=CXQ:'/@17YEW$V4=7*@+*)HR'
M]_"B&L+%-"0Q=;J?C'B9H.OX(Z*EL[_79:@\O2K>VQK'V,(Q>5&1*ZRP.XZR
MO- ]1Y\73BWZZS,7+*T!@IJ)GD3.N9+KHJAB=*FS7)>T46-TFRJZY:JR]\PI
M+K/8F4[5%Q%5C%CGV42XT9@"+C(Q)TL^/LU@UN+PG!OSMKUFTCCG,HV<+(-B
M$FN=8P(@\I[>SK4P-MPQ2_9EU\2FY-JLOQ%Q?EY6>%0>1!TZIR-R")8P5GW-
MFX/P@0SCY1W4M,)R<Z:DE5-&;C/XQ&:5!2ER ?%"UR<R@8=RT@_>IJB,':<M
M<YLE'.0"6PXLR84UZ3#K<"2U7'!'<TCJ3'(PE!Y(X/K82$V;URDN)&TX"K*F
MSBFEM5V/*EIJWN+=C36'GR"+R0C"\$VT.E[O=3R-O5VP*(*]IAV\( VCV9\/
M9!BO;G]_'CO%R-LMME4-1M]&=U*.)(/P8H05?0C0Z57+U)?Q0^(]IP*=_);$
MH%!7C+E8O8"9ZOG_J&;456)H#U-[E)D?N7BPJ2 N7<I)2@[TAY*./=Y$ \.Q
M!>Q5$I@>T@94[%%&%$ Z#]D+[1G$7K"L1*FHWY+,^6FL$ILHI'^I<7<%_][A
MZ^]8 -VR@0@T"'[\'GFY3I[NXD?D[R]-#1;MK=9ZN.-7EB</E5<W+SH_GY\I
M8@=W/JU3T;!KI?)?XS%F2)H0#E';9L4LP04FO<\HS$@<4UZSP@A .+<IZ'T]
MM<NK%-37ME]D==>@#XQPHG;$N 9% UB15RF.>0!TA2/EZXJVE9MH;.UUW;0)
M:G-/0-M\"1DHH%B2Q(-8 AB.%V!#&5_D?=Z&9B(8H62MV!=]1/&"60U!Z442
M0^'5H8 6)OG0>/405PUL_-0$-CBP\5,3V+B? W5[ZQ9.5#Q%)5\;M=VA0:+E
MP0F1+".DR]IP-NKWZ2V%/73B$KH2G'?=*Y:]XI6-0 'B%1=.S8>EQF5%'5:2
M+SP?E$2"\^!%-WC9#5[1![=U3#V7\=79J>8>W9B/#V08V]NW(^V_IB.3&,TR
M_UEAQ$E'\DKB*1:DL-.+:U+  5*.H!M<80N<X,ZA.8[M:Y9E\;*=S8D8FAR@
M^BXFET00>D,;2I@0A=G>.OS QUZ(N(=AZ)*SDJ.)L-8SV(6-J#Z086SOW(ZH
MND29[9:E,^A:I*1AR4N'+%,F2IMF#FL_VU+,@D! $@?'8P&!E7*N)9\HNWZY
M%;QYD"K6=.%@$=IF^:["R1[D,H/[3!9AQEFDWQ.TIK'UG79P$Z!S/ITR;#7"
MEXJ+#"X99[,<E'N.*',USP-=1H2J'6C7YJ<36'_T;Y/K GY5X#$_S4+V.F/9
M6PXJ\RQ9(Y#2\FRY*&WD%TS7-1IEZ/'!?),+O+>Q\P&N%&5:%7;DE&)M^G6D
M4QA:Q#-=!,6+,0T)S&S0.'GEO"3,DJ1M\+K'J=%DN?DDJB<UNL3C[(.)C(BF
MZ31:XH$,8_O9[6@)-M,H:0ED4,K3.W8<'VR]V%3[J+?3/!=!Q<EX<\^>X;*N
MLZX(\^@GA_C85*>;6&$O44GAE'AA:H*TS& 4);/,P%?%T4"S(2&;,^8PL7TW
M?@(IU67T)+*FG"=.5,('#72]RL#2S\6V*-XIKRY2X6-(Z%3O:JUIH.ZR13%E
MTD)OC*?SZY1KNSC97RZJG4(1C TEAY.72&(V/V8X>%@<L=JO2R0TC]K+<N8L
MW"+/1<>FBOK>%Q?%ZGIB'+"IF<U:.B([NV[<T3@^QJ#V9\RZ9<-7EF.6N7)H
MXK64DC?>,F#43Z4C<.ZLNF%:;IMFM5&P#V08V[NWHV#W0R&IND3P=D@))ZPX
M?C%5;SZJ*PL%'-D7X,8@S^L=@[XZY!G55U-20(N/? R:PR6 (Y%CG5J<1"'1
ML-"]@F!S*8DRP2NB8H:)&H%U,5Y3#J:"RI:K1EW6ETT9U.%<\=]-O6QTM#9I
M<NA.PW'J6%V9:3@I)&B]#Z?.%0RRV34/9!C;MX&7A5WS,44M"P)['/Z;@Y$B
M=!1>8*MBS\')^A ]MZ*;=\W R LA+J@>AM28P$IH192SGWGN6M\:1Q2G.:?]
MCN$$AOT)LB[4>LC4."NBV*AZ-^D'H;O44Q>&JI#+;A';G?,A@>R;3TEBCC,2
M<@>,P@E%#ZX?33>PMX7*AYU!"#-<EH6)3C09X@:.==ZR/K"6#;/KWF HBL6F
M"*,GY5 U>%T)JBUO$#X;1U\P72.AS"T82AR%,ZT38.JPDD@!!E,BBY3.^8XF
M@[-"5/N%<C4)B_+*TH0R+B/86"JNB:MC<.+?)F9.3A\N,^::2&BBH98E$XGN
MQ5U$;9&UD 6H]-,KSI',.SHD)<V@99(S>&V"R17UJ2O&Z\A%3O"*R:AEB_+2
M&1[2+F);$G>,NF(NK@CR3Q5HT^F@D0Z3@3Y1!1I*@E;@CT1N0U3Y;5("+U#8
M:3)%2K':PF%LT[I5C(UX=]&R&\X*7VJ,.44;RA4&MR=FW3Q.#8_"AZ3O2LN&
M*V=\>^"RR&2#3QDS-.$U,&U'R1<[,96*;HQZ@+E-R-Z,LA$R2F!%2/@S&E/V
M^0C>_XJ,8,(YX=4#WWX5;.QA)\(,3TKXP'LU)*1#^#KHV_4[,5WH\$XC-TP<
MTO$/DZ^3+NUPFY/S@0QC^S:0['!ROL\8A8=7>LXZU3!;D #]*WWULGP/-PB/
M;):WL[/I\'U&!,PKG^EBO'KNQFG<(#H)I'Z%<L8FQ")")6-U75W_H0G6L4(N
M#N/Q)NRFS4BL _.M&I%]V41D.2+[LHG(WI,&N TP/N&:Y,!7A<F@%G\4!5X_
M5S!Y[F$H#@J##><[YI6VOEW?-"*1XCB]RN^]\-8C.41NF1X1!&A[)4GI?T4^
M$:HB#:,%V1@(AES_F.[PX27H055HP%>47(*=9BH9HRS@S3U,SM4YOZ##+,3_
MH-&8)M7.5*:(!"]'X':^K:%5CZU;RE8OIXDR_W(7\XD@[R\YM06JGO,<N6(@
M=86(/,-<"BXG0J\K3!<@S;JG;'^%V25&S+I<%DHJ+.:&3(^-YB2,7[,C7/_>
M<?!1H(LZH2ZA#SK;V@"^V-U"+"0"2HHH'YUO7C((L83#T6OVC2S\D$KR*S\.
M9]!+^@JH@6-V*JAW!$-_C3,\X1+*--'NW.NNX"DK5T^WJ]4Q1H4#=7\MDT:-
MT.%M_<_D(C(2AGVP52W)Y:[71*?,<#X(W[.&:LH4Q6-7+'&6)M"@*"N2";)*
M/&$R>HN[AB!]Z?M9J"2I!P0EG>!%")I@^T<53C,-"^P#& 2HN9V5U-S KI^K
MYKC,=YGJAM&U5G#JP+:<LB(L#BJXC*#O>)T7$"XR,',JUA#UQ5#(,]C].2\5
M,I!TZLU@4%6'5;S3-8#/ZTDYNYHV3,B4;?P:=OD"]#*R8V8!VN(<]N;G'*)8
MKCSKX&W16=OLE0<P"-@KSU8S'F?( ;2]N\NV(@BE$SM<)I7?0A [@2G VR<1
MW. ,P$D0$9T.YQW3[IA3% //?+IZ%(1'-\C;A8A[\MW@IR=,8&J+'GNA2-0#
M^ABC/8@G%NT,QD PWRH^A7$&[5_RR6IPS@*8,H^&<U''FFWQ  8!VV*U^O4]
M"OD39^>^*I39'"@M2#=?Q?(CFF^6Y^60O+9ND" K49S%0'O(,8+&6%Q!DO3+
M7(#F)48?ZN\S!*B43, WO%(+8!5BDB*2X*[Y(CX627R^JB12\B@>V&S8I((^
M%:LF$5(\91X4<R;-A A/&!#9:E:)Y!H=&W+-8+_19.OCNMC^OM15%"E3[+;=
M*CF/)(E)8ZD<3@+2@.8ZRNP!UFG4M1XC@[_*&X_10]L"(#NK>8SVT@P.&5 +
M[=91>J4]BM8KD9.W@6#$.:@>I,_CYX,I/L[19/,S-2LNTDR?5TPV5;$M4[CT
M9TCI-"LTWHX"<'0ILV!$Y@M@#N U7Y7'(EJKW=)[+ Q<ADXNZCTBKS3B,M1%
M!31DR,L40H&PB:?DT7.)6RP9HDF4=;^H0\ST5\TCQD:62!RAF%PZAS)-I[XY
M4.'+$E8*3^;@$A: ,5(:5%J+$^QJ")4PND O2EA&HEG"V'\CZ@]@$"#JJUVR
M#W66*$OYB?#!"\A78Y&+;";( )>]O8R:\(]KKYB%00_\9# <XD\FR(1#G,<E
M1JLL8GGWN^[W D'HRC4\,!PW?KXT)YT(9ZF&^)4\4#0-65AI2;Q2PVI3&M]T
MG9^*?=5)&%%*A*F]S."/.=*$<Y6B@#STN,4O5#SFL9DZS**:<)IU.3'#CC&D
MJJ""4;(U[8QKHMG$#V$0L(E7<PE\C"@*]EHS0P]D/_E01$EG0)'CT =6'*(D
M"Q((;L-A27!XOK-J&8OE^\X P"1-@).1[-NF>BPV#<?;4VC^Z9!A19)PSR]*
MH:8*2SQE#$K91.Q7YI!BV8,1CJN,AX;P>B;R$M[^Q5YICUW1[AB7%W6)[UN3
M3(U<@@F.GIE/<M: ]!:CE&GZY2E($AL$$U,A4DU<8BDV*S HE BW!6=YA%34
M+$?MDJ73+"+[Q$_O\#(2FCW^  8!>WPU9XL0++5;^Y(A60(:H\EGH'XNY1&B
MX>6R@QSE=!.:1J%[@]9'N'RC&[R;/_T(YQ&?=;1W'80S(>7W0\882DT'5@]#
M(8$R29Q28:,KAH#-V$$ 9H@$H 0OE!JC#I5:J6-#-8VPA&?./&W4(X69_A-F
M+)<2&4(>+E:YII/S-^ZW,WZ_:F!8#,-ZU<"P[DE%O/BV@!EM'RY\1DKB'__U
MZG4),(GH<K0:J4\^:9O*L+88V?Y4U1GWS<;7CK>GV$8W2=M13HG+'N-BE<M;
MV'>_,VB\,>]4#?>Z4J6ON J4L>,KM967?P<3MO^W(YF1TR@SNHXGR-(BU!;=
MXD\Z]W$TXRM5@Q%Q,F,R)7WC2H6N:$29!FA\*/(\3";X$F6BFP0+*I< FI4K
M%T;$G\S,8+$NQN24IB.'%%LBVZ^>[9K"5DZ%"FZ"KQ)($B6I7=9?@513E&1*
MP[.YB7G(H[!ML4Q4+V)RB;N.':5*%>6M\35Q3AI:'M0?#WQAH[0*-,S@+Y1O
MX0S(95JCD:V:0MS32;YU50AUWYGGE0UD3?:N#SR-R=*I".62-BZ1&=OUXUF6
M1/F%7QZJJP,L8\0B;SSO6$B30SM@$WD$E"]?Q70$W1%++"=\!QKL5#ZI2X.E
M;-8HUH@]UA?ENS%_%*:E,4T?1$!A^S8H#LE%[^2)M%O7)8K4,-<(08VDW-#5
M#MT@F$F5.A@(2=FTG*6X+QPBMA 34\GRM1W"8H:<I"_TQ;H&HRE4I#-0R?&B
M$4_$5&.H;S9+3C#CN*W4@/"?<SK"E#F<QH1&41D''5Q&"D/E/'5=-T<*V4&<
MQ*Y@.AKKU"CG*=L\YVSADV9O?MH\V0S&X0AS>=NM_LG@EP/&K(R#G:VM+?C<
MYODFJ)&KJTVTZK&M36BF4YVETD28#(C%4U(Y%PPW J$;Q-T83@OWVLUY9G(D
M:$)_S6?):<MC9M0KPX.BW,A1-V":(LK2$Y(92_IBYPZ/6S?#'BXME\PL[M11
MD#R[!=1@=9;)CB8WKZ%"<L?'PZG-(*MFC@G'DUSN?!+J@\/32L%3)<%Y)^]P
MI!TM\V7A^79+C^/E]M;.ANIL[)JJF7OH DWA)%)T9K+) G\=P1E[=#'/B6H<
ME@K6RBTJO6A8)OF0DMV(1T= B@X3 ZY! @?U-*2/2450PZ(!5D:FWZ+JHJ;V
MFC!A)E[NW%,AL'(^6>Z46T-FK'DP71N@Y!CG_');"YDPC/SQVL'J>:*/RW!+
M=6O.[&.89JM39!&)47+]D#+P+:DFT>ZZ8>@[M#^*VQW#F\';/XZIZKMW6:(C
M@$JQ,0X"EC?&'.RS6"5?7@>ELT(P#'^^^7'P=D5WQO96X\]@?\;VUM_>H7%?
M F^,O7;K2&P=T7YU(KQF WPDUO_@H-WZ/#@]Z)^<!)\_](_[A^^[GIN98B(C
M_^QBFV(TXPI.QEAWLI>Z? B#W9OR<QKSP#5TQ!(H.VTQ65W'D>6VS65$2/T]
M[O/LM/?N8S_8ZW_\>'+4VQL<_/+/)UM/Z-]'O?U]_>^5AWH5C8H+?'3K!Z.]
MAW".J&D.'=)_>T+:Y\WI\:H?>*+5UNE^L'>(73_XYY.=;^CG)1JF8.#HM6 5
M6KL^M[D6[P:'OPWZ/(;!P9X5KM-]9V3?/1HX(>Y\*"6Q@@' _QS?QL+>VF**
M,#[[X>[7=?[S'2UE:2P[/_VPP"K:WGRN[:*_8.UO6WAEN#]MW?W:K8$@W_$,
MD,WJN=?N5I;O>#A[LQ3)HK';^VFC8==8,$^1/N6N->M=2V/_D#O]#S4!F3G*
MPIP*XSU2P?R1#,NW-W 1;-^/8^ FE^#'?.^^S87_ Z[9BV_9>,G^\ZYOV<W-
MZ''>C'J_'/?[^SR&WL%^T-O;ZQ^=]O?O2OO_U7KR@1S@(I6[?X69?8<WOA=K
M/A[W#O1BK>] ZZB+/AQ^W.\?-YIGG:\.C^$B>_<J9FW%<!W5RA__L_2_/YN%
M;O3-XQU#(X;W$F"Z\T!$HR0;Z?SFZ'^1K[EX_A(FC&;%CA^IK$BP*&8CDO<L
MDKK?]RA#=_/)Q8OL?&\]UJ0YQ,P EAYAC;I88]%\9*'RQMIZQ++Z&*+G/8/C
MY+YS]#'-YH]4,IWP^=+@^3VAZM<L>/Z=\69X],YCSN\/CW]MMP[?!R>?WIWL
M'0^.3@>'![<9-+^/0=P^&!U[C<#G^^G_QFG:;IV%DJ@74('02L:^H!HZZSO,
MNUFF&X'8;Q?"?IK^C#03&CWM(:?7=U37P4]<N$D9CB+?]T EJX[\FG2G;["2
M:L]3-)V^Z6R6P6T]D4/R>]K8W+GEK(K%+7V.DG.J9@PK_%_;V]MVA9T#_UO&
M<M?F(A)G!"O\QV4\)-?9*7LGV3:2WVL+<C!Y<I1EX64ZI!*NE'U,Z;26OFS5
M7FA.-*G!;I@B.4?(J^ *9DE7D^V:UPHG=W9CNQ.4[T"K]6:#WND('\R;DT]'
M;[??_(A_!!LX*9P6_>;36UNSD-.A*<M9&/'&P;LH_2T*@T$RW&3>RE7Z@ .B
M''RL/XM)GW.= ^X-+-A'S%F6!QO_K7_4X=DP\R1<':8>QHI+XV1_YY3,3*LA
MW"P>29UFI LPK=Q)Y9?ZL:;/W>#J(LU7[(8:C3)D)8ER=P(V*P:X9WQ_\WER
MG59MCH_F^&B.C\ [/O398,^#89J@+,B&15XH-(]1O?Y@^""P,)JA[BA38JS6
M%R%T\.O=&%[AC;-.Z3./5'G<B1%]ZT+F"DZU:I,IZ8?ERL*1T+E5JSU(X08I
MFXA4M7P4.6S2=30RDG=LJ!+P'AFG5UJ"^<@5HJNE'[451N_G+M, YU<\=% O
M?,^AL?N\A-M%JHT'"]>13K^\XS[O(Q/0TBY?G]RZNNC\M(8K\:P,^[[[3G]/
M@.3VM]':+%C3T?7N:"/V#ZZC3'*V/'9YFP=%,^G-SEC716HZVHC]HU^DZR"!
MS6'0[(IFD9J.-F+_-UBD:]-(FM.@V1;-(C4=;<3^;[E(34<;L;^+1?HNTHD;
M=/HF#3UYN]%C/%.GD:2UE:3'9Z<^HJ$\U(XV6^=QRMLC&LIW=;24 B98N"H2
M[E9QF"Z&Z29(P1O^]SV#N9D94,%@+<DDO"- F<W.J]+]8B'*ISHW;U&*8LU\
M6-#.\Q^>>"^Z:^=D,5)#LF=L"J/N&B8-RO^Z28->[U;'3:\ZC0M'B^-P\&T>
M:OKFJ:D>0'HQ[-F F9]%2>T&=+(5RN_6?G>0Y(C11>@C(_AM443&^&,%,:EC
MINNK*%-MK]W2N,H-S#>0+("AXNP[Q84756Q20SC'!.O.1MP8U2Y3A*24*HL.
M#CC"# .L*6<*XG;H&V'$U<3Q,Y@DD<Z*=FNBOG 1T7F@1C@\2IB@\FNC4<2U
MLOPZK5).C4N.YOI'\D^N<T=ET+G>*\S2'/\.7[W@OG:]VGW8<?OA=LO'(3O#
MZNJBE?6%AC=%*U<1R<MRB9\UN<2W3<1]']F=;SZ][9U@3<U?^P>GF$C49!'?
M"_CY_>%QN_5;[^.G?G#<W^L/?NOOLVKZMGPXK $-7U,YOLDH<5W],Z?ZH_*Z
M5'J4?SG?$D!\[3<H#0PT\11K4XNBJ6CI<I7L82J95Z:'ND@6_@":)\1[-\!J
M6S^OW?+]';'K=X"IWKUK>#(R[?! 0#Y[M#O"\+Z1XW<.PA9?WJ,;UT&Z:19/
MI[K6>3*,C;(NBF--#ZV_H]9;N<//[S_EHLG8J1>==<S8V;G_A*^'[A*^'=+,
M1]7N0U^R![K'FFR31S;IC3)[!.T^]"7[&^ZK)E/B+^_H0]\5:ZQP&D7VM]E7
M#<K_K^]H+9S@VH#B;A-07-. 8O]?'P;O!J?M%O,4]IB;L DNWN,2_'&8M%MQ
M6$#+%Z$:270.>:+^;-9AJ;^\S-:[><N<?<?A.,Q0Q;5;46X)OT8A1U950827
MRL9?@Q'Z3H.#]#*DD.NSK6ZPL[6SK8DOX76F- Z0T3A0T)=+-5+!,,VF::8(
MY^*SAHHD.+2AW78+OGY='8<N-+X?QNI*96$01Y,(^X4 FR3,\HMH6OH,.T2<
MK_PU=,NWO8"/2!;_&+QOMWI'1Q\'>W@N_QF<NAR("!\:A9:V-5##8J9B'?HG
MC,%\&E8P "A;N.(O7B-V:QH5\ Z#F^KQ1B5T4KM%+<,/HB3RL%O0I6@8(HTC
M?S# _P>Y/0N#40@:9T+L>[ ?,KW'\+=I$B)J:@('=A!>PD02H&J8)HS)0IZ]
MLYS,#@-NH'[2%BT1-@8GR,E7V\J%N@R#)+T*TN%PEB'R 7Y/(:H1D]'*S 17
M47X1:GK*<91-:N;63JF>LNMF99/6K@SY @US,IM.XW BHS,DA!DVI%4$<1;*
MV/43,(WTOIG++G,(0[_BF,@.LS26#L'<3[.0*0IIK N6ME$ #VPH%05PD!:X
MQ>S)=!Z!L'LP0TUMN;OYO$R;:C3%.(WC](K0D :0N)%W>).<A="B/?',ZS^W
M6W^ OAEFT9D+9(3NYV#(8&.,'X*]KJ(8)?-<94AR&TS"XB(E(P>NS\-9; 5Q
MK) *EM0-HSO=!Q#=J6!__MG(Y0,;RBEHGG9+F+_U$<3V!*X:?!2K$OD4[.,L
MG1@EN]B* 37&,LK-Z8,JG:)(=#6R=R/J" N[)C5OM\:S.)Z#O1.-2+22-%%Y
M'N8YG6@+3T#+E,ZX./BZDH.LS*5^#:\Z=<(>?BGVLM+-X%Y[V6[5=M,>T7PL
M*3B"HB'U@)L_THMV1)_01UOE])/%99O!X!.UNLG""=K)<'[_&W02F; .\%KE
MVH3Q&'EWFS/I80^E_S4<S@I$I)+]@3(Y4O,Z,<1[T/^X'/SK/.P&6[4L3^G!
MIV;?:O!-*A1AM[PJ1=_C]/T[!:LL$N_!>N -[NZA]_#9SH/OXO9=K_-#DNX'
MNACK"3[X&TQF(\U-M]:Z6XVXWFNW5JM-WJCB1K;7>0&:;C7B^F 7X!2=W(TI
M_."0:<\9C/47HM*6U*Y'WHYWA_N_$X''A]-?/[[]_U!+ P04    " #W28%3
MZ=G$1;P,   ?(P  &@   &)I=FDM,C R,3$Q,S!?.&ME>#DY>C$N:'1MW5IM
M4R,W$O[N*O\''<GML56V>4LV"3A4C(&LLRQ+@-VK?-3,R+;"C.35:&R<7W]/
MMS3V&-B\U+%W5Y=48CPCM?KEZ>ZG!?W7MV\OCMNM_NNSP2E]WHYN+\Z.^SOA
M$P]VZC<G[TY_P2?]V[\2-[>_7)Q]OS6VQA^*O;V9%T.9Z\3ICGBM\KGR.I4=
M<2--V;U13H^/1"'=1)M#L7LDO+KW72R?X&NJC%=NZ_B%2<K947_GZOASG= _
M.3[1]H-6X:@;E59.E>+]3'@KI/AR_^O>KGBK\UQ;(TY5XMNM<YGJ7/NE6&@_
M%8.Y,I42'R /.\6[V<PZ7QGM-<2<5R;KB(O>54](D_WQ6C$:Q>7]G9/C3]G]
M'<R^41.KQ/M1IR1;R_^R-W^M2J_'2W;GM3*V(RX_=."N5!6)<F*O(_9W]_?(
MIJ##"Y/)<GHD@NO;K9%)>QVQ?3FX.1W\?"A.1A]&+\7VBSS[6-FC&!_'7X1U
MPD^5B.^&MIA)LXPO7R)B::X-U,Z[I9<3)=*P0&1JKG([TV8BM#%V+KV>*Y&Y
M:D+BG)PA!.W6.$KW3DE?P&W"CH51E;.YG9!4#B,_R-1$&6P,<G1I7:9<&<RC
M13*;2Y.J3.18X&B%DJ7JA 4<$+S3AE&6 5=BW(15N_69<+4]M'FN4M(Z7]9>
M)),?R*!=9>W6=FOF[%QGY+V*,P-Y$2PI8FIP+I <3<?"45_N/5@QAD28+#TO
M2W-;*H''EW8>0'*P&U#2^ZP ?<X<@+3@OW\J(>&S64XASL@_,^D\T+%VRU/N
M%;(4"VQS"LM50!\ ++W,EZ7O.IU.R2/[';&8TL_:I'F5(:320"L]DYX/FW4!
M>6 0^\38V4(D%H?:RHFK*?01^PGP3"$!EI%9^[M[D"2<&CN9>NN64"/5GL5F
MM*W="OL.UMLNSP[V=K^A;8/\MZG2A7(O7$FFEYTZ,4NI,S&L+#!RB@(P/'O'
M!W+R]FJDW4YU*8PUW4SG%:<.P8)P%1 &+:IRY;5V*T5BPAWD4B_O%+WT4V>K
MR524R&B'5W=JN4IZ ;"ITEL3K<&VLN)L0"& TQ""56;6Z4V.PN$3)XN2+)19
M!@1; VD:JB$<^(+:$((5X.T1\-J[3WGI2KH[;4IK:B_5^0_MD0#P@;J?(0L#
M6*82?D <UV%$^<ELY4D4@6>L7>FQ+!^W6SB',,'F/5+FX*E(/RIH4^ -@5=D
M8KDT&3"CNC*M(.A.9P;^U.;7RBU[,;3/EBW/FGO#J<Q0/5PA#=8HHY$]5XCT
MV*+<B+?2H/R[)WLT)U^'6@-Y1&6==FLSD=4])03')E%B82F8DW4N>R4+JF/
M]EPKCJ#*9P)Z8Q62>"$=-8E%C-&JVZP:#2U"B4!Y-CZB/:*YW:I,H;PH5,9X
M-DIEY?]V'-#R!PF!]?>ZT._1F;]ZX.WC<OJXXY7PJ+KC4AP*BT@I!;CB:(/\
M1ZS:K=)2%4)Z<Q#U9-J=.+OPTXZ81\FQ '43F=X1(E0Z-40&EAS<7(^50/54
MJ">1:D"!GOB3*HYMBH(6>$2>+Y'<9BV%<1'3EUJG \F;0X523>I$IE=PS!T
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M;;?>N=E4FL#O4X!;9]0F8T_<CES 5G3FN"HA.K@6K#S7X&-EJ<W+3L#I^>E
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M-%!9B[C08W63:C'(YO2K7 3CXF+X2%;3$L3!ND/QQ2[&J6_. :7WQTG!*OQ
MM\)EJF645=\W]G=H_\J;_&73^?^FIY^*Y],B(WG]([*^?R3>A3Y_*"[H"NS_
MF+M_BET#!.%O7/H[\<]B_@502P,$%     @ ]TF!4]G'I^K]"@  @(8  !4
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MMZ4=S;-H70,"VC4A:0F# @5R!\)2!&AF\A"OP/R+8#$,EYK2#RPMJW94*EF
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M^L@8"/L-)FR/0B3>3XH(S1P?"/!C:R#QWU%O/#P:D9"/9I1SE] 1 >KE5?9
M[']@8O?K? 7@;Q?N^FXO+7#V.T6 ^/]\+?B/U")%X($J)A-[25< ]D?&0.H7
MF-0]"E%YWXH$2GMK"LY_\&$?R$-"/6 Z)KSP:&"/Z3#N"G,H<I2<LU8F*O9_
M*5%@Z#O&4.0H:6B-Q(:!]S.E]IP)CBI^:RARE 2T3F3#S&^%86;M9@ ^9^GX
MQX/3?=;'5E#&*$FG3Q0*V_))@S!N8B/$]] 2RA@EUPR)0^'<MWH4X4.1T-5'
MN@Z!/C*%DD;),8/R4% _*)82M1ZQN'[0.+:%PD;)+,,"46@_D=4PL:K8A!53
M@_70O46@[%'22I!<E! ,12S57.X\+N[+S)Z/Z[Y,@D-Z34%H.%#RS1=(1PG*
M=9)87'KSYXX)V@V%HM(</$>$%X" S%>"_>QEV,_@V%'RT%J9KP3[^<NPG\.Q
MH^2BM3(QL??MQWOU))>>&6BO,10Y2BY:(Q$3>'ZEN5</2BY8L4*JCOI1"2AZ
MQ!0U+!:UPQ<7>4AO+RVAO!'3U6IQF)P?I#:$_\?F=7>2U?90YHB):TAHTP\8
MB[B[AQ:^I40')E"^*+EJI9RFD;H(*TK\W7?? @H4)0&M$M,PSSOIYCYF4@2?
MQQY;0;FB9)(^44T/O&X]L?:>^CM?@U>PH0RKAS(:QOA-,6,]Z,LTS<3F&8UG
M5LQC"L6+DOX%Y36,>B0YBYEA8OK)WB$J1G@UYRH[*&249,\OK&'"#XJZ2%-[
MVYVOXW(;#M3]9.(;>4/V4.(HN5Z]4%SR0ZTSJE[*OZ(4- HH:1]4=-/C#(TS
M.^RMNV?C)[=CQC/*'%E!6:.D?#Y1#;/]+)\4<3OW1NMT++E_>TBE(90P2H(7
MD-8PY#T_JO$>F$#!HF1VE7*0QH3;53PC8DK]JQ>J+:& 43*]D#BTL7<*&GNG
M+QQ[43(^GR@DML7:<'M&W8\YFQ+_3K)@ ? ^&TSB :E-[]_+M_RX/=TJS?T8
MV _5V#VF4. X6R1#\II&G27,T*1P:< $$;%-J;;[VCS9>7TI: !P]E "1:,\
MWO]&.?\HY%*,*-%2T*2XU0\]X?<6@48!<0ZQ1BY*"+Y*GEE**E\(JCSG@,<4
MBAQQ[M C#V?M9;&H>7OM*5[>$2+N*P$%CSB)&!:+M#[-4.<S6]#WQ)"-AR'^
MOA)0_H@3BF&Q:.OG5=]>>*8R/&=^8 BEC;@4ME(:"N112CB_R3035 ?'E@-#
M*&3$-:^5TE @WZ943>V@]D')I9EM]G:&8'L*0*$CKFP-2L6!O_JQC[S8_Q8D
M7V$-?CL!(G:O2*S7;L2Q6TA17,E%0I2'>L@>RAUU8Z5?:,/D[\V,JMW[I]R9
MH<W;0HL>ZDM!HX"2KD)%XUQ;=W;R!R^M>W90WHB):94PG#U3V9BS>, E"=Z7
M[YE!^2)FH16R4/#>$/&LLKF)UP]*QI2ZZ1.]/=L "1&P FA($//3%Z' >5P@
MT]1M)I+Q\VAF1>O[S.3O,K7^!1\:!,M!0X.YB1,@'.DN2/_8Z$63F_4CG5#E
MEBD\T96YL0T]AV^* ,6A\4%]HQ 80T68+CM'NN[L ?>VVN(;]\N]D=4>^1]0
M2P$"% ,4    " #W28%3C3'J\S0#   "#   $0              @ $
M8FEV:2TR,#(Q,3$S,"YX<V102P$"% ,4    " #W28%3;DC:NJ,<  #?O@
M%               @ %C P  8FEV:2TR,#(Q,3$S,%\X:RYH=&U02P$"% ,4
M    " #W28%3;TBTJHO(  !N^P0 &@              @ $X(   8FEV:2TR
M,#(Q,3$S,%\X:V5X,3!Z,2YH=&U02P$"% ,4    " #W28%3CJLQ8(Q"  !A
M_P( &@              @ '[Z   8FEV:2TR,#(Q,3$S,%\X:V5X,3!Z,BYH
M=&U02P$"% ,4    " #W28%3*O5_1GQ"   6W@$ &@              @ &_
M*P$ 8FEV:2TR,#(Q,3$S,%\X:V5X,3!Z,RYH=&U02P$"% ,4    " #W28%3
MZ=G$1;P,   ?(P  &@              @ %S;@$ 8FEV:2TR,#(Q,3$S,%\X
M:V5X.3EZ,2YH=&U02P$"% ,4    " #W28%3V<>GZOT*  " A@  %0
M        @ %G>P$ 8FEV:2TR,#(Q,3$S,%]L86(N>&UL4$L! A0#%     @
M]TF!4W2O5/=:!P  XU<  !4              ( !EX8! &)I=FDM,C R,3$Q
@,S!?<')E+GAM;%!+!08     "  ( "<"   DC@$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
